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ABSTRACT 
The organization of the plasma membranes of mammalian cells has been studied for over 
forty years, with our understanding evolving from the fluid mosaic model of Singer and 
Nicholson to a more nuanced model acknowledging lateral heterogeneity in protein and lipid 
distributions. Within this area of research, lipid rafts have received intense focus, perhaps 
because they have defied easy characterization. They are thought to be sphingolipid- and 
cholesterol-enriched features tens to hundreds of nanometers in size dependent upon cholesterol, 
although their composition and size are still debatable as are other characteristics such as their 
lifetime, location, percent coverage of the membrane, and their mechanisms of formation and 
maintenance.  
The capability of chemically assaying the lipid composition at relevant size regimes has 
been unattainable by any single technique until the recent application of high resolution imaging 
mass spectrometry to biological samples. Using a high resolution imaging secondary ion mass 
spectrometry instrument (NanoSIMS 50, Cameca), we have chemically mapped the distributions 
of labeled sphingolipids and cholesterol within the plasma membrane of murine fibroblasts with 
sub-100 nm resolution. This required the incorporation of non-perturbing heavy isotope labels 
into lipid molecules of interest and sample preparation that preserved native lipid organization. 
These experiments have revealed sphingolipid-enriched domains with an average size of 
200 nm that adopt a non-random clustering into micron-scale patches in the membrane of 
fibroblast cells. Analysis of the cholesterol distribution reveals a relatively homogeneous 
distribution throughout the membrane that does not colocalize with sphingolipid-enriched 
domains. Depletion of cholesterol alters the surface coverage of domains and their long-range 
organization, but does not affect average microdomain size or short-range organization. These 
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results are contrary to the lipid raft hypothesis, which states that lipid rafts are biologically 
relevant to cell function, they are defined by enrichment of both cholesterol and sphingolipids, 
and their formation is driven by the interaction of these two molecules. These results contribute 
significantly to our understanding of membrane organization and may reshape the conception of 
lipid distributions within mammalian plasma membranes. Further studies using this methodology 
to chemically image mammalian cell membranes may also elucidate the mechanisms that 
produce lipid heterogeneity and the purposes these domains serve in the cell. 
Imaging mass spectrometry, in conjunction with multivariate analysis, has also been 
applied to the analysis of cell membranes for the purpose of classifying cell type or 
differentiation state. Cells display a characteristic combination of proteins, lipids, and glycans 
based on their origin or developmental state. Time-of-flight (TOF) SIMS samples the full mass 
spectrum, to which multivariate analysis such as principle component analysis (PCA) or partial 
least squares discriminant analysis (PLS-DA) can be applied. Such analysis reveals characteristic 
patterns of peak intensities rather than single ions, which can be used to classify or predict cell 
type. Using this approach, we were able to predict the differentiation state of primary 
hematopoietic cells harvested from mice with better than 88% accuracy when the cells in the 
training set and the test set were from mice of similar age and a restricted peak set including only 
ions known to originate from biomolecules was utilized to build the PLS-DA model. We were 
also able to distinguish, with some success, murine fibroblast NIH-3T3 cells that differed only in 
the amount of sialic acid expressed in the membrane. This technique will be of use for 
characterizing cells grown on substrates that exhibit spatial variations intended to guide 
particular stem cell fates, where bulk measurements are inadequate and location-specific 
information about cell identity is needed. 
 iv 
 
ACKNOWLEDGMENTS 
Although this dissertation bears a single name, it was in truth a collective effort. 
Completing my doctorate would not have been possible without the love, support, advice, 
friendship, and commiseration of many. 
My greatest thanks go to my advisor, Professor Mary Kraft, for giving me a second 
chance to earn my PhD and providing me with an interesting and fruitful project as well as many 
hours of thoughtful conversation. I could not have asked for a better advisor. 
Thanks also go to my labmates who collaborated materially with me: to Dr. Chris 
Anderton for insightful talks and welcome coffee breaks; to Haley Klitzing for her good humor 
even in the longest hours spent at Livermore; to Bill Hanafin for his tireless help in countless 
problems and projects; to Rayna Kim for her help with fluorescence microscopy and in keeping a 
good attitude; to Robbie Wilson for his help with everything from instrument training to new 
software; and to Dr. Kaiyan Lou for his contributions to all of us. 
I thank my friends who provided the support and guidance I needed to move forward 
even as they were working on their own doctoral degrees: Bryan Hart for his willingness to 
answer endless questions about biology; Crystal Randall for her steadiness and great stories; Abe 
Qavi for inspiring me to be a better student, scientist, and person; and Teresa Martin for her 
frankness and her willingness to be a sounding board. Thanks to Maggie Donnelly, to Jennifer 
and Jonathan Kemling, to Nikki Held and Dave Cervantes for many wonderful times together. 
Thanks to Mark Geiger, for everything. 
 v 
 
Everyone who has worked in large organization knows that no one succeeds without the 
help of amazing secretaries and staff. I want to thank in particular Julie Sides and Martha 
Freeland in the chemistry department, and Vania Petrova and Tim Spila at the Frederick Seitz 
Materials Research Laboratory. I also thank Drs. Peter Weber and Ian Hutcheon at Lawrence 
Livermore National Lab for allowing us access to their laboratory and equipment that enabled 
our work. 
Thanks to Juraj Cech, for all the good and wonderful things he has brought to my life. 
Thanks to my mom, dad, and my brother for forming me into the person I am and giving me the 
love and support I needed to succeed. 
 
 “A man's work is nothing but this slow trek to rediscover, through the detours of art, those two 
or three great and simple images in whose presence his heart first opened.” -Albert Camus  
 
 
 
 
 
 
 
 
 
 
 vi 
 
TABLE OF CONTENTS 
CHAPTER 1.          INTRODUCTION ...................................................................................... 1 
CHAPTER 2.          DIRECT CHEMICAL EVIDENCE FOR SPHINGOLIPID DOMAINS  
                                IN THE PLASMA MEMBRANES OF FIBROBLASTS ............................ 22 
CHAPTER 3.          SPHINGOLIPID DOMAINS IN THE PLASMA MEMBRANES OF  
                                FIBROBLASTS ARE NOT ENRICHED WITH CHOLESTEROL ............ 95 
CHAPTER 4.          IDENTIFYING DIFFERENTIATION STAGE OF INDIVIDUAL  
                                PRIMARY HEMATOPOIETIC CELLS FROM MOUSE BONE MARROW  
                                BY MULTIVARIATE ANALYSIS OF TIME OF FLIGHT-SECONDARY  
                                ION MASS SPECTROMETRY DATA.................................................... 128 
CHAPTER 5.          DISTINGUISHING CELLS BASED ON THE AMOUNT OF  
                                MEMBRANE-EXPRESSED SIALIC ACID USING MULTIVARIATE  
                                ANALYSIS OF TIME OF FLIGHT-SECONDARY ION MASS  
                                SPECTROMETRY DATA ....................................................................... 161 
CHAPTER 6.          CONCLUSIONS AND FUTURE OBJECTIVES ..................................... 175 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1 
 
CHAPTER 1. 
INTRODUCTION 
The Plasma Membrane and its Lateral Organization 
 Even though it is a basic structure of the cell and accessible via optical microscopy for 
hundreds of years, the plasma membrane and its organization continue to be areas of intense 
study and contention. The membrane separates the interior of the cell from its environment and 
serves as the interface through which the cell mediates many functions, including adhesion to the 
extracellular matrix or other cells, endocytosis of nutrients or foreign bodies, transduction of 
signals, and selective permeability of ions and small molecules. Understanding membrane 
organization will provide key insights in how the cell performs these functions, many of which 
are likely to overlap with matters of interest in human health and disease, as countless human 
illnesses involve the membrane. 
The membrane is fundamentally composed of a lipid bilayer with associated and 
transmembrane proteins, and is intimately connected to the underlying actin cytoskeleton of the 
cell. The plasma membrane was originally considered to be a passive barrier, and one of the 
original conceptions of membrane organization described by Singer and Nicholson’s fluid 
mosaic model depicted the lipid and protein components flowing within a two-dimensional fluid 
with only the most transient of interactions occurring among them.1 Forty years of subsequent 
research have shown this model to be incomplete and have replaced it with a more accurate and 
sophisticated understanding of the lateral organization of the plasma membrane. Discovered 
early on were caveolae (“little caves”), flask-shaped invaginations in the membrane which are 
lined with the protein caveolin that give the structures their shape.2 These features lend 
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themselves to visual identification through their characteristic shape in addition to their unique 
composition.  
Not all such compositionally-distinct features in the plasma membrane have proven so 
easy to delineate, however. Lipid rafts, features believed to be tens to hundreds of nanometers in 
size and enriched with sphingolipids and cholesterol that provide platforms for concerted protein 
function (Fig. 1.1), have evaded thorough characterization despite the effort of many researchers 
over several decades. Basic parameters such as their size, surface coverage, location, lifetime, 
and organization as well as the pathways that create and maintain them and the roles they play in 
cell function have been difficult to determine and remain controversial.3 
 Lipid rafts—also called lipid microdomains, detergent-resistant membrane (DRMs), 
detergent-insoluble glycolipid-enriched (DIGs) membranes, and glycosphingolipid enriched 
membranes (GEMs)—were originally isolated using a method of detergent extraction that gave 
rise to many of their names. It was observed that some components of the membrane did not 
solubilize even in high concentrations of detergent, and suggestively, this DRM fraction was 
enriched in sphingolipids, cholesterol, and some proteins observed to cluster in the membrane, 
creating an association of the DRM with lipid rafts. Rafts are thought to be enriched in 
sphingolipids and cholesterol, which associate preferentially and with a greater degree of order 
than is present in the phospholipids that dominate the bulk membrane, according to the results of 
several studies.4,5 This property, in theory, allows the bulk membrane to be solubilized under 
certain detergent conditions without disrupting the lipid rafts, which then can be isolated and 
compositionally analyzed.6 Detergent extraction is still employed by some as a method for 
identifying lipid raft-associated proteins and lipids even though the DRM fraction is not identical 
to intact plasma membrane domains; the structures that are isolated through detergent extraction 
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are not representative of native membrane features. Instead, species that natively reside in 
different membrane structures or compartments are artificially incorporated into the DRM 
fraction.7 
 Evidence for lipid rafts also emerged from the field of virology. The study of influenza, 
an enveloped virus that exits its host cell by budding through the membrane and taking a coating 
of the infected cell’s lipids with it, revealed that influenza viral envelopes contained a higher 
proportion of sphinoglipids and cholesterol as compared with the bulk membrane of the host 
cell.8 Influenza directs the synthesis of its own proteins but does not possess the genetic material 
necessary to direct the synthesis of lipids, and so it was concluded that the virus exploits the 
naturally-occurring lipids in the cell membrane to form the envelope.9,10 However, there are 
other potential explanations for this observation; perhaps the transmembrane regions of the 
inserted viral proteins actively attract this mixture of lipids around it,11 or measurements of bulk 
membrane components incorrectly included lipids from the intracellular membranes such as the 
mitochondrial membrane or the endoplasmic reticulum, which are known to have distinct lipid 
compositions from the plasma membrane.12 This hypothesis is not based on direct evidence of 
the presence of lipid rafts in the membrane but merely invokes them as a convenient way to 
explain the unexpected result of enriched sphingolipids and cholesterol in viral envelopes.  
As lipid rafts are thought to be enriched in cholesterol, cholesterol depletion has long 
been used as a way to perturb membrane organization and to observe the effects on particular 
membrane components. This is commonly achieved using cyclodextrins, cyclic oligosaccharides 
that have an internal cavity that selectively accommodates cholesterol and can remove it from the 
plasma membrane when incubated with cells.13 Cholesterol depletion can also be accomplished 
metabolically using cholesterol biosynthesis inhibitors.14 Some proteins that form clusters in the 
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membrane will reorganize upon cholesterol depletion, which has been interpreted as a result of 
the cyclodextrin removing cholesterol from the lipid rafts, thereby abrogating sphingolipid-
cholesterol interactions and dispersing raft components into the bulk membrane.15 Many studies 
visualizing the organization of membrane components or their interactions employ cholesterol 
depletion to observe the effects on the localization or diffusion of the protein or lipid of interest. 
However, cholesterol depletion appears to have more far-reaching effects on the cell membrane 
and morphology than simply changing the lipid composition in localized areas,16 and the effects 
of cholesterol depletion may stem from processes not directly related to lipid raft dispersion.17,18 
Ultimately, studies employing cholesterol depletion are inferring information about lipid 
organization and do not directly assay the lipid composition within the membrane. 
Characterization of Lipid Rafts 
Since the emergence of the aforementioned evidence and widespread recognition of the 
lateral organization present within the plasma membrane, a great deal of work has been done to 
characterize lipid rafts within the context of the membrane to reach a consensus on their basic 
physical properties and functions. Because some proteins appear to cluster within lipid rafts as 
ascertained through detergent extraction, and there are several experimentally convenient 
methods for labeling proteins including the use of fluorescent or gold-labeled antibodies, 
information about lipid rafts is often extrapolated from observations of raft-associated proteins 
using fluorescence or electron microscopy. This provides a method for observing putative lipid 
rafts not only in intact cell membranes but also in live cells.  
 A wide variety of fluorescence techniques have been applied to studying the protein 
organization within the plasma membrane. Confocal microscopy allows the visualization of a 
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thin section of the sample by excluding out-of-focus light from the detector, providing a way to 
examine only proteins within the plane of the membrane while also offering improved spatial 
resolution over wide-field fluorescence microscopes. An entire cell can be imaged and observed 
over time and under different conditions, and the colocalization of two proteins of interest can be 
explored using two antibodies bearing different fluorophores. Förster resonance energy transfer 
(FRET) probes interact on length scales of ~10 nm, making it possible to evaluate whether two 
potentially raft-associated species are in proximity more frequently than would be expected for a 
random distribution or if they form a complex, testing their colocalization within discrete 
domains.19,20 
Time-resolved methods provide information regarding protein movement and diffusion. 
Membrane components contained in rafts are expected to exhibit distinct diffusional behavior 
from components in the bulk membrane, as manifested by slower diffusion rates or by diffusion 
confined within a small volume; these expectations stem from the assumption that rafts are 
characterized by a greater degree of order or tighter packing of lipids, and that components that 
selectively incorporate into lipid rafts will infrequently escape to diffuse within the bulk 
membrane. The percentage of putative raft-associated molecules that exhibit anomolous 
diffusion behavior can be used to predict the prevalence of lipid rafts within the membrane, and 
the area within which a “trapped” lipid raft-associated species diffuses suggests the raft size. 
Total internal reflection fluorescence microscopy (TIRFM) can be used to observe individual 
membrane proteins by exciting fluorophores using an evanescent field that extends only about 
100 nm into the sample. TIRFM is frequently used to conduct single particle tracking 
experiments (single particles in this context being single biomolecules) and diffusional studies to 
determine if proteins of interest are contained within rafts and do not exhibit free diffusion in the 
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membrane.21 Fluorescence correlation spectroscopy (FCS) also provides time-resolved 
information by tracking how long a fluorescent particle remains within a well-defined 
illuminated area, and can be used to not only determine trapping of proteins within rafts, but can 
help elucidate the biological mechanisms behind membrane organization.22 
 Studies have also been conducted using fluorescent lipid probes to elucidate the 
composition of rafts within intact cell membranes. Mueller and coworkers23 used stimulated 
emission depletion (STED) microscopy combined with time-resolved FCS to study the diffusion 
of several fluorescence lipid analogs within a region 30 nm in diameter on the level of single 
molecules. The authors generated a set of fluorescent lipid analogues mimicking four types of 
saturated phosphoglycerolipids, four types of unsaturated sphingolipids, and three types of 
gangliosides, and observed the diffusional behavior of these analogues sequentially (that is, each 
fluorescent probe was tested one at a time) in live PtK2 (male rat kangaroo kidney epithelial) 
cells by illuminating a small volume in the membrane and extinguishing fluorescence in the 
surrounding area using stimulated emission. FCS data is generated by averaging thousands of 
transits of the fluorescent molecules within the illuminated area, generating an average focal 
transit time which can be compared to the average focal transit time for a freely-diffusing 
molecule. The deviation from free diffusion (i.e., longer average transit times) the authors 
observed was more pronounced for the putative raft-associated species such as the unsaturated 
sphingolipids and the gangliosides, particularly as the focal volume interrogated was reduced in 
size. They attributed this observation to the formation and dissolution of molecular complexes 
formed in the membrane; however, it is uncertain that labeling a small portion of the cellular 
pool of lipid species and averaging thousands of transit times reveals the true average behavior 
of the lipids. Alternatively, averaging thousands of observations may have obscured useful 
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information about the diffusional behavior of single molecules. Moreover, the chemical 
composition of the membrane must be inferred from the indirect diffusional information, and 
while the data suggest the formation of molecular complexes, such complexes are not observed 
directly. Other probes have been developed, including fluorescent cholesterol analogues,24,25 
which are useful in some contexts but have the same limitations as noted above. It is an 
interesting phenomenon in the field of lipid rafts that techniques that probe very small volumes 
within the membrane or that focus on single molecule tracking often conclude that lipid rafts 
must be vanishingly small and consist of only a few molecules, in contrast to the larger 
assemblies of several hundreds of nanometers in size that are observed using confocal 
microscopy. Curiously, many fluorescence techniques determine a size for lipid rafts that is 
compatible with the resolution of that technique, an observation that has not been explained and 
which contributes to the ongoing controversy concerning the size and nature of lipid rafts. 
Electron microscopy, including transmission electron microscopy (TEM) can be used to 
image membrane samples with exceptional resolution. Immunogold labeling is convenient for 
identifying proteins of interest, as electrons pass less easily through heavy metals than they do 
organic material and cause gold nanoparticles to appear distinctly dark in TEM micrographs. Not 
only can clusters of proteins be imaged, but each gold nanoparticle (typically 2-10 nm in 
diameter) is easily distinguished, allowing cluster and pattern analysis of labeled proteins. Hess 
and coworkers26 used gold-labeled antibodies to visualize the influenza protein hemagglutinin 
that was stably transfected into a cell line derivative of NIH-3T3 murine fibroblasts (the Clone 
15 cell line) and using TEM, found that hemagglutinin clusters non-randomly within the 
membrane, sometimes with hexagonal or trigonal packing patterns. They also noted that protein 
clusters were correlated with electron-dense regions of the membrane that were visibly darker in 
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TEM images, which is suggestive of distinct lipid compositions in these regions. However, the 
lipid composition of these dark patches has not been elucidated. Similar approaches have been 
applied to visualizing the clustering of other proteins, including the high affinity IgE receptor 
FcεRI, GM1, Thy-1, and GPI-anchored prion protein, to better understand the lateral 
heterogeneity within cell membranes.27,28 Cholesterol depletion is frequently employed to show 
that protein clustering is cholesterol-dependent and to make the case that the proteins must be 
clustering within lipid rafts with a distinct, cholesterol-dependence composition.29 
There are several main caveats to using microscopy for studying membrane organization. 
One concern with antibody labeling, separate or in conjunction with fluorescence labeling, is the 
potential for crosslinking of antibodies or aggregation of fluorescent labels. Such behavior could 
cause clustering that appears to arise from association of the protein of interest with rafts but is 
instead artificially induced by the label. In addition, whether protein clustering is due to 
interactions with proteins in or associated with the cytoskeleton, as opposed to interactions with 
distinct lipids, must be inferred; no direct evidence of lipid rafts is acquired. Lipids in particular 
present a challenge to probe via fluorescence, as lipids are such small molecules in comparison 
to the fluorescent moieties attached to them and modification can easily change the polarity of 
the lipid and induce non-native behavior.30 Furthermore, even if fluorescent probes that exhibit 
high fidelity to native behavior could be developed and imaged with excellent spatial resolution, 
they still would not provide chemically-specific composition information about the neighboring 
unlabeled molecules within cell membrane. 
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Imaging Mass Spectrometry 
Unlike fluorescence and electron microscopy, imaging mass spectrometry (IMS) is 
capable of providing direct chemical information about a sample surface. It is a surface 
characterization technique that creates an atomic and elemental map of the sample surface. The 
primary ion beam is systematically raster-scanned over the sample, generating and extracting 
secondary ions from each location from the surface that are collected and transferred to a mass 
analyzer. From the mass-to-charge (m/z) ratios measured for the secondary ions, information 
about the chemical structure of the parent molecules in the sample can be inferred. The data can 
be used to generate a chemical map of the surface, where the intensity at each pixel denotes the 
amount of analyte detected in that location.  
IMS has been used in parallel with traditional histology to analyze biological samples 
such as tissue sections for some years, the gross structures in which are compatible with the 
lateral resolution of IMS (on the order of several microns).30 As the technology has advanced and 
achieved better lateral resolution, it has been applied to single cells as well.31,32 There are two 
basic modes of SIMS analysis, static (discussed below) and dynamic SIMS. Dynamic SIMS 
employs an ion dose high enough (more than 1012-1013 ions/cm2) such that the number of 
incident primary ions exceeds the number of atoms in the sample surface, ensuring extensive 
fragmentation of the sample molecules.33 This produces high-yielding monoatomic and diatomic 
secondary ions, enabling trace analysis and generating elemental information about the sample. 
The primary ion beam is operated in continuous mode, and erodes the sample over time, 
allowing for depth analysis as new surface layers of the sample are exposed with each raster. 
Dynamic SIMS provides the highest resolution at ~50 nm, which is compatible with membrane 
features such as lipid rafts that are thought to be tens to hundreds of nanometers in size.  
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The NanoSIMS 50 (Cameca), a high resolution imaging secondary ion mass spectrometer 
(SIMS) (Fig. 1.2), is one such instrument capable of analyzing biological samples with high 
resolution. It features both Cs+ and O- primary ion sources for generating negative and positive 
secondary ions, respectively, and the configuration of the primary and secondary ion optics is 
coaxial rather than oblique, resulting in improved secondary ion capturing and overall sensitivity. 
Up to five or seven secondary ions, depending on the NanoSIMS model, are detected in parallel 
using a magnetic sector mass analyzer with sufficient mass resolution to distinguish the 
interfering isobars 12C15-N- and 13C14N-, which differ by less than one one-hundredth of an amu 
(26.9996 versus 27.0059 amu). In order to use this instrument to visualize the parent 
biomolecules, which requires the identification of the parent molecules using monoatomic and 
diatomic secondary ions, component-specific isotope labeling is necessary. While destructive in 
principle, evaluation of the analysis depth reveals that with the use of monoatomic primary ions, 
secondary ions are ejected only from the first few atomic layers (~3 nm).34 This depth is 
compatible with the cell membrane, which is considered to be ~7 nm thick,35 enabling the 
selective chemical imaging of the membrane without sampling from the material lying beneath 
it. Thus, NanoSIMS analysis is best suited for elemental and trace analysis that requires 
exceptionally high resolution and surface sensitivity, and is an excellent tool for imaging the 
distribution of isotope-labeled membrane components with ~50 nm lateral resolution. This 
technique was demonstrated to be applicable to isotope-labeled lipid bilayer films as a proof-of-
concept, detecting heterogeneous lipid features as small as 100 nm in diameter.36,37,38  
A related and more popular technique is time-of-flight (TOF) SIMS, which is operated in 
static mode. In contrast to the high ion dose used in dynamic SIMS, static mode employs an ion 
dose that is a magnitude of order smaller than the number of surface atoms in the sample (less 
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than 1012-1013 ions/cm2),33 operated in a pulsed rather than continuous mode. While this 
approach generates fewer secondary ions, fragmentation is minimal and results in larger 
secondary ions and intact parent molecules that can be identified through their m/z ratios. This 
technique is best suited for analysis of unlabeled samples where lower lateral resolution is 
acceptable (~1 μm) but the generation of a full mass spectrum is desirable. The utilization of a 
TOF mass analyzer enables the detection and generation of the full mass spectrum instead of a 
limited selection of secondary ions, as is detected using the NanoSIMS instrument. The limited 
lateral resolution of TOF-SIMS is insufficient for imaging nanoscale membrane features, but is 
useful for imaging other types of biological samples including single cells. Collecting a complete 
mass spectrum of secondary ions from the sample surface enables TOF-SIMS to be used in 
conjunction with multivariate analysis (MVA) to exploit patterns in peak intensities and reduce 
the complexity contained in mass spectrometry data to glean information about the biomolecules 
expressed on the sample surface.39 The following section explains one more specific application 
of TOF-SIMS to biological samples. 
Multivariate Analysis (MVA) Applied to TOF-SIMS Spectra of Biological Samples 
 One challenge inherent to IMS of biological samples is the narrow range of elemental 
variety in cells and the high degree of structural similarity between related biomolecules. 
Frequently, insufficient secondary ions are collected in TOF-SIMS analysis to distinguish 
biomolecules of interest, whether they are proteins composed of the same set of amino acids, 
lipids with similar head groups, or glycans with identical sugar residues linked in distinct 
sequences. Small secondary ions that are detected in adequate yields are often common to 
several parent biomolecules and therefore unusable for parent molecule identification. A 
successful approach to overcoming this challenge uses MVA to distinguish changes to the global 
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pattern of peak intensities rather than relying on changes in individual (and potentially 
unidentifiable) peaks in TOF-SIMS spectra of biologicals. 
 Principal component analysis (PCA) is a form of MVA that reduces complexity in a data 
set by constructing new variables that are linear combinations of the original variables that 
capture the greatest possible amount of variability in the data set (Fig. 1.3). In other words, the 
method seeks to identify commonalities among the original variables and construct a new, 
smaller set of uncorrelated variables, thereby reducing the dimensionality of the data.40 PCA is 
computed by finding the eigenvectors and the eigenvalues of the covariance matrix (covariance 
is the tendency of two variables to vary together). The covariance matrix is square and 
symmetric, calculated by centering the data and rotating the matrix until the diagonal elements 
are the variances of the rotated variables. The rotated variables are the eigenvectors, and the 
variances are the eigenvalues. The eigenvector with the largest eigenvalue is the first principal 
component, the eigenvector with the second largest eigenvalue is the second principal 
component, and so on, until most of the variance in the model has been captured. By applying 
PCA to TOF-SIMS spectral data, information about small molecular weight species that is 
typically unusable for analyte identification becomes valuable as it contributes to the new 
variables, or principal components. The method has been used to distinguish different types of 
tissue from mice,41 different types of microorganisms in a culture,42 as well as other applications. 
 Partial least squares discriminant analysis (PLS-DA) is another form of MVA related to 
PCA that extracts useful information from complex TOF-SIMS spectra. It uses a set of known 
calibration samples, called a training set, to construct a linear regression model that identifies 
predicted and observable variables and projects them onto a new space. When applied to TOF-
SIMS data, the new variables are the linear combinations of mass peaks that are most useful for 
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separating distinct classes of samples. This PLS-DA model is then used to predict the 
classification of unknown samples; consequently, PLS-DA is a supervised technique for which 
the classifications are predefined and the variables which most accurately determine 
classification are sought.43 This is in contrast to PCA, an unsupervised method that seeks to 
capture the greatest amount of variance in the data set without predefined classifications. For 
example, PLS-DA applied to TOF-SIMS data was recently used to discriminate between rat 
esophageal epithelial cells (REEC) and NIH-3T3 murine fibroblast cells.44 First, cells of known 
origin (either REEC or NIH-3T3), constituting the training set, were analyzed and used to build 
the model. Then, cells of unknown origin were analyzed, and the TOF-SIMS data was input into 
the PLS-DA model to predict the cell type, which could not be accomplished by SIMS alone. 
The authors found that the unsupervised PCA model alone could not clearly distinguish the cell 
types, but the supervised PLS-DA model could identify the unknown cells based on the 
information provided in the training set. 
Scope of the thesis 
 This thesis describes the use of IMS to determine the distribution of membrane 
components and, in conjunction with MVA, determine cell type or differentiation state. This was 
accomplished through two related but distinct experimental approaches. High resolution SIMS 
data of fibroblast cells was acquired using the NanoSIMS 50 and analyzing cells in which the 
membrane components of interest were metabolically labeled with identifying heavy isotopes. 
These data reveal the distribution of sphingolipids and cholesterol with <100 nm lateral 
resolution. The second experimental approach involved TOF-SIMS analysis of unlabeled 
primary hematopoietic stem cells from mice or of NIH-3T3 murine fibroblast cells with varying 
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amounts of sialic acid presented on the membrane in combination with MVA to determine cell 
type based on complex spectral information. 
 Chapter Two describes the development of the application of high resolution SIMS to 
biological samples for the purpose of determining sphingolipid distribution. High resolution 
SIMS has historically been applied to geological samples and required optimization for delicate 
biological samples such as cells. In addition, the metabolic isotope labeling method used to 
incorporate nitrogen-15 into sphingolipids and carbon-13 into all lipid species is described. The 
effect of cholesterol depletion using methyl-beta-cyclodextrin (mβCD) was also evaluated. The 
goal of this work was to establish the viability of high resolution SIMS for studying membrane 
organization and to determine if the distribution of sphingolipids was homogeneous or 
heterogeneous in the plasma membrane of mammalian cells. 
 Chapter Three extends the methodology described in the preceding chapter to 
determining the distribution of cholesterol, the other component hypothesized to be enriched in 
lipid rafts. The metabolic labeling scheme was expanded to include cholesterol labeled with 
oxygen-18. The effect of cholesterol depletion with mβCD was investigated to determine the 
effect on cholesterol distribution in the membrane. Work was also done to evaluate how much 
cholesterol is removed under the standard depletion conditions used and how quickly cells could 
replenish the removed cholesterol. Confocal microscopy was used to evaluate the effects of 
cholesterol depletion on the actin cytoskeleton. 
 Chapter Four discusses the use of TOF-SIMS analysis and MVA to distinguish primary 
hematopoietic stem cells taken from mice. Cells were harvested from bone marrow, sorted into 
three different groups based on differentiation state as assessed by antibody labeling, and affixed 
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to substrates before TOF-SIMS analysis. PCA was used to identify peaks that were important for 
discriminating cell differentiation states, and PLS-DA was used to create training sets that could 
predict the differentiation state of unknown cells. 
 Chapter Five covers a related study focused on a single cell type, NIH-3T3 cells with 
different levels of sialic acid expressed on the surface. TOF-SIMS and MVA, including PLS-DA 
and PCA, were used to analyze and differentiate these sample types. The goal was to evaluate 
whether this approach was sensitive enough to distinguish very similar cell types based on 
different amounts of a single component, and if TOF-SIMS and MVA were compatible with 
profiling cells based on membrane-expressed glycans. 
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Figures 
 
 
 
Fig. 1.1 Lipid rafts are compositionally distinct features within the plasma membranes of cells 
that are purported enriched in sphingolipids and cholesterol, which adopt a different packing 
structure than the bulk membrane dominated by phospholipids. Some proteins preferentially 
cluster within this different chemical environment. Adapted from Ref 43. 
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Fig. 1.2 A schematic of the NanoSIMS 50 (Cameca) depicting the relevant components required 
for instrument operation. A feature of particular note is the co-axial optics for the primary and 
secondary ion beams, which minimize the focal area of the beam and enhancing secondary ion 
collection. Once collected, secondary ions a magnetic sector mass spectrometer for m/z 
determination. Reproduced from Ref 36. 
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Fig. 1.3 A visual representation of principal component analysis (PCA), in which linear 
combinations called principal components (PCs) are defined that capture the variance within a 
data set. The first PC is typically defined such that it captures the greatest amount of variance; 
subsequent PCs are defined such that they capture the greatest amount of remaining variance 
within the data set. 
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CHAPTER 2. 
DIRECT CHEMICAL EVIDENCE FOR SPHINGOLIPID DOMAINS  
IN THE PLASMA MEMBRANES OF FIBROBLASTS 
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Introduction 
Lipids play important roles in eukaryotic cells, serving as structural units that establish 
the plasma membrane and bioactive signaling molecules that regulate cellular function.1 Spatial 
organization within the plasma membrane is critical to coordinating lipid signaling and numerous 
other processes that occur at the cell surface.2 Thus, the hypothesis that lipids are organized in 
compositionally and functionally distinct domains within the plasma membrane has been 
investigated for decades.3 Microdomains with a variety of lipid compositions and dependencies 
on lipid and protein interactions may exist in the plasma membrane,4–8 but the most intensely 
studied lipid microdomain model is that of lipid rafts.9 Lipid rafts are defined as dynamic and 
small (10-200 nm) plasma membrane domains that are enriched with cholesterol and 
sphingolipids.9,10 Despite intense research, the distributions of most lipid species, including 
cholesterol and sphingolipids, within the plasma membrane remain ill-defined. Moreover, the 
inability to directly visualize lipid domains without the use of potentially perturbing tags and 
inconsistencies in the reported sizes of lipid domains have evoked skepticism in the concept of 
compositionally distinct lipid domains7,6,11,12 within the plasma membrane.  
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Here, we used chemical imaging as a direct approach to lipid detection to decisively 
answer the question: How are sphingolipids distributed in the plasma membranes of intact cells? 
We focused on sphingolipids because 1) they are believed to be segregated within 
compositionally distinct lipid domains, such as lipid rafts,9,10 2) their ability to form hydrogen 
bonds within the headgroup exceeds that of other membrane lipids,9 and 3) sphingolipid 
metabolites play important roles in regulating cell survival and proliferation.1 We studied a 
transfected mouse fibroblast cell line that stably expresses influenza hemagglutinin (Clone 15 
cell line) because sphingolipid and cholesterol domains are thought to be associated with the 
hemagglutinin clusters within the plasma membrane.13,14 To visualize the sphingolipids with 
respect to the other membrane lipids, we metabolically labeled the cells so that the cellular 
sphingolipids (i.e., sphingomyelin, ceramide, and glycosphingolipids) contained nitrogen-15, and 
all membrane lipid species (i.e., sphingolipids and glycerolipids) contained carbon-13. We then 
employed a Cameca NanoSIMS 50—a secondary ion mass spectrometry (SIMS) instrument with 
as good as 50 nm lateral resolution—to image the cells. The lipid-specific isotopes were imaged 
to map the distribution of the parent lipid species.15 This high-resolution chemical imaging of 
metabolically generated 15N-sphingolipids within the plasma membranes of intact cells enabled 
us to quantitatively determine the sphingolipid organization. We found that sphingolipids were 
segregated within ~200 nm diameter domains that non-randomly clustered into sphingolipid-
enriched plasma membrane patches with micrometer-scale dimensions. We emphasize that these 
sphingolipid assemblages are not necessarily lipid rafts and should be referred to as sphingolipid 
domains, as we did not directly assess the cholesterol enrichment that is integral to lipid rafts. 
 
 
 25 
 
Results 
Metabolic labeling achieved high level of molecule-specific 13C and 15N incorporation  
We metabolically labeled Clone 15 cells using uniformly 13C-labeled fatty acids and 15N-
sphingolipid precursors, 15N-sphingosine and 15N-sphinganine, such that the 15N-sphingolipids 
reached a steady-state distribution in the plasma membrane without resulting in the incorporation 
of nitrogen-15 into cellular proteins.16 The uniformly 13C-labeled fatty acids varied in chain 
length and degree of saturation to ensure their incorporation into all sphingolipid and 
glycerolipid species, presumably producing an even distribution of 13C-lipids in the cell 
membrane. This global labeling of most lipids with carbon-13 allowed evaluation of plasma 
membrane integrity and detection of spatially dependent systematic errors in sensitivity or 
heterogeneous lipid distribution caused by artifactual lipid clustering that may have occurred in 
preparing cells for SIMS analysis. Approximately 80% of the N-palmitoyl sphingomyelin, the 
most abundant cellular sphingolipid we detected, contained one 15N-isotope, and 13C16-palmitic 
acid was incorporated into approximately 80% of the N-palmitoyl sphingomyelin (Fig. 2.1). 
Little (<2%) nitrogen-15 enrichment of phosphatidylethanolamine due to 15N-sphingolipid 
catabolism was detected for these labeling conditions, so nitrogen-15 incorporation into non-
sphingolipid species was negligible. Approximately 60% of the fatty acids in the cellular 
glycerolipids were uniformly 13C-labeled. The cells were prepared for SIMS analysis by 
chemical fixation in glutaraldehyde at room temperature, followed by osmication, a procedure 
known to immobilize lipids since osmium tetroxide acts as a multivalent cross-linker.17 This 
procedure produces a membrane whose organization is retained during the inevitable drying 
process needed for introduction into the vacuum of the NanoSIMS analysis chamber.17 
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NanoSIMS images show uniform distribution of cellular lipids in the plasma membrane 
The distributions of 13C-lipids and 15N-sphingolipids in the plasma membranes of intact 
cells were visualized by simultaneously acquiring the 12C1H-, 13C1H-, 12C14N-, and 12C15N- 
secondary ions with NanoSIMS and constructing quantitative 13C- and 15N-enrichment images. 
Secondary electron images that show cell morphology were collected in parallel to the secondary 
ions. The quantitative enrichment images were constructed by ratioing the lipid-specific ion 
signal at each pixel to the naturally abundant ion (i.e., 13C1H-/12C1H- or 12C15N-/12C14N-), which 
minimizes signal variations induced by sample topography and produces a value that depends on 
the local abundance of rare isotope-labeled molecules.18 This ratio was divided by the 
corresponding natural abundance ratio, producing an “isotope enrichment factor” that quantified 
the amount of 13C-lipids or 15N-sphingolipids in the plasma membrane compared to an unlabeled 
(natural abundance) cell.18 The isotope enrichment factor was color-coded and mapped to the 
corresponding pixel in the output image. After calculating the moving average over a 3-by-3 
pixel window, the lateral resolution of the enrichment image was 87 nm, compared to the 70 nm 
diameter of the analysis beam. Based on operating conditions and the sputtering rate determined 
on other biological samples,19 we estimate the sputtering depth was 3 nm, much less than the 
thickness of the plasma membrane (7.5 nm), ensuring that a minimum number of secondary ions 
were collected from the underlying cytoplasm.19,20  
The secondary electron images of a representative Clone 15 fibroblast cell (Fig. 2.2) 
show the cell had normal morphology, and the plasma membrane and microextensions were 
intact. The 13C-enrichment images (Fig. 2.3) show that the 13C-lipids, which include both 
sphingolipids and glycerolipids, were continuously distributed in the plasma membrane of the 
Clone 15 cell, confirming that the labeling, sample preparation, and NanoSIMS imaging did not 
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create artifacts, and that the plasma membrane was intact. Also, the 13C-enrichment images of 
the cell (Fig. 2.3) show no local elevations in 13C-enrichment that would signify a regional 
excess of lipid material, which might be caused by the detection of intracellular vesicles docked 
to the plasma membrane or fixation-induced lipid aggregates. Finally, the isotopic ratio did not 
vary as a function of distance from the nucleus. Moreover, in a control experiment, NanoSIMS 
imaging of unlabeled cells showed no significant 13C- or 15N-enrichment or variation, further 
demonstrating that cell topography is not a significant factor in the context of the analysis of 
isotopically labeled lipids in the plasma membrane (Fig 2.4). 
Sphingolipid-enriched domains are present within the plasma membrane 
Metabolic labeling achieved 15N-isotope incorporation into more than 80% of the cellular 
sphingomyelin, allowing the location and density of sphingolipids in the membrane to be 
mapped with relatively high signal-to-noise in the 15N-enrichment images (Fig. 2.5). The 
presence of distinct membrane domains enriched with 15N-sphingolipids is evidenced by local 
elevations in 15N-enrichment dispersed within a matrix of lower 15N-sphingolipid abundance on 
the surface of the representative Clone 15 cell. Similar microdomains enriched with 15N-
sphingolipids were also detected on >25 other cells we imaged. Based upon the analysis of 
59,301 3-by-3 pixel subregions on the Clone 15 cell shown in Fig. 2.5, a 15N-enrichment factor 
≥12 is at least two standard deviations (2 s.d.) above the mean 15N-enrichment factor for the 
domain-free regions (7.8, 1 s.d.=2.1), and therefore represents a statistically significant elevation 
in the local 15N-sphingolipid enrichment in the plasma membrane. From the 15N-enrichment 
images of this cell (Fig. 2.5) and others (Fig. 2.6, and Table 2.1), the 15N-sphingolipid-enriched 
domains were more abundant on the main body of the cell than its extensions. As discussed 
above, based on the 13C-enrichment images, these areas of 15N-enriched domains cannot be 
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explained by a local excess of lipid material caused by the presence of intracellular vesicles 
adjacent to the plasma membrane or fixation-induced lipid aggregates. An excess of all cellular 
lipids within the 15N-sphingolipid domains would be detectable as a concomitant elevation in the 
13C-enrichment. The 13C-enrichment factors in the domain and non-domain regions on the Clone 
15 cell are not statistically different (Kruskal-Wallis test, p= 0.99), confirming the local 15N-
sphingolipid enrichment was not caused by excess of lipid material. Debris on the substrate near 
the cell was also enriched with 15N-sphingolipids, consistent with previous reports that 
fibroblasts deposit lipids along with other cellular material when migrating.21 Other Clone 15 
cells exhibited similar characteristics (Fig. 2.6). 
15N-enriched material is not nonspecifically adsorbed on the cell surface  
We performed control experiments to test whether the 15N-enriched domains on the cell 
were actually isotope-labeled material adsorbed to the cell surface. Fixed, unlabeled cells that 
were placed in labeling media for 30 min did not have 15N-enriched domains (Fig. 2.7). In 
contrast, 15N-enriched domains were detected when live, metabolically labeled cells were 
incubated in label-free media for 30 min to allow the endocytosis of material on the cell surface 
(Fig. 2.7). Thus, the local elevations in 15N-enrichment are plasma membrane domains enriched 
with 15N-sphingolipids and not isotopically labeled material adsorbed on the cell.  
Fluorescent sphingolipid domains are present in plasma membranes of live Clone 15 cells 
To further confirm that the 15N-sphingolipid-enriched domains are not artifacts of preservation, 
we compared the distributions of fluorescent sphingolipid analogs in the plasma membranes of 
live and glutaraldehyde-fixed Clone 15 cells. This work was performed by a collaborator, 
Vladimir Lizunov, at the National Institutes of Health in the laboratory of Joshua Zimmerberg. 
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Fluorescent sphingolipid analogs were biosynthetically generated within Clone 15 cells by 
metabolically labeling the cells with BODIPY-sphingosine for 2 h. Subsequently, the cells were 
incubated in unlabeled growth medium for another 2 h to allow for the removal of 
nonspecifically adsorbed material from the cell surface and the delivery of newly synthesized 
BODIPY-sphingolipids to the plasma membrane. Total internal reflection fluorescence 
microscopy (TIRFM) imaging of the plasma membrane at the bottom of the cell revealed a 
fluorescent plasma membrane that contained patches of high fluorescence. The highly 
fluorescent patches were stable for several minutes and did not exhibit movement characteristic 
of transport vesicles, indicating these fluorescent patches were plasma membrane domains 
enriched with BODIPY-sphingolipids. Similar to the 15N-sphingolipid domains observed using 
high-resolution SIMS, the fluorescent sphingolipid patches were irregularly shaped with 
dimensions between ~300 nm and 2 µm, and they appeared to be more abundant near the center 
of the cell. The microextensions of the representative cell also appear to be strongly labeled with 
BODIPY-sphingolipids. Elevated levels of BODIPY-sphingolipids were observed on the 
microextensions of some but not all of the Clone 15 cells we examined (Fig. 2.8). This finding is 
in contrast to the absence of 15N-sphingolipid domains that were detected on the cellular 
microextensions with SIMS. The high fluorescence signal detected on the cellular extensions 
with TIRFM may be attributed to the detection of both the dorsal and basal plasma membrane on 
these thin extensions. This small discrepancy in the SIMS and TIRFM results may reflect a 
difference in the composition of the dorsal and basal membrane on the cellular microextensions. 
Subsequent glutaraldehyde fixation reduced the contrast in the fluorescence microscopy image 
but did not alter the appearance or induce the formation of additional BODIPY-sphingolipid 
domains (Fig. 2.8). This absence of a general change in lipid organization following 
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glutaraldehyde fixation, and the similarity in the appearance of the sphingolipid domains that we 
observed in live cells with fluorescence microscopy and in fixed cells with SIMS, further verifies 
that the 15N-sphingolipid domains we detected were not artifacts of cell fixation or SIMS 
imaging. Overall, these experiments support the hypothesis that the images of the sphingolipid 
organization we obtained with high-resolution SIMS are snapshots of the sphingolipid 
distributions that were present in the live Clone 15 cells.  
Size and coverage of 15N-sphingolipid domains are independent of fixation temperature  
We performed temperature-of-fixation control experiments to test whether the room-
temperature fixation used in our experiments could induce domain formation. Low temperatures 
can induce phase-separation in model membranes and artifactual sphingolipid clustering in the 
plasma membranes of unfixed cells.22,23 This artifactual sphingolipid clustering does not occur 
after preserving the cells with aldehyde fixatives similar to those we employed,22 so lipid 
rearrangement in our experiments could only have occurred when the cells were first exposed to 
room temperature glutaraldehyde. We compared Clone 15 cells that were chemically fixed with 
room temperature and 37°C glutaraldehyde solutions. The 15N-enrichment images of the cells 
fixed at 37°C (Figs. 2.9 and 2.10) show 15N-sphingolipid microdomains that are similar in 
appearance to those in the membranes of cells fixed at room temperature. Thus, as suggested by 
our findings on live cells, low temperature-induced sphingolipid demixing did not drive the 
formation of the 15N-sphingolipid microdomains we observed in the plasma membrane.  
To specifically assess whether room temperature fixation increased the size or abundance 
of the 15N-sphingolipid domains on the cell surface, we compared the mean sphingolipid domain 
size and surface coverage measured on cells fixed with room temperature and 37°C 
glutaraldehyde solution. The 15N-sphingolipid-enriched domains in the membranes of cells fixed 
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at both temperatures exhibited both circular and oblong morphologies, where the length of the 
longest axis ranged from roughly 100 nm to 2 μm. We quantitatively identified the dimensions of 
the sphingolipid domains using a particle definition algorithm that defined the domain centers as 
the pixels in which the 15N-enrichment factor was at a local maximum and at least 2 s.d. above 
the mean 15N-enrichment factor for the non-domain membrane regions.24 The domain edges 
were located by expanding out from the center until the 15N-isotope ratio dropped below the 
Gaussian diameter, which is 13.5% (1/e2) of the 15N-enrichment factor at the domain center, or 
until another domain was encountered.24 For each of the Clone 15 cells that were fixed at 37°C, 
we identified more than 1,400 sphingolipid-enriched domains that covered 8 to 13% of the cell 
surface (Table 2.1), consistent with the surface coverage estimated for liquid-ordered domains on 
live cells at 37°C.25 The sphingolipid domain surface coverage measured on each Clone 15 
fibroblast cell fixed at room temperature was very similar (9 to 15%). Because the majority of 
the sphingolipid domains had irregular or oval boundaries (Fig. 2.11), we characterized the 
domains in terms of their area and equivalent diameter, which is the diameter of a circular region 
with the same area. The sphingolipid domains on the Clone 15 cells fixed at room temperature 
had mean areas between 0.029 and 0.038 μm2, and mean equivalent diameters between 180 and 
205 nm (Table 2.1). The sphingolipid domain sizes (Fig. 2.11b and Table 2.1) measured on the 
cells maintained at 37°C are not statistically different (two-sample Kolmogorov-Smirnov test, p= 
0.98) from those on the cells fixed at room temperature. Thus, the surface coverage and size of 
the sphingolipid domains were independent of the glutaraldehyde fixation temperature.  
15N-sphingolipid microdomains are clustered in the plasma membrane  
The frequency distribution of sphingolipid domain sizes (Fig. 2.11b) illustrates that most 
domains had effective diameters smaller than 300 nm. This suggests that the micrometer-size 
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domains visible on the cells are actually clusters of multiple microdomains. To quantify the 
sphingolipid microdomain distribution on each cell, the x-y coordinates of the microdomain 
centers and cell perimeter were tabulated and analyzed. For all of the cells we quantitatively 
analyzed, the sphingolipid microdomain density was higher on the body of the cells than on their 
extensions (Table 2.1), confirming our earlier conclusion from visual inspection of the 15N-
enrichment and fluorescent microscopy images. Next, we quantitatively assessed whether the 
observed spatial distribution of sphingolipid microdomains on the body of each cell deviated 
from a random distribution at different length scales, and whether this spatial distribution 
depended on the fixation temperature. We performed a modified Ripley's K-test on the 
coordinates for the centers of the sphingolipid microdomains located on the cell body.13 The 
Ripley's K-test statistic, L(r) – r, calculated as a function of distance for each cell is shown in 
Fig. 2.11c. For both temperatures, the L(r) – r values are larger than the 99% confidence level 
(CI 99, data are normalized so that the CI 99 equals unity) at radial distances between 0.2 and 5 
μm, indicating the sphingolipid domains are clustered over distances of 0.2 and 5 μm regardless 
of fixation temperature.  
Next, we investigated the frequency distribution of nearest neighbor distances, which is a 
measure of the shortest distance from the center of a sphingolipid microdomain to the center of 
the closest domain. The nearest neighbor domain distances observed for all of the cells have a 
maximum frequency between 200 and 300 nm (Fig. 2.11d inset), indicating the nearest neighbor 
distance was not affected by fixation temperature. Because this nearest neighbor distance is only 
slightly larger than the mean effective domain diameter calculated for each cell, the edges of 
most domains are less than 100 nm from those of their nearest neighbors. To assess whether the 
sphingolipid microdomains organization is nonrandom on the cell body, we compared the 
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frequency distributions for the observed microdomains to a simulated population of randomly 
distributed microdomains on the cell body. The plot of the difference between the frequencies of 
observed and simulated nearest neighbor distances would be a straight line at zero if the 
microdomains were randomly positioned on the cell body. Instead, the frequencies of nearest 
neighbor distances observed between 200 and 300 nm were higher than expected for a random 
distribution (Fig. 2.11d), and nearest neighbor distances between 300 and 800 nm occurred less 
frequently than expected. This finding that the sphingolipid microdomains are positioned more 
closely to their nearest neighbors than would be expected for randomly distributed microdomains 
suggests the microdomain clusters we observed are a nonrandom characteristic of membrane 
organization.  
We further assessed the sphingolipid domain organization in the membrane by comparing 
the frequencies of pairwise domain distances measured on the cell to those calculated for the 
simulated population of randomly distributed domains. The pairwise domain distances are 
measured between the centers of all sphingolipid domains on the cell body. The difference 
between the frequencies of observed and simulated pairwise domain distances is shown in Fig. 
2.11e. For both fixation temperatures, pairwise distances less than 10 µm were observed more 
frequently than expected for a population of randomly distributed domains, and radial distances 
between 15 and 20 µm usually occurred at a lower frequency than expected. Thus, fixation 
temperature did not affect the long-range sphingolipid organization in the membrane. 
Furthermore, the significantly higher than expected frequency of pairwise distances observed 
between 5 and 10 µm for all cells suggests the clusters of multiple sphingolipid microdomains 
are more abundant at regions of the cell body that are 5 to 10 µm across.  
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 Based on these results, we conclude the sphingolipid microdomains cluster into larger 
sphingolipid-enriched patches that are more abundant within multi-micrometer regions on the 
cell body. The use of room temperature glutaraldehyde solution to chemically fix the cells did 
not alter the sphingolipid domain size or spatial distribution. This finding suggests the 
glutaraldehyde fixation immobilized the proteins and prevented any lipid reorganization.  
Sphingolipid domain abundance and organization is cholesterol dependent 
Having verified that the sphingolipid organization we observed represents native cell 
membrane structure, we evaluated the effects of cholesterol depletion on sphingolipid domain 
size, abundance, and organization. Methyl-β-cyclodextrin (mβCD) was used to reduce the 
cholesterol in the Clone 15 cells by approximately 30% prior to fixation. This level of cholesterol 
depletion was employed to minimize changes in cell morphology, as confirmed by scanning 
electron microscopy (Figs. 2.12a, 2.13a, and 2.14a). The 15N-enrichment images of the 
representative mβCD-treated Clone 15 cell reveal microdomains enriched with 15N-sphingolipids 
are present in the plasma membrane (Fig. 2.12b). Five other mβCD-treated Clone 15 cells 
showed similar features (Figs. 2.13b and 2.14b for examples), indicating cholesterol depletion 
did not eliminate the sphingolipid microdomains. Like the Clone 15 cells with normal cholesterol 
levels, the 15N-sphingolipid microdomains are more abundant on the main bodies of the mβCD-
treated cells than on their extensions (Table 2.1). The sizes of the sphingolipid microdomains and 
the average 15N-enrichments measured on the dorsal surfaces of the mβCD-treated cells were not 
lower than those of the untreated cells (Table 2.1 and Table 2.2). However, the fraction of the 
cell surface that was covered by sphingolipid microdomains was much lower for the mβCD-
treated cells than the untreated cells. These observations suggest that cholesterol depletion 
reduced the percentage of the sphingolipids that were associated with domains instead of 
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inducing microdomain internalization. Thus, depletion of cellular cholesterol decreased the 
sphingolipid microdomain abundance on the cell surface but did not alter the average 
sphingolipid concentration in the membrane, the size distribution of the remaining 
microdomains, or their preferential localization on the cell body. 
Next, we assessed whether cholesterol depletion affects the organization of the 
sphingolipid microdomains on the cell body. The amplitudes of the Ripley’s K-test statistic,  
L(r) – r, for the mβCD-treated cells are larger than the 99% confidence interval at radial 
distances between 0.2 μm and the longest accessible distance on each cell, indicating 
sphingolipid microdomain clustering persisted despite acute cholesterol depletion. However, the 
L(r) – r amplitudes for the mβCD-treated cells were smaller than those of the untreated cells at 
radial distances above 0.5 or 2 μm, depending on the individual cell (Fig. 2.11c). In addition, 
instead of increasing over all accessible length scales, L(r) – r for the mβCD-treated cells reached 
a maximum at distances between 1 and 2 µm and then decreased with increasing distance. These 
data indicate that cholesterol depletion did not affect sphingolipid microdomain clustering on 
length scales below 1 μm, but it did decrease this clustering on length scales above 2 μm. 
Assessment of the nearest neighbor and pairwise microdomain distances also indicated 
cholesterol depletion altered long range (>2 μm) but not short range sphingolipid microdomain 
organization. The similarity between the nearest neighbor plots for the mβCD-treated and 
untreated cells indicates cholesterol depletion reduced but did not eliminate nonrandom 
clustering of sphingolipid microdomains in the membrane (Fig. 2.11d). Like the cells with 
normal cholesterol levels, the nearest neighbor domain distances of 200 nm occurred most 
frequently on the cholesterol-depleted cells (Fig. 2.11d, inset), indicating the edges of most 
sphingolipid microdomains were positioned in close proximity (<100 nm) to their nearest 
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neighbor. In contrast, the pairwise domain distance plots for the mβCD-treated cells were very 
different from each other and from those of the untreated cells. This indicates that depletion of 
cellular cholesterol with mβCD indiscriminately disrupted the long-range clustering of the 
sphingolipid microdomains in the plasma membrane. 
Membrane organization is not determined by interactions between influenza 
hemagglutinin and sphingolipids  
We also briefly investigated the effects of influenza hemagglutinin on membrane 
organization. One hypothesis states that sphingolipid domain formation is induced by favorable 
interactions between hemagglutinin clusters and sphingolipids in the plasma membrane,13,14 and 
predicts that sphingolipid domains depend on the presence of hemagglutinin in the membrane. 
We used NanoSIMS to visualize the 15N-sphingolipid distribution on metabolically labeled 
mouse fibroblast cells that did not express influenza hemagglutinin (NIH-3T3 cells), and found 
plasma membrane domains enriched with 15N-sphingolipids, as seen in a representative cell (Fig. 
2.12). The similarity in the appearance of the 15N-sphingolipid domains in the membranes of 
cells that do and do not express hemagglutinin indicates the hemagglutinin did not induce 
sphingolipid domain formation. 
The hemagglutinin expressed by Clone 15 cells forms clusters in the plasma membrane 
that are hypothesized to be associated with sphingolipid- and cholesterol-enriched domains.12,13 
As an initial test of this hypothesis, we used fluorescence microscopy to simultaneously image 
the distributions of BODIPY-sphingolipids and immunolabeled hemagglutinin (labeled with 
Cy5.5-labeled anti-hemagglutinin Fab fragments) in the membranes of live cells. TIRFM images 
reveal that the basal membrane contained elongated and irregularly shaped BODIPY-
 37 
 
sphingolipid domains (green, Fig. 2.13a) and circular hemagglutinin clusters (red, Fig. 2.13b). 
The overlay of the two channels (Fig. 2.13c) shows that despite their dissimilar morphologies, 
many of the hemagglutinin clusters were partially co-localized with BODIPY-sphingolipid 
domains, suggesting that favorable hemagglutinin-sphingolipid interactions contribute to, but do 
not dictate, plasma membrane organization.  
Discussion 
We provide here data that counter the hypotheses that sphingolipid-enriched domains in 
the plasma membrane are nanoscopic or nonexistent.10, 11,10,12 We have directly imaged the 
distributions of sphingolipids on the entire dorsal surface of intact Clone 15 cells by combining 
metabolic labeling strategies with high-resolution SIMS. Our results show the cellular 
sphingolipids are enriched within ~200 nm diameter membrane microdomains, which are 
clustered within 5-10 μm diameter patches on the cell body. This sphingolipid clustering is 
cholesterol dependent and cannot be attributed to label-induced perturbations in molecular 
interactions or sphingolipid trafficking because the 15N-sphingolipids we imaged were 
biosynthesized within the cell and have the same chemical structure as native sphingolipids. 
Though we acquired chemical images from fixed cells, our data indicate that they represent 
snapshots of the sphingolipid organizations that were present in live Clone 15 cells. This 
conclusion is supported by 1) the exclusion of artifactual elevations in the local 15N-sphingolipid 
abundance caused by vesicles adjacent to the membrane, isotopically labeled debris on the cell 
surface, or non-specific lipid clustering induced by cell preservation; 2) the absence of changes 
in the fluorescent sphingolipid organization during and following glutaraldehyde fixation; 3) the 
similarity in the appearance of the 15N-sphingolipid domains detected with SIMS and the 
fluorescent sphingolipid domains imaged in the membranes of live cells; 4) the exclusion of 
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temperature-induced sphingolipid reorganization during preservation; and 5) analytical controls. 
These experiments should lay to rest the debate over the existence of compositionally distinct 
lipid domains in the plasma membrane that has been in the literature for decades.  
As mentioned in the introduction, the sphingolipid assemblages we detected are not 
necessarily lipid rafts and should be referred to as sphingolipid domains. Lipid rafts are defined 
as associations of cholesterol, sphingolipids, and proteins.9 We did not image cholesterol in this 
work, and therefore these sphingolipid domains should include, but may not exclusively be, lipid 
rafts. Hereafter, we discuss the characteristics of the sphingolipid domains we observed and 
relate them to what is known about sphingolipid organization and plasma membrane domains, 
including lipid rafts. 
We undertook this study with Clone 15 cells because they express influenza 
hemagglutinin. Electron microscopy has shown that hemagglutinin clusters in the plasma 
membrane and associates with well-defined, micrometer-scale patches of darkly staining lipids.13 
However, our data of NIH-3T3 cells demonstrates that hemagglutinin is not required for 
sphingolipid domain formation in the plasma membrane. Furthermore, co-localization between 
the hemagglutinin and the sphingolipid domains was incomplete, suggesting that favorable 
sphingolipid-hemagglutinin interactions influence, but do not completely determine membrane 
organization. Further work would be necessary to better understand the role of hemagglutinin 
and sphingolipid organization.  
The abundance and organization of the sphingolipid domains we observed were 
dependent on cholesterol, which is an important criterion of the lipid raft hypothesis. Cholesterol 
depletion is expected to perturb the molecular interactions that hypothetically drive the formation 
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of cholesterol- and sphingolipid-enriched rafts in the plasma membrane. Cholesterol depletion 
also alters the cytoskeleton organization26,27 and membrane-cytoskeleton interactions28 that, 
according to the alternate “picket-fence” hypothesis, corral membrane lipids within different 
domains.29 Our finding that mβCD treatment reduced the abundance of microdomains on the cell 
surface, but not the size of the remaining domains, suggests that cohesive interactions with 
cholesterol are not solely responsible for sphingolipid domain formation. The reduction in the 
number but not size of the sphingolipid microdomains and their altered clustering following 
cholesterol depletion may instead be caused by long-range changes in the organization of the 
cortical actin cytoskeleton and its association with the membrane.26,30 Future studies of 
cholesterol and sphingolipid distributions in the plasma membrane would be necessary to 
definitively determine whether the sphingolipid domains are cholesterol-enriched, and their 
dependency on cytoskeleton organization. 
The multi-scale sphingolipid clustering observed in this study contrasts with many 
previous observations of sphingolipid organization. However, our finding that sphingolipid 
microdomains form micrometer-scale clusters in the plasma membrane suggests a hierarchical 
sphingolipid organization that may explain this discrepancy, and why some reported sphingolipid 
domain sizes range from micrometers to nanoscopic.8,25,31,32,33,34,35,36 The lipid domains detected 
by ourselves and others with fluorescence microscopy,25,31,32 and the sphingomyelin patches 
imaged in the plasma membranes of uncrosslinked keratinocytes with immunoelectron 
microscopy33 often had micrometer-scale dimensions. We postulate that these large sphingolipid 
domains were clusters of microdomains that required either higher spatial resolution or statistical 
tools to be resolved. Hierarchical sphingolipid organization may also explain the ostensibly 
contrary finding that sphingomyelin and GM1 are trapped within molecular complexes located in 
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<20 nm diameter membrane areas.34 The clustering of these nanoscopic sphingolipid complexes 
within larger plasma membrane subdomains is consistent with the reported non-negligible 
probability of having more than one sphingomyelin trapping event within a 200 nm diameter 
detection region.34 Likewise, the 15N-sphingolipid microdomains we detected with high-
resolution SIMS may have consisted of numerous nanoscopic molecular complexes that were 
below our detection limit. Thus, the presence of multiple length scales of sphingolipid 
organization within the plasma membrane may cause the domain size measured to reflect the 
length scale accessible to the analysis method. Previous observations of GM1 and GM3 
microdomain size difference and segregation from one another8,35,36 suggest that the plasma 
membrane contains multiple types of microdomains that differ in sphingolipid subspecies 
composition and diameter. This finding implies that the micrometer-scale sphingolipid patches 
we observed in the Clone 15 fibroblast cells may consist of microdomains that are each enriched 
with a different sphingolipid subspecies. This additional potential source of inconsistencies 
between observed sphingolipid domain sizes deserves additional attention. Further studies 
involving the simultaneous imaging of numerous sphingolipid subspecies will be required to 
confirm the existence of multiple types of sphingolipid domains within the plasma membrane, 
and establish their sizes.  
The sphingolipid microdomains we detected were more abundant on the cell body than 
the cellular extensions, which is in contrast to the cellular locations where sphingolipid domains, 
including cholesterol- and sphingolipid-enriched lipid rafts, are reported to 
concentrate.8,25,35,37,38,39 The range of locations reported for domain localization suggests this 
disagreement stems from the difference in the cell types studied. For example, liquid-ordered 
membrane domains believed to be enriched with sphingolipids and cholesterol were more 
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abundant on the filopodia of macrophages but not fibroblast cells.25 Certain glycosphingolipids 
localize on the filopodia of platelets but not of untreated L929 fibroblast cells,38 whereas 
glycosphingolipid domains are located on the leading and trailing edges of migrating T cells,39 
the microvilli of MDCK cells,36 and the main bodies of fibroblast cells.8,35 These results imply 
that the conclusions drawn from studies of one cell type may not be applicable to others. The 
extent that the sizes and locations of sphingolipid membrane domains vary among cell types 
warrants further investigation.  
High-resolution SIMS detection of metabolically labeled sphingolipids provides direct 
evidence for micrometer-scale sphingolipid-enriched patches comprised of numerous 
sphingolipid microdomains in the plasma membranes of fibroblast cells. Multiple levels of 
sphingolipid organization combined with differences in the cell type studied may resolve 
inconsistencies in previously reported domain characteristics. The exact mechanism responsible 
for this hierarchical sphingolipid organization is not clear, but the long-range domain 
organization we observed suggests cellular machinery is involved in its maintenance. In addition 
to the cytoskeleton, protein scaffolds consisting of membrane proteins such as caveolins, 
tetraspanins, stomatin, and flotillin7 may divide the plasma membrane into different 
compartments.7,4,29 Furthermore, the sensitivity of several endocytosis and exocytosis pathways 
toward cholesterol and sphingolipid abundance40,41 and recent modeling studies42 suggest that 
dynamic membrane trafficking also plays a role in establishing sphingolipid organization. By 
adding a new dimension of analysis—chemically specific compositional imaging at the scale of 
tens of nanometers—new insight into the causes and functional consequences of plasma 
membrane organization can be obtained. 
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Materials and Methods 
Materials. Uniformly carbon-13, labeled algal fatty acids (98 atom% carbon-13) with a range of 
different lengths and degrees of saturation were obtained from Cambridge Isotope Laboratories. 
Fatty acid-free bovine serum albumin (BSA) powder, 13C18-steric acid (99 atom% carbon-13), 
and other cell culture additives were purchased from Sigma. HyQtase, Hyclone lipid-reduced 
fetal bovine serum, Hyclone calf serum, and all solvents were purchased from Fisher Scientific. 
Poly-L-lysine (0.1% aqueous solution, MW 30,000 – 70,000 ) and all chemical fixation reagents 
for cell preservation were purchased from Electron Microscopy Sciences. Standard cell growth 
medium (high glucose Dulbecco’s modification of Eagle’s medium (DMEM) supplemented with 
10% calf serum, 104 U/mL penicillin G, and 10 mg/mL streptomycin) was prepared by the Cell 
Media Facility in the School of Chemical Sciences at the University of Illinois. The new cell line 
that expresses influenza hemagglutinin (Clone 15 cell line) was obtained by standard technique 
for selecting stably transfected cells after transient expression in a NIH-3T3 mouse fibroblast 
line with a DNA plasmid for the hemagglutinin from the 1957 pandemic Japan strain of 
influenza (Blank, Yin, Mekhedov, and Zimmerberg, unpublished results). 
Synthesis of 15N-sphingolipid precursors 
General: The reaction scheme for the synthesis of the 15N-sphingolipid precursors is shown in 
Scheme 2.1. 15N-L-serine (98 atom% nitrogen-15) was purchased from Cambridge Isotope 
Laboratories. Acetyl chloride was purchased from Sigma-Aldrich and distilled before use. Dry 
methanol was obtained by refluxing methanol in magnesium turnings, followed by distillation. 
Tetrahydrofuran (THF) was pretreated with sodium and benzophenone and then distilled under 
argon. Triethylamine was dried before use by distillation from calcium hydride under argon. 
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Acetone was distilled from potassium permanganate prior to use. Ethyl amine was purchased 
from Aldrich and distilled over potassium hydroxide before use. o-Iodoxybenzoic acid (IBX) 
was synthesized from 2-iodobenzoic acid following literature procedure.43 Unless otherwise 
specified, all other reagents were obtained commercially and used without further purification. 
Reactions were cooled to 0 °C using ice/water bath, -23 °C using a dry ice and 3:7 
ethanol/ethylene glycol bath, and -78 °C using a dry ice/acetone bath. Flash chromatography was 
performed with silica gel 60, 230-400 mesh from Silicycle. Proton magnetic resonance spectra 
were recorded on a VARIAN UNITY instrument at the indicated frequency. Mass spectra were 
recorded on a Waters Quattro II.  
15N-boc-L-methyl serinate (5): Acetyl chloride (3 mL, 42 mmol) was slowly added over a period 
of 5 min to dry methanol (25 mL) at 0 °C under argon. After stirring at 0 °C for 10 min, 15N-L-
serine (0.98 g, 9.2 mmol) was added. The reaction mixture was slowly heated and refluxed 
overnight. The reaction was cooled to room temperature, and the solvent was removed under 
reduced pressure. The resulting white solid 4 (1.45 g, 100% yield) was used without further 
purification. Di-t-butyl dicarbonate (3.04 g, 13.9 mmol), and then dry triethylamine (5.18 mL, 
37.2 mmol) was added dropwise to a 0 °C suspension of 4 (1.45 g, 9.24 mmol) in dry THF (30 
mL) under argon. The reaction mixture was allowed to warm to room temperature while stirring 
overnight, and then was refluxed for 3 h under argon. The solvent was removed under reduced 
pressure; the residue was dissolved in ethyl acetate (150 mL) and washed with water (100 mL), 
saturated ammonium chloride solution (100 mL), and brine (100 mL). The organic layer was 
dried over anhydrous magnesium sulfate, filtered and concentrated via rotary evaporation. Crude 
product was purified by flash column chromatography (silica gel) using 1:1 hexane/ethyl acetate 
as eluent yielded compound 5 as a colorless oil (1.93 g, 95% yield). 1H NMR (400 MHz, CDCl3) 
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δ5.46 (dd, J1 = 91.1 Hz, J2 = 6.8 Hz, 1 H), 4.40 (br s, 1 H), 3.86 ~ 4.02 (m, 2 H), 3.79 (s, 3 H), 
2.27 (br s, 1 H), 1.46 (s, 9 H).  
15N-(S)-3-tert-butyl 4-methyl 2,2-dimethyloxazolidine-3,4-dicarboxylate (6): Boron trifluoride 
etherate (105 μL, 0.51 mmol) was added to a room temperature solution of 5 (1.87 g, 8.49 mmol) 
and 2,2-dimethoxy propane (10.5 mL, 85.4 mmol) in dry acetone (30 mL) under argon at room 
temperature. The reaction was stirred at room temperature for 4 h, and then cooled in an 
ice/water bath. Triethylamine (250 μL, 1.79 mmol) was added to the reaction mixture, and the 
solvent was removed under reduced pressure. The resulting residue was dissolved in 200 mL 
ethyl acetate and washed with saturated ammonium chloride solution (150 mL), water (150 mL), 
and brine (150 mL). The organic layer was dried over anhydrous magnesium sulfate, filtered and 
concentrated via rotary evaporation. Crude product was purified by flash column 
chromatography (silica gel) using 6:1 hexane/ethyl acetate as eluent, yielding compound 6 as a 
colorless oil (1.72 g, 78 % yield). 1H NMR (400 MHz, CDCl3) (two rotamers) δ 4.49 (dd, J1 = 
6.7 Hz, J2 = 2.6 Hz, 1 H for one rotamer), 4.38 (dd, J1 = 7.0 Hz, J2 = 3.1 Hz, 1 H for the other 
rotamer), 4.15 (m, 1 H), 4.05 (m, 1 H), 3.76 (s, 3 H), 1.68 (d, J = 1.5 Hz, 3 H for one rotamer), 
1.64 (d, J = 1.7 Hz, 3 H for the other rotamer), 1.54 (d, J = 1.7 Hz, 3 H for one rotamer), 1.50 (br 
s, 9 H for one isomer & 3 H for the other isomer), 1.42 (s, 9 H for the other rotamer).  
15N-(R)-3-tert-butyl 4-hydroxymethyl-2,2-dimethyloxazolidine-3-carboxylate (7): A solution of 6 
(1.67 g, 6.44 mmol) in dry THF (10 mL) was added to a 0 °C suspension of lithium aluminum 
hydride (367 mg, 9.67 mmol) in dry THF (20 mL). The reaction was warmed to room 
temperature, stirred for 3 h, and then was cooled to 0 °C. 10% potassium hydroxide (4 mL) was 
slowly added and the solution was stirred at room temperature for 30 min. The resulting white 
precipitate was removed by filtration through a filter funnel with Celite. The filtrate was diluted 
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with ethyl acetate (250 mL), and washed with water (150 mL), pH 7 buffer (150 mL), and brine 
(150 mL). The organic layer was dried over anhydrous magnesium sulfate, filtered, and 
concentrated via rotary evaporation to afford crude product 7 (1.38 g, 92% yield) as a slightly 
yellow oil that was used without further purification in the next step. 1H NMR (500 MHz, 
CDCl3) δ 4.11 (m, 1 H), 3.9 – 4.04 (m, 2 H), 3.74 (m, 2 H), 3.64 (br s, 1 H), 1.44 -1.60 (m, 15 
H).  
15N-(S)-tert-butyl 4-formyl-2,2-dimethyloxazolidine-3-carboxylate (8): A mixture of compound 7 
(1.38 g, 5.94 mmol) and o-iodoxybenzoic acid (2.00 g, 7.14 mmol) in dimethyl sulfoxide 
(DMSO, 25 mL) was stirred at room temperature for 4 h, and then diluted with ethyl ether (200 
mL). White solid precipitate was removed by filtration through a filter funnel with Celite. The 
filtrate was washed with water (200 mL × 2) and brine (150 mL), and the organic layer was dried 
over anhydrous magnesium sulfate, filtered and concentrated via rotary evaporation. The 
resulting residue was purified by flash column chromatography (silica gel) using 4:1 hexane/ 
ethyl acetate as eluent to afford compound 8 (0.95 g, 69% yield) as a colorless oil. 1H NMR (400 
MHz, CDCl3) (two rotamers) δ 9.62 (d, J = 1.6 Hz, 1 H for one rotamer), 9.55 (d, J = 2.5 Hz, 1 H 
for the other rotamer), 4.35 (m, 1 H for one rotamer), 4.20 (m, 1 H for the other rotamer), 
4.04~4.15 (m, 2 H), 1.66 (s, 3 H for one rotamer), 1.61 (s, 3 H for the other rotamer), 1.56 (s, 3 H 
for one rotamer), 1.52 (br s, 9 H for one isomer & 3 H for the other isomer), 1.44 (s, 9 H for the 
other rotamer).  
 15N-(S)-tert-butyl, 4-((R)-1-hydroxy-2-hexadecynyl)-2,2-oxazolidine-3-carboxylate (9): 1.6 M n-
butyl lithium in hexane (2.78 mL, 4.45 mmol) was added dropwise to a solution of -23 °C 1-
pentadecyne (1.07 g, 5.13 mmol) in THF (40 mL) under argon. The reaction mixture maintained 
at -23 °C and stirred for 30 min, and then a solution of compound 8 (0.89 g, 3.9 mmol) in THF 
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(20 mL) was added dropwise via cannula over 3 min. The reaction mixture was stirred at -23 °C 
for 1 h, after which it was slowly warmed to room temperature. The solution was cooled in an 
ice/water bath, and acetic acid (250 μL) was slowly added. The solvent was removed under 
reduced pressure. The resulting residue was dissolved in ethyl ether (200 mL), washed with 
saturated ammonium chloride solution (150 mL), pH 7 buffer (150 mL), and brine (150 mL). 
The organic layer was dried over anhydrous magnesium sulfate, filtered, and concentrated via 
rotary evaporation. Crude product was purified by flash column chromatography (silica gel) 
using 6:1 hexane/ethyl acetate as eluent to afford the compound 9 (1.27 g, 75% yield) as a 
colorless oil. 1H NMR (400 MHz, CDCl3) δ 4.78 (d, J = 8.3 Hz, 1 H), 4.51 (m, 1 H), 4.06~4.18 
(m, 2 H), 3.91 (m, 1 H), 2.19 (td, J1 = 6.2 Hz, J2 = 1.7 Hz, 2 H), 1.58~1.50 (m, 15 H), 1.40~1.20 
(m, 22 H), 0.88 (t, J = 6.8 Hz, 3 H). 
15N-sphingosine (10) and 15N-sphinganine (11): A solution of compound 9 (1.27 g, 2.90 mmol) 
in THF (30 mL) under argon was added via cannula to a -78 °C blue solution of lithium (300 mg, 
43.2 mmol) in dry ethyl amine (45 mL). The reaction mixture was stirred at -78 °C for 4 h and 
slowly warmed to room temperature. The solvent was removed under reduced pressure. The 
resulting residue was dissolved in ethyl ether (300 mL), washed with water (200 mL) and brine 
(200 mL). The organic layer was dried over sodium sulfate, filtered, and concentrated via rotary 
evaporation to give crude product, which was recrystallized using 1:1 hexane/ethyl acetate to 
afford a ~1:1 mixture of 15N-sphingosine (10) and 15N-sphinganine (11) (523 mg, 60% yield) as 
a waxy solid. These two sphingoid bases could be separated by flash column chromatography 
(silica gel) using 40:10:1 chloroform/methanol/ammonium hydroxide as eluent. 15N-sphingosine 
10: 1H NMR (400 MHz, CDCl3) δ 5.75 (m, 1 H), 5.46 (dd, J1 = 15.4 Hz, J2 = 7.1 Hz, 1 H), 4.04 
(br, s, 1 H), 3.65 (br s, 2 H), 2.85 (br s, 1 H), 2.15 (br, s, 2 H), 1.37 (quintet, J = 6.8 Hz, 2 H), 
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1.40~1.20 (br s, 20 H), 0.88 (t, J = 6.8 Hz, 3 H); LR-ESI MS (M+H) 301.3, found 301.4. 15N-
sphinganine 11: 1H NMR (500 MHz, CDCl3) δ 3.70~3.60 (m, 3 H), 2.87 (br s, 1 H), 1.49 (br s, 2 
H), 1.40~1.20 (br s, 26 H), 0.88 (t, J = 6.7 Hz, 3 H); LR-ESI MS (M+H) 303.3, found 303.4. 
Metabolic labeling. Clone 15 cells for NanoSIMS analysis were grown on 5 mm by 5 mm 
silicon substrates (Ted Pella) that were coated with poly-L-lysine (MW 30,000 – 70,000) and 
placed into the culture dish when the cells were passaged. The Clone 15 cells were cultured in a 
high glucose Dulbecco’s modification of Eagle’s medium (DMEM) supplemented with 10% calf 
serum, 104 U/mL penicillin G, 10 mg/mL streptomycin, and 6.4 μM 15N-sphingolipid precursors 
(1:1 molar ratio of 15N-sphingosine and 15N-sphingosine) for three days at 37°C in 5% CO2. An 
appropriate volume of 6 mM 15N-sphingolipid precursor solution was added to the cell culture on 
each subsequent day to obtain a final concentration of 3.2 μM 15N-sphingolipid precursors in the 
culture. On the fourth day, the cells were passaged and plated into new culture dishes with 
DMEM supplemented with 1% calf serum, 10% lipid-reduced fetal bovine serum, 6.4 μM 15N-
sphingolipid precursors, 215 μM 13C-fatty acids (4:1:28 mass ratio of UL-13C- algal fatty 
acids/13C-stearic acid/fatty acid-free BSA), 50 μM cholesterol, and 20 μM ethanolamine. The 
growth medium was supplemented with 1% calf serum, 10% lipid-reduced fetal bovine serum, 
15N-sphingolipid precursors, cholesterol, 13C-fatty acid mixture, and ethanolamine each day. On 
the sixth day, the cells were passaged and reset at 2×106 cells with fresh medium and 
supplements in dishes that also contained sterilized and poly-L-lysine-coated silicon substrates. 
The next day, the silicon substrates with adherent cells were removed from the culture dish and 
prepared for NanoSIMS analysis (see below). The remaining cells in the culture were used to 
assess label incorporation. 
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Lipid extraction and analysis of labeled metabolic precursor incorporation. The excess cells 
in the same culture as the cells attached to the silicon substrates prepared for analysis by 
NanoSIMS were rinsed with phosphate buffered saline (PBS), detached with HyQtase, and 
collected via centrifugation. Lipids were extracted using Bligh & Dyer’s protocol.44 
Sphingomyelin enrichment was assessed using an Agilent 1100 liquid chromatograph mass 
spectrometer equipped with a Gemini 3u C6-Phenyl 110A column, connected to a MSD Trap 
XCT Plus ion trap. Isocratic separation was performed with methanol at a flow rate of 300 
μL/min. The incorporation of 15N-sphingolipid precursors and 13C-fatty acids into N-palmitoyl 
sphingomyelin, the most abundant sphingolipid species we detected in the cells, were determined 
by using the mass peaks m/z 703.5 (natural abundance-N-palmitoyl sphingomyelin, Fig. 2.1, 12), 
704.5 (15N-palmitoyl sphingomyelin Fig. 2.1, 13), 719.7 (14N-palmitoyl sphingomyelin-13C16, 
two isotopomers, Fig. 2.1, 14a and 14b), 720.7 (15N-palmitoyl-13C16 sphingomyelin, Fig. 2.1, 15 
), and 735.7 (14N-palmitoyl sphingomyelin-13C32, Fig. 2.1, 16) at retention time 1.5 min. The 
contribution of N-palmitoyl sphingomyelin isotopologues other than 15N-palmitoyl 
sphingomyelin to peak m/z=704.5 was removed by subtracting 43.3% of the intensity of the 
natural abundance N-palmitoyl sphingomyelin peak at m/z 703.5 from the intensity of peak m/z 
704.5. This corrected intensity of peak m/z 704.5 corresponds to 15N-palmitoyl sphingomyelin. 
The contribution of sphingomyelin isotopologues other than 15N-palmitoyl-13C16 sphingomyelin 
to peak m/z 720.7 was removed by subtracting 25.8% of the intensity of the sphingomyelin (14N-
palmitoyl-13C16 sphingomyelin) peak at m/z 719.7 from the intensity of peak m/z 720.7. This 
corrected intensity of peak m/z 720.7 corresponds to 15N-palmitoyl-13C16 sphingomyelin. The 
fraction of N-palmitoyl sphingomyelin that contained a nitrogen-15 isotope was calculated as the 
ratio of the sum of 15N-palmitoyl sphingomyelin and 15N-palmitoyl-13C16 sphingomyelin peak 
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intensities to the sum of the peak intensities from all N-palmitoyl sphingomyelin isotopologues. 
The fraction of N-palmitoyl sphingomyelin that was biosynthesized from uniformly labeled 13C-
palmitic acid was calculated as the ratio of the sum of 14N-palmitoyl sphingomyelin-13C16, 15N-
palmitoyl sphingomyelin-13C16, and 14N-palmitoyl sphingomyelin-13C32, over the sum of the 
peaks produced by all N-palmitoyl sphingomyelin isotopologues. The amounts of the individual 
sphingomyelin isotopologues were calculated as the ratio of the peak intensity for that species 
divided by the sum of the peaks produced by all N-palmitoyl sphingomyelin isotopologues. 
For the cells that were metabolically labeled in the same culture as those in Figs. 2.2, 2.3, 
2.5, and 2.6, we determined that 15N-sphingolipid precursors had been incorporated into 83% of 
the N-palmitoyl sphingomyelin, and 13C-palmitic acid had been incorporated into 83% of the N-
palmitoyl sphingomyelin. The fraction of the N-palmitoyl sphingomyelin isotopologues 12, 13, 
14 (14a and 14b), 15, and 16 in these cells were 0.05, 0.12, 0.07, 0.71, and 0.05, respectively. 
For analysis of the fraction of uniformly labeled 13C-fatty acids incorporated into the 
cellular glycerolipids,45 2.5 mL of 95% ethanol and 50 μL of 33% KOH (aq) were added to the 
lipid extract, the lipids were saponified at 70 °C for 45 min. The solution was cooled to room 
temperature and was acidified with three drops of concentrated HCl. The fatty acids were 
extracted into hexane, and the hexane was evaporated. The fatty acids were resuspended in 
MeOH:CH2Cl2 (1:2), 20 μL of 2M trimethylsilyldiazomethane in hexane was added to solution 
and allowed to react for 60 min. The composition of the resulting fatty acid methyl esters 
(FAME) was assessed using an Agilent 7890A gas chromatograph mass spectrometer equipped 
with a ZB-Wax column (30 m x 0.25 mm, 0.25 μm film thickness). The oven was raised initially 
to 140 °C for 5 min, then stepped from 140 °C to 265 °C at 5 °C/min, and maintained at 295 °C 
for 15 min. Helium carrier gas was flowed at a rate of 1.3 mL/min. The inlet was used in splitless 
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mode and was maintained at 280 °C. The mass selective detector scan range was 50-800 m/z to 
detect the six FAMES of interest: C16:0, C16:1, C18:0, C18:1, and C18:2. The 15N-enrichment 
in phosphatidylethanolamine due to the degradation of 15N-sphingomylelin to 15N-ethanolamine 
was evaluated using cells that had been cultured in the presence of the 15N-sphingolipid 
precursors for 24 days, which is about twice as long as the cells analyzed in these experiments. 
Lipids extracted as described above were separated by preparative thin layer chromatography 
using 65:25:4 chloroform/methanol/water. The plate was stained in an iodine chamber and the 
band that corresponded to phosphatidylethanolamine was scraped off of the plate, and submitted 
for 15N-isotope enrichment analysis. As a control, a band of silica gel was scraped from blank 
preparatory plate that had been developed using the same solvent system. The 15N-enrichment of 
phosphatidylethanolamine sample and blank silica gel sample were performed on an automated 
N/C analyzer-mass spectrometer (ANCA-MS) by the Rittenberg technique.46 The 15N-
enrichment in the phosphatidylethanolamine sample extracted from the metabolically labeled 
cells was ~2% of 15N abundance, whereas the natural abundance level is 0.37%. 
Cell preservation. Cell preservation was performed at room temperature. Silicon chips with 
adherent cells were removed from cell culture and rinsed twice with PBS (with Ca2+ and Mg2+) 
and twice with Hendry’s Phosphate Buffer (HPB). Cells were fixed for 30 min in 4% 
glutaraldehyde diluted in HPB, then rinsed once for 5 min in HPB, and twice for 5 min in triple 
distilled H2O. The cells were further fixed in 0.4% osmium tetroxide solution (freshly diluted in 
water and filtered through 0.22 μm syringe filter) for 15 min. The samples were rinsed three 
times for 5 min in water and allowed to air dry. 
NanoSIMS analysis. To prevent sample charging during NanoSIMS analysis, the samples were 
coated with ~3 nm of iridium using a Cressington 208HR high resolution sputter coater with a 
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MTM-20 thickness controller before NanoSIMS analysis. High resolution secondary ion mass 
spectrometry was performed on a Cameca NanoSIMS 50 instrument (Cameca, France) at 
Lawrence Livermore National Laboratory (Livermore, CA). Measurements were made with a 
~0.24 pA, 15 keV 133Cs+ primary ion beam focused onto a ~70 nm spot with an analysis area of 
15 x 15 µm2 (see below for the depth and beam diameter). Measurements consisted of four 
replicate scans of 512 x 512 pixels with a dwell time of 1 ms/pixel. The 12C1H-, 13C1H-, 12C14N-, 
and 12C15N- secondary ions, and secondary electrons were simultaneously collected. A mass 
resolving power of ~6,700 was used to separate isobaric interferences from the isotopes of 
interest, e.g., 13C1H from 12C1H2 at mass 14, and 12C15N from 13C14N at mass 27.  
Image analysis. A custom software package (L’image, L.R. Nittler, Carnegie Institution of 
Washington) run on the PV-Wave platform (Visual Numerics, Inc.) was used to process the 
NanoSIMS data, save secondary electron images, determine the primary ion beam diameter, 
make isotope enrichment images, define regions of interest (ROIs), and export quantitative data 
from the ROI.47 The lateral resolution of the secondary electron images is equal to the diameter 
of the 133Cs+ primary ion beam (70 nm, see below). Quantitative 15N- and 13C-enrichment images 
(12C15N-/12C14N- and 13C1H-/12C1H-) that show the distributions of 15N-sphingolipids and 13C- 
lipids, respectively, were constructed using a 3 x 3-pixel boxcar smoothing algorithm, producing 
isotope enrichment images with 87-nm-lateral resolution. The isotope enrichment is expressed as 
the measured 12C15N-/12C14N- or 13C1H-/12C1H- ratio divided by the natural abundance ratio 
(0.00367 and 0.011237, respectively). These 15N- and 13C-enrichment factors are a measure of 
the amount of 15N-sphingolipids and 13C-lipids in the plasma membrane in comparison to an 
unlabeled (natural abundance) cell. 
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Calculation of analysis depth. The sputtering depth that corresponds to four raster scans is ~3 
nm, calculated using eq. 1, a sputtering rate of 2.5 nm·μm2/pA·s determined on other biological 
samples,19 and a total sputter time of 1049 s. 
ܣ݈݊ܽݕݏ݅ݏ	݀݁݌ݐℎ = ݏ݌ݑݐݐ݁ݎ	ݎܽݐ݁ × ݌ݎ݅݉ܽݎݕ	݅݋݊	ܾ݁ܽ݉	ܿݑݎݎ݁݊ݐ × ݏ݌ݑݐݐ݁ݎ	ݐ݅݉݁
ݎܽݏݐ݁ݎ	ܽݎ݁ܽ
			(݁ݍ. 1) 
Determination of diameter of 133Cs+ primary ion beam. The diameter of the 133Cs+ primary 
ion beam was determined by calculating the distance over which the secondary electron signal 
intensity changed from 84% to 16% of the maximum intensity (Fig. 2.17).47 A beam diameter of 
69 nm was measured. The lateral resolution of the isotope enrichment images is 89 nm because a 
3 x 3-pixel boxcar smoothing algorithm was applied to these images. 
Assessment of statistical significance of the 15N-sphingolipid-enriched domains in the 
plasma membrane. The secondary ions detected at every pixel depend on the species 
concentration, as well as concentration-independent factors, such as sample topography and local 
chemical environment. Because isotopes of the same elements (12C15N- and 12C14N-, or 13C1H- 
and 12C1H-) are influenced by these concentration-independent conditions to roughly the same 
extent, expressing the isotope pair as a ratio (12C15N-/12C14N- and 13C1H-/12C1H-) minimizes the 
concentration-independent variations, producing a concentration-dependent, quantitative 
NanoSIMS signal.7 To verify this, NanoSIMS imaging and data analysis was performed on a 
region on an unlabeled (natural abundance) Clone 15 fibroblast cell was as described above. The 
mean 15N-enrichment for the 10,923 ROIs on the cell was 1.1, and σ = 1.4. Thus, random signal 
variations or non-concentration dependent factors, such as sample topography, are not 
responsible for the lateral variations in 15N-enrichment observed in the experimental cells. 
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We perform two analyses to determine the threshold for the lowest 15N-enrichment that 
denoted a statistically significant elevation in the local 15N-enrichment in the plasma membrane. 
In the first approach, L’image was used to select large ROIs in the 12C15N-/12C14N- NanoSIMS 
image that corresponded to areas on the cell where local elevations in the 15N-enrichment were 
not visible. These domain-free ROI were divided into a grid of 3 by 3-pixel ROIs, and the 
nitrogen isotope ratio (12C15N-/12C14N-) was extracted from each 3 by 3-pixel ROI. This process 
was repeated for every NanoSIMS image acquired on the cell. A mean ± standard deviation (μ ± 
σ) of 25.2 ±7.0 counts 12C15N- and 962 ± 153 counts 12C14N- were acquired at each ROI on Cell 
1, where the standard deviation (σ) is the observed standard deviation among the ROI. The 
standard deviation in the 12C15N- count rate is ~1.4 times greater than the Poisson error (√25.2 =5.02). On average, the error of the mean (standard deviation of the cycle ratio divided by the 
square root of the total cycles) for the 15N-enrichment factor measured at each domain-free ROI 
was 1.9. The nitrogen isotope ratios extracted from each ROI with L’image were used to 
calculate the average 15N-enrichment factor and standard deviation for all of the domain-free 
ROI were calculated. A 15N-enrichment factor greater than 11.9, which is two standard 
deviations above the average 15N-enrichment factor for the domain-free regions of the 
membrane, designated the lower threshold value to define the 15N-sphingolipid-enriched 
domains. The number of ROIs analyzed, total area of these ROIs, mean 15N-enrichment factor, 
and its standard deviation for Cells 1 - 3 are provided in Table 2.3. NanoSIMS images of Cell 1 
are shown in Figs 2.2, 2.3, and 2.5. Fig 2.6 shows the NanoSIMS images acquired from Cell 2 
and Cell 3. 
The variation in a large number (103 – 105) of SIMS measurements made on a 
homogeneous material is approximated by a Gaussian distribution.48 Therefore, if the membrane 
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contained 15N-sphingolipid-enriched domains, the frequency distribution of 15N-enrichment 
factors collected from the entire cell would be best-fit by a mixture of two normal distributions. 
Thus for the second approach, L’image was used to draw one large ROI that encompassed the 
portion of the cell that did not overlap with a previous NanoSIMS analysis on the secondary 
electron image. This large ROI was divided into a grid of 3 by 3-pixel ROIs, and the nitrogen 
isotope ratio (12C15N-/12C14N-) was extracted from each 3 by 3-pixel ROI. This process was 
repeated for every NanoSIMS image in the mosaic of the entire cell. The nitrogen isotope ratios 
extracted from all of the ROIs on the cell, the corresponding 15N-enrichment factor was 
calculated for each ROI (59,301 ROIs for the cell in Figs 2.2, 2.3, and 2.5), and these 15N-
enrichment factors were imported into MatLab 7.8.0 R2009a. The frequency distribution of the 
experimental 15N-enrichment factors extracted from the ~60,000 ROIs on the cell were fitted 
with the best-fit probability density function (PDF) of a unimodal normal distribution and a 
mixture of two unimodal normal distributions using the MatLab Statistics ToolboxTM. To 
calculate the maximum likelihood estimates for the parameters of the one normal distribution 
model, the initial starting point for the mean (μ) was centered on the 50th percentile, and the 
initial starting point for the standard deviation (σ) was the square root of the variance. For Cell 1, 
the best fit normal distribution had a mean of 8.9 and standard deviation of 3.5. The initial 
starting points for calculating the maximum likelihood estimates for parameters of the mixture of 
two normal distributions were an equal mixture (mixing parameter, p = 0.5) with means centered 
at the 25th and 75th percentiles, and equal standard deviations based on the variance of the 
mixture in terms of the mean of each component. For Cell 1, the best fit PDF for the model of a 
mixture of two normal distributions predicted μdomain-free = 7.8, σdomain-free = 2.1, μdomain = 12.0, 
and σdomain=3.7 for the 15N-enrichment factors. These best-fit PDFs are plotted with the 
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experimental frequency distribution for the 15N-enrichment factors in Fig. 2.18. Data sets for the 
best-fit unimodal normal distribution and mixture of two normal distributions were simulated 
using the MatLab Statistics ToolboxTM in order to plot their cumulative distribution functions 
(CDF). The simulated data set for the best-fit unimodal normal distribution for Cell 1 consisted 
of 59,301 normally distributed data points with μ = 8.9 and σ = 3.5 The data set for the best-fit 
mixture of two normal distributions consisted of 59,301 data points in total, where 35,741 data 
points (60.27% of the data points in the set) were normally distributed with μ = 7.8 and σ = 2.1, 
and 23,560 data points (39.73% of the set) were normally distributed with μ = 12.0 and σ = 3.7. 
The experimental and model CDFs plotted using the MatLab Statistics ToolboxTM (Fig. 2.18) 
show the mixture of two normal distributions is a better fit of the data, further confirming the 
plasma membrane contained 15N-sphingolipid-enriched domains. Based on this approach, a 15N-
enrichment factor greater than 12.0 ([μ+2σ]non-domain) designates a statistically significant 
elevation in the local 15N-enrichment on Cell 1, in good agreement with the value obtained with 
our first approach. Thus the sphingolipid-enriched domains in the plasma membrane were 
quantitatively defined as the regions that have 15N-enrichment factors greater than 12.0. The 
same procedure was used to assess Cells 2 and 3, and similar results were obtained (Table 2.3).  
To assess the fits of the model PDFs, the two-sample Kolmogorov-Smirnov test statistic 
was calculated to determine the maximum difference between the experimental and model 
cumulative distribution functions (CDF) using the MatLab Statistics ToolboxTM. For Cell 1, the 
two-sample Kolmogorov-Smirnov test statistic was 0.071 for the one unimodal normal 
distribution model, and 0.014 for the mixture of two normal distributions. The smaller test 
statistic for the mixture of two normal distributions confirms that this model approximates the 
experimental data better than the single normal distribution, as illustrated by Fig. 2.18. The 
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Kolmogorov-Smirnov test statistics calculated for Cell 2 and 3 also confirmed the mixture of two 
normal distributions better fit the experimental data acquired from each cell. For Cell 2 (Fig. 
2.6a, c, and e), the two-sample Kolmogorov-Smirnov test statistic was 0.061 for the one 
unimodal normal distribution model, and 0.047 for the mixture of two normal distributions. For 
Cell 3 (Fig. 2.6b, d, and f), the two-sample Kolmogorov-Smirnov test statistic was 0.0829 for the 
unimodal normal distribution model, and 0.024 for the mixture of two normal distributions 
(Table 2.3). The experimental and model PDFs and CDFs for Cells 2 and 3 are plotted in Figs. 
2.19 and 2.20, respectively.  
Statistical significance of difference between 13C-enrichment factors in domain and non-
domain membrane regions. The statistical significance of a difference between the 13C-
enrichment factors, and therefore the local abundance of all cellular lipid species, in the 
sphingolipid-enriched domains and the non-domain membrane regions were assessed with a 
Kruskal-Wallis test. ROIs of the sphingolipid-enriched domains were selected by using a particle 
definition algorithm implemented in L’image. This algorithm defined the domain centers as the 
pixels on the cells that were local maxima and had 15N-enrichment factors > 12. The domain 
edges were located by expanding out from the center until the 15N-isotope ratio dropped below 
the Gaussian diameter, which is ~13.5% (1/e2) of the 15N-enrichment factor at the domain center, 
or another particle was encountered. The isotope enrichment factors were extracted from the 
3,155 ROIs of the sphingolipid-enriched domains on Cell 1. The 13C-enrichment factors for the 
domain-free areas were obtained using the large, domain-free ROIs that were defined in the 
“Assessment of the statistical significance of the local elevations in 15N-sphingolipid enrichment 
in the plasma membrane” section above. Because the average size of the 15N-enriched domains 
was ~38 pixels, the domain-free ROIs were divided into a grid of 6 by 6-pixel ROIs, and the 
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13C1H-/12C1H- ratio was extracted from each of the 5,557 6 by 6-pixel ROI. A Lilliefors test 
indicated the 13C-enrichment factors extracted from the domain and non-domain membrane 
regions were not normally distributed, so a non-parametric Kruskal-Wallis test was used to test 
whether these two populations came from the same continuous distribution. The Kruskal-Wallis 
test performed with the MatLab Statistics ToolboxTM returned a probability value of 0.99, 
signifying the difference between the between the 13C-enrichment factors measured in the 
domain and non-domain regions was not statistically significant (p < 0.05 denotes a statistically 
significant difference). The same procedure was used to tabulate the 13C-enrichment factors 
extracted from domain and non-domain regions on Cells 2 and 3, and to test for statistically 
significant variations between the two areas on each cell. For Cell 2, 13C-enrichment factors were 
extracted from 4,040 15N-enriched domains and 2,252 non-domain regions. For Cell 3, 13C-
enrichment factors were extracted from 2,477 15N-sphingolipid-enriched domains and 4,263 non-
domain regions. A Kruskal-Wallis test did not detect a statistically significant difference between 
the 13C-enrichment factors measured in the domain and non-domain regions on each cell (p = 
0.34 for Cell 2 and p = 0.59 for Cell 3, Table 2.3). 
Evaluation of non-concentration dependent lateral variations in 15N-enrichment factor in 
the plasma membrane. The secondary ions detected at every pixel depend on the species 
concentration, as well as concentration-independent factors, such as sample topography and local 
chemical environment. Because isotopes of the same elements (12C15N- and 12C14N-, or 13C1H- 
and 12C1H-) are influenced by these concentration-independent conditions to roughly the same 
extent, expressing the isotope pair as a ratio (12C15N-/12C14N- and 13C1H-/12C1H-) minimizes the 
concentration-independent variations, producing a concentration-dependent, quantitative 
NanoSIMS signal.49 To verify this, NanoSIMS imaging and data analysis was performed on a 
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region on an unlabeled (natural abundance) Clone 15 fibroblast cell was as described above. The 
mean 15N-enrichment for the 10,923 ROIs on the cell was 1.1, and σ = 1.4. Thus random signal 
variations or non-concentration dependent factors, such as sample topography, are not 
responsible for the lateral variations in 15N-enrichment observed in the experimental cells. 
Discussion of potential artifacts of membrane preservation. As preservation of cell 
membrane organization is critical to these studies, potential artifacts induced by preservation 
must be considered. As discussed in the chapter, the surface tension forces that occur during 
dehydration may induce the formation of highly condensed, non-specific lipid aggregates.50 
Because the local abundance of all membrane lipid species (sphingolipids, phosphatidylcholine, 
phosphatidylethanolamine, etc.) would be higher within these condensed lipid aggregates than 
elsewhere in the membrane, their presence would be evidenced by local elevations in both the 
13C- and 15N-enrichment detected by NanoSIMS. Next, drying-induced phase separation can 
occur in unfixed model lipid membranes, but this phase separation does not occur when 
cholesterol concentrations are similar to those in cell membranes.51 Thus dehydration-induced 
phase separation is unlikely to occur in our samples. Finally, exposing the cells to room 
temperature during fixation might cause phase separation. Low temperatures (4 °C) induce the 
clustering of the sphingolipid, GM1, in the plasma membranes of unfixed cells, but treatment of 
the cells with aldehyde fixatives similar to that we employed prior to exposure to low 
temperature prevent this artifactual clustering.22 Thus temperature-induced phase-separation 
might have only occurred in our samples during the short time interval when the cell was 
exposed to room temperature before glutaraldehyde fixation was complete (≤ 35 min). However 
exposure to room temperature is likely insufficient to have induced substantial phase separation 
in our cells, as only 10–25% of vesicles derived from cell membranes exhibited phase separation 
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detectable by fluorescence microscopy at room temperature.52 This result is corroborated by the 
detection of domains enriched with fluorescently labeled sphingolipids in the plasma membranes 
of Chinese hamster ovary (CHO) cells at 37°C. Therefore we do not expect that substantial 
amounts of phase-separation occurred in our samples, and drying artifacts in the form of 
condensed lipid clusters are our primary concern. 
Control experiments. Control experiments were performed to assess the possibility that the 15N-
enriched regions on the cell that were visible in the NanoSIMS images resulted from isotopically 
labeled precursors or debris adhering to the cell surface as opposed to metabolically labeled 
lipids in the plasma membrane. In the first set of these experiments, unlabeled (natural 
abundance) cells were incubated in the labeling medium for 30 min to permit nonspecific 
adhesion to occur. Both live and chemically fixed (non-living) cells were employed to address 
the possibility that the live cells might uptake the isotopically labeled precursors and metabolize 
them into isotopically labeled membrane lipids within the incubation period. Because fibroblast 
cells endocytose about half the surface area of their cell membranes per hour,53 a second set of 
experiments was performed in which metabolically labeled cells were incubated in label-free 
medium for 30 min to allow endocytosis of any isotopically labeled material that may have non-
specifically adsorbed to the cell surface. The 30 min incubation time was selected as a 
compromise between a longer incubation time that would allow more extensive membrane 
recycling to occur, and shorter times that would minimize the amount of newly biosynthesized, 
unlabeled (natural abundance) lipid species that would be incorporated into the plasma 
membrane in the absence of isotopically labeled precursors. 
Unlabeled (natural abundance) Clone 15 cells were set in a culture dish that contained 
eight 5×5 mm silicon substrates coated with poly-L-lysine and were cultured in DMEM 
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supplemented with 10% calf serum, 104 U/mL penicillin G, and 10 mg/mL streptomycin at 37 °C 
in 5% CO2. After one day of growth, four of the substrates with adherent cells were removed 
from the culture, exposed to 2% paraformaldehyde/0.05% glutaraldehyde in HPB for 10 min to 
chemically fix the cells, and then the substrates with the fixed cells adhered were returned to the 
culture dish. The medium was removed from the dish, the dish was rinsed once with PBS, and 
the standard metabolic labeling medium described above was added to the dish. The labeling 
medium used for this purpose was not freshly prepared but was instead taken from another 
culture dish. This ensured that the composition of the medium was identical to the last medium 
the metabolically labeled cells had encountered before chemical fixation, and that the unlabeled 
cells were exposed to any substances introduced into the medium by growing cells during 
metabolic labeling that might be responsible for adherent debris. The culture dish was returned to 
the incubator for 30 min, and then the substrates were removed and preserved as previously 
described. The live cells that remained adhered to the dish were harvested and used to assess the 
amount of isotope incorporation within these cells as described above. Uniformly labeled 13C-
fatty acids were ~9% of the total fatty acids in the live unlabeled cells incubated in labeling 
medium, which is somewhat higher than that measured in unlabeled cells that were never 
exposed to labeling medium (1.4%). Analysis of the sphingomyelin fraction extracted from the 
unlabeled cells incubated in labeling medium confirmed that the incorporation of 15N-
sphingolipid precursors into these cells was below the detection limit (~15 atom % 15N), which is 
similar to the results obtained from unlabeled cells that were never exposed to the labeling 
medium. Note that at low levels of 15N-sphingolipid precursor incorporation into sphingomyelin, 
assessment of the 15N-sphingomyelin levels becomes inaccurate because the contributions of 
15N-sphingomyelin and 15N-palmitoyl-13C16 sphingomyelin to the intensities of m/z 704.5 and 
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720.7, respectively, are much smaller than the contributions of other sphingomyelin isotopomers 
(i.e., carbon-13, 1.1237% natural abundance) to these peaks. In contrast, low levels of uniformly-
labeled (UL)-13C-fatty acid incorporation can be detected because the mass difference between a 
UL-13C-fatty acid and the corresponding naturally abundant fatty acid is much larger (1 amu per 
carbon atom). 
In the second set of experiments, Clone 15 cells were cultured in labeling medium with 
poly-L-lysine-coated silicon substrates included in the culture dish for NanoSIMS analysis as 
previously described. After one day in the second passage in labeling medium, the culture dish 
was rinsed once with PBS, and DMEM that did not contain isotopically labeled metabolic 
precursors was added to the dish. The culture dish was returned to the incubator for 30 min, and 
then the substrates were removed and chemically preserved as previously described. The live 
cells that remained adhered to the dish were harvested, and the isotope incorporation into the 
sphingomyelin and all lipid species in these cells were analyzed as described above. Nitrogen-15 
was incorporated into ~79% of the sphingomyelin, and 62% of the fatty acids in the cellular 
lipids were uniformly labeled with carbon-13. A positive control sample was created that 
consisted of cells that were metabolically labeled with the standard procedure. Biochemical 
analysis of the positive control cells indicated nitrogen-15 was incorporated into ~78% of the 
sphingomyelin, and 75% of the fatty acids within the cellular lipids were uniformly labeled with 
carbon-13.  
NanoSIMS analysis was performed on one cell from each of the five different 
preparations (Table 2.4, Fig. 2.7): 1) cells that were metabolically labeled with the standard 
procedure (positive control); 2) metabolically labeled, live cells exposed to unlabeled medium 
for 30 min; 3) natural abundance live cells incubated in metabolic labeling medium for 30 min; 
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4) natural abundance chemically fixed (dead) cells incubated in metabolic labeling media for 30 
min; and 5) unlabeled (natural abundance) cells (negative control). For samples 1, 3, 4, and 5, 
NanoSIMS analysis was performed using a 0.23 pA, 15 keV 133Cs+ primary ion beam to image 
10 x 10 µm2 region on cells with a dwell time of 1 ms/pixel. The NanoSIMS images of samples 
1, 3, 4, and 5 shown in Fig. 2.7 consist of four replicate scans of 512 x 512 pixels. For the 
analysis of the metabolically labeled cells incubated in label-free media for 30 min (sample 2), a 
~0.9 pA, 15 keV 133Cs+ primary ion beam was used to image 10 x 10 µm2 regions on the cells 
with 256 x 256 pixels and a dwell time of 0.5 ms/pixel. Eight replicate scans were collected each 
NanoSIMS measurement on sample 2 in order to obtain the same primary ion dose per area as 
samples 1, 3, 4, and 5.  
The 15N-enrichment and 13C-enrichment images of both the metabolically labeled cell 
(positive control) and the metabolically labeled cell incubated in natural abundance medium for 
30 min are similar in appearance (Fig. 2.7). Therefore, the membrane recycling that occurred 
during the 30 min incubation in unlabeled medium did not alter the appearance of the 15N-
enriched domains, which indicates these features are 15N-sphingolipid-enriched domains and not 
labeled material adsorbed on the cell surface. This conclusion is supported by the results of the 
unlabeled cells that were exposed to labeling medium: 15N-enriched domains are not visible on 
the surface of the live or fixed unlabeled cells exposed to labeling medium. In addition, the 
isotope compositions measured on the unlabeled cells exposed to labeling medium did not differ 
from natural abundance levels in a significant manner. The statistics for the enrichment factors 
measured on cells from all of these samples are listed in Table 2.4. Thus the 15N-enriched 
domains on the experimental cells are caused by 15N-sphingolipid-enriched domains, and not 
from isotopically labeled material adhered to the cell surface. 
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Analysis of Sphingolipid Domain Organization. The clustering of the domains on the cell 
body was assessed using the SpatStat spatial statistics package (version 1.22-1) run in R (version 
2.12.2).54,55 The x-y coordinates for the cell body were recorded by loading the montage of 
secondary electron images of the cell into GraphClick 3.0 and tracing the edges of the cell body 
but omitting the lamellipodia. The coordinates for the cell body were expressed in pixel-units, 
and were used to define the observation window in SpatStat. The x-y coordinates of the domain 
centers with respect to the whole cell were calculated from the coordinates of the pixels where 
the domain centers were located within each 15N-enrichment image (exported from L’image), 
and the coordinates of each 15N-enrichment image in the montage of the whole cell. These 
coordinates were used to create a point pattern that represented the observed domains within the 
observation window that corresponded to the cell body. 
The Ripley’s K-test was performed on the point pattern corresponding to the domain 
centers using translation edge correction in order to calculate the number of domains within a 
radius, r, of any given domain on the cell surface.56,57 Analysis was restricted to distances less 
than ¼ the smallest length of the observation window. Data were normalized to the 99% 
confidence interval, which was calculated according to: 
 CI A N99 1.68  (18) 
where A is the area of the observation window and N is the total number of domains within the 
window. 
 For comparison to the experimental domains observed on the cell surface, we simulated a 
population of spatially random domains within the observation window that represented the cell 
body. The number and effective diameters of the domains in the simulated population were 
identical to those that were experimentally observed on the cell body. We first determined the 
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frequency distribution of effective domain diameters experimentally observed on the cell body 
using a bin size of 1 pixel. We tabulated the number of domains with a specified effective 
diameter that were experimentally observed on the cell body. Then, an algorithm was used to 
randomly add domains (“points”) with the specified effective diameter (encoded as a “mark”) 
one-by-one to the observation window that represented the cell body. New domains were 
generated independent of the preceding domains, and those that lay outside of the observation 
window were rejected. To prevent the domains from overlapping, the simulated domains were 
also rejected if the distance between the center of the simulated domain and the center of the 
closest domain was less than the sum of the radii of these two domains. Once the number of 
domains with a given diameter in the observation window equaled that experimentally observed 
on the cell body, the process was repeated for the next effective domain diameter. These steps 
were repeated until the correct number of domains had been simulated for every observed 
effective diameter. 
 The nearest neighbor distance, which is the distance from the center of each domain to 
the center of its nearest neighbor, was computed for each of the (1) experimentally observed 
domains on the cell body, and (2) simulated, spatially random domains. For each population 
(e.g., experimental and simulated), the frequency distribution of nearest neighbor domain 
distances was tabulated using a bin size of 50 nm, and normalized to the total number of domains 
in the population to produce the fraction of the total. The difference between the frequencies of 
observed and simulated nearest neighbor distances was calculated by subtracting the fraction of 
the simulated domain population with nearest neighbor distances within each 50 nm increment 
from the fraction of experimentally observed domains with nearest neighbor distances in the 
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same range. The difference between the frequencies of observed and simulated nearest neighbor 
distances are plotted in Fig. 2.11. 
The pairwise domain distances, which are the distances between the center of each 
domain and the center of every other domain on the cell body, were computed for (1) every 
domain that was experimentally observed, and (2) every domain within the simulated population. 
The frequency distributions of pairwise domain distances for the experimental and simulated 
domains on each cell were tabulated using a bin size of 0.5 μm, and normalized to the total 
number of domains in the population. The difference between the frequencies of observed and 
simulated pairwise domain distances was calculated for each 0.5 μm increment, and is plotted in 
Fig. 2.11e. 
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Figures, Schemes, and Tables 
 
Fig. 2.1 Structures of cellular sphingomyelin isotopologues. The 15N-sphingomyelin 
isotopologues were biosynthesized from the 15N-sphinganine or 15N-sphingosine fed to the cells. 
Exogenous UL-13C-palmitic acid was biosynthetically incorporated into sphingomyelin at two 
metabolic steps: acylation of the sphingoid base (14b, 15, and 16); and in de novo sphinganine 
biosynthesis (14a and 16). The location of carbon-13 isotopes are indicated by an asterisk. For 
the cells that were metabolically labeled in the same culture as those analyzed with NanoSIMS, 
15N-sphingolipid precursors had been incorporated into 83% of the N-palmitoyl sphingomyelin, 
and 13C-palmitic acid had been incorporated into 83% of the N-palmitoyl sphingomyelin. The 
fraction of the N-palmitoyl sphingomyelin isotopologues 12, 13, 14 (14a and 14b), 15, and 16 in 
these cells were 0.05, 0.12, 0.07, 0.71, and 0.05, respectively. The fraction of N-palmitoyl 
sphingomyelin with nitrogen-15 is the ratio of the sum of 15N-palmitoyl sphingomyelin and 15N-
palmitoyl-13C16 sphingomyelin peaks to the sum of the peaks from all N-palmitoyl 
sphingomyelin isotopologues. The fraction of N-palmitoyl sphingomyelin biosynthesized from 
UL-13C-palmitic acid is the ratio of the sum of the peaks from 14N-palmitoyl sphingomyelin-
13C16, 15N-palmitoyl sphingomyelin-13C16, and 14N-palmitoyl sphingomyelin-13C32, over the sum 
of the peaks from all N-palmitoyl sphingomyelin isotopologues. 
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Fig. 2.2 Secondary electron images of a Clone 15 fibroblast cell were acquired in parallel with 
the secondary ion signals using NanoSIMS. Montage of 15 μm by 15 μm secondary electron 
images shows the morphology of a representative Clone 15 cell (Cell 1). 
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Fig. 2.3 13C-enrichment images of a Clone 15 fibroblast cell were acquired in parallel with the 
secondary electron (Fig. 2.2) and 15N-enrichment (Fig. 2.5) images. Montage of quantitative 13C-
enrichment images reveals the distribution of all lipids in the plasma membrane of the Clone 15 
cell (Cell 1). The color scale shows the measured 13C1H-/12C1H- ratio divided by the natural 
abundance ratio, corresponding to the 13C-lipid enrichment compared to an unlabeled cell. The 
mean 13C-enrichment for the entire surface of the cell was 16.3 (arrow, s.d. = 22.5). The elevated 
13C-enrichment and the absence of statistically significant lateral variations in the 13C-enrichment 
on the cell verify the plasma membrane was intact. Speckling is due to low counts of the CH 
isotopologues. 
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Fig. 2.4 NanoSIMS images of an unlabeled cell. (a) Secondary electron image shows 
topography. (b) 13C-enrichment image shows the 13C-abundance on the cell. Speckling is due to 
low ion counts. The even 13C-enrichment across the cell demonstrates that topography does not 
cause variations in the isotope ratio. (c) 15N-enrichment image shows the 15N-abundance on the 
cell. The even isotope ratio across the cell demonstrates the 15N-enrichment does not vary due to 
topography. 
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Fig. 2.5 15N-enrichment images were acquired of the entire surface of a Clone 15 fibroblast cell. 
The montage of 15N-enrichment images shows the 15N-sphingolipid distribution on the Clone 15 
fibroblast cell (Cell 1). The color scale represents the measured 12C15N-/12C14N- ratio divided by 
the natural abundance ratio, corresponding to the 15N-sphingolipid enrichment compared to an 
unlabeled cell. The mean 15N-enrichment factors for domain-free regions and the entire cell are 
7.8 (open arrow, s.d. = 2.1), and 9.5 (solid arrow, s.d. = 3.6), respectively. Lateral variations in 
the 15N-enrichment, and thus the 15N-sphingolipid distribution, are clearly visible. The enlarged 
views of the secondary electron, 13C-enrichment, and 15N-enrichment images that were acquired 
at the outlined region on the cell (inset) demonstrate that the 15N-sphingolipid domains do not 
coincide with cell topography or an excess of cellular lipids. The color scale for the 13C-
enrichment image shown in the inset is provided in Fig. 2.3.  
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Fig. 2.6 The 
morphologies of two 
additional Clone 15 
fibroblast cells are 
shown in the 
montages of 15 μm by 
15 μm that were 
acquired in parallel to 
the lipid-specific 
secondary ions (a, 
Cell 2; b, Cell 3). The 
13C-enrichment 
images show the local 
abundance of all 13C-
lipid species in the 
membranes of Cell 2 
(c) and Cell 3 (d). 
Color scales are the 
13C1H-/12C1H- ratio 
divided by the natural 
abundance ratio. 
Speckling is due to 
low counts of CH 
isotopologues. The 
mean 13C-enrichment 
on the surfaces of 
Cells 2 and 3 (solid 
arrow) are 26.3 (c, s.d. 
= 23.9) and 22.9 (d, 
s.d. = 25.6), 
respectively. The 15N-
enrichment images 
show the abundance 
of 15N-sphingolipids 
in the membranes of 
Cell 2 (e) and Cell 3 
(f). Color scales show 
the 12C15N-/12C14N- 
ratio divided by the 
natural abundance 
ratio. (e) The mean 
15N-enrich-ment factors for the domain-free regions (open arrow) and the entire surface (solid 
arrow) of Cell 2 is 8.9 (s.d. = 2.7), and 10.3 (s.d. = 3.7), respectively. (f) The mean 15N-enrich-
ment factors for the domain-free regions (open arrow) and the entire surface of Cell 3 are 8.4 
(s.d. = 2.7), and 9.1 (s.d. = 3.7), respectively. 
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Fig. 2.7 15N-enrichment and 13C-
enrichment images of Clone 15 
fibroblast cells exposed to 
metabolic labeling medium for 
various time intervals to test for 
nonspecific adsorption of labeled 
material on the cell surface. 15N-
enriched domains were present on 
both the metabolically labeled cell 
(positive control) and the 
metabolically labeled cell 
incubated in label-free (natural 
abundance) medium for 30 min 
while alive. The 13C-enrichment 
images also appear similar. In 
contrast, the unlabeled cells that 
were either living or chemically 
fixed when exposed to labeling 
medium for 30 min did not exhibit 
15N-enriched domains. A low level 
of 13C-enrichment was observed, 
suggesting that small amounts of 
13C-fatty acids had adhered to the 
cell or incorporated into the cell 
membrane. These results indicate 
that the 15N-enriched domains on 
the experimental cells were caused 
by 15N-sphingolipid-enriched 
domains, and not from the 
adhesion of isotopically labeled 
material to the surface of the cell. 
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Fig. 2.8 TIRFM detection of BODIPY-sphingolipids in the plasma membrane of a Clone 15 cell. 
Stacks of 120 frames were acquired before and after fixation. Images were background 
subtracted and averaged though the stack to improve the signal to noise ratio. (a) BODIPY-
sphingolipid domains are visible in the plasma membrane of the living Clone 15 cell under 
physiological conditions. Scale bar is 10 μm. Enlargement of the region indicated in (a) reveals 
the sizes and distribution of BODIPY-sphingolipid domains in the plasma membrane of the 
living Clone 15 cell. Enlarged view of the BODIPY-sphingolipid membrane domains (b) in the 
living cell and (c) following glutaraldehyde fixation. The sizes and distributions of the 
sphingolipid domains were largely unaltered by fixation. Images were acquired by collaborator 
Vladimir Lizunov at the National Institutes of Health in the laboratory of Joshua Zimmerberg. 
BODIPY-sphingosine was synthesized by Dr. Kaiyan Lou, and relevant cell culture protocols 
were developed by Raehyun Kim, both at the University of Illinois, Urbana-Champaign.  
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Fig. 2.9 SIMS images were acquired of the entire surface of a Clone 15 cell that was preserved 
with 37ºC glutaraldehyde solution. (a) The montage of secondary electron images shows the cell 
has normal morphology. (b) The montage of 15N-enrichment images that were acquired in 
parallel reveals the 15N-sphingolipid distribution in the plasma membrane. The 15N-sphingolipid 
domains are similar in appearance to those in the membranes of the cells that were fixed with 
room temperature glutaraldehyde solution. The mean 15N-enrichment factor for the entire surface 
and the domain-free regions on the cell are 9.2 (solid arrow, s.d. = 4.8) and 7.4 (open arrow, s.d. 
= 2.8), respectively. Cells preserved at 37ºC were cultured, preserved, characterized, and 
analyzed using NanoSIMS by Haley Klitzing. 
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Fig. 2.10 NanoSIMS images of two additional Clone 15 fibroblast cells that were preserved with 
37ºC glutaraldehyde solution. The montages of 15 μm by 15 μm secondary electron images that 
were acquired in parallel to the lipid-specific secondary ions show the morphologies of the 
second (a, Cell 2 37ºC) and third (b, Cell 3 37ºC) Clone 15 fibroblast cell that was preserved 
with 37ºC glutaraldehyde solution. The 15N-enrichment images show the local abundance of the 
15N-sphingolipids in the membranes of Cell 2 37ºC (c) and Cell 3 37ºC (d). The color scale 
represents the 12C15N-/12C14N- ratio divided by the natural abundance ratio. (c) The mean 15N-
enrichment factor for the entire surface (solid arrow) and the domain-free regions (open arrow) 
on Cell 2 37ºC are 8.5 (s.d. = 4.6), and 5.1 (s.d. = 1.9), respectively. (d) The mean 15N-
enrichment factor for the entire surface (solid arrow) and domain-free regions (open arrow) on 
Cell 3 37ºC are 6.3 (s.d. = 3.4) and 5.6 (s.d. = 2.4). Cells preserved at 37ºC were cultured, 
preserved, characterized, and analyzed using NanoSIMS by Haley Klitzing. 
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Fig. 2.11 Sphingolipid-enriched domain size and spatial distribution. (a) The 15N-sphingolipid 
domains detected with the particle definition algorithm at a region on a Clone 15 cell are outlined 
in white. (b) The frequency distributions of sphingolipid domain sizes measured on cells fixed 
with either room temperature (rt) or 37°C glutaraldehyde solution, or treated with methyl-β-
cyclodextrin (mβCD) show these treatments did not affect microdomain size. (c) Plot of the 
Ripley's K-test statistic, L(r) – r, as a function of distance. Data are normalized so the 99% 
confidence interval (CI 99, dashed line) equals one. L(r) – r exceeds the CI 99 for all accessible 
distances >0.2 μm regardless of fixation temperature, signifying non-random microdomain 
clustering. Cholesterol depletion decreased domain clustering at distances >2 μm. (d) Plot of the 
difference between the frequency distribution of nearest neighbor (NN) domain distances 
measured for the observed (expt) domains (inset) and a simulated (sim) random domain 
distribution on the cell body versus distance. For all treatments, NN distances of approximately 
200 nm occurred more often than expected for a random distribution. (e) Difference in the 
pairwise domain distances (PD) measured for the observed and simulated randomly distributed 
domains is plotted as a function of distance. For both fixation temperatures, the higher 
occurrence of domain-domain distances between 5 and 10 μm than expected for randomly 
distributed domains (inset) indicates the microdomain clusters were more abundant within 5 to 
10 μm diameter patches on the cell body. Treatment with mβCD disrupted this long-range 
microdomain organization.  
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Fig. 2.12 A metabolically labeled mouse fibroblast cell that does not express influenza 
hemagglutinin (NIH-3T3 cell line, the parent line from which Clone 15 was derived) was 
chemically fixed and imaged with SIMS. (a) Montage of secondary electron images of the NIH-
3T3 fibroblast that were acquired with NanoSIMS. Cracks in the cell (arrows) occurred after cell 
dehydration. (b) Montage of 15N-enrichment images that were acquired in parallel to the 
secondary electron images shows domains enriched with 15N-sphingolipids were present in the 
plasma membrane. This indicates that influenza hemagglutinin is not required for sphingolipid 
domain formation. The color scale shows the 15N-sphingolipid enrichment compared to an 
unlabeled cell. 
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Fig. 2.13 TIRFM detection of (a) BODIPY-sphingolipids (green) and (b) influenza 
hemagglutinin (red) in the plasma membrane of a living Clone 15 cell at 37 C. (c) The overlay 
of the two images shows co-localization between the sphingolipids and hemagglutinin, denoted 
by the yellow color. Stacks of 120 frames were collected for each channel and averaged to 
increase signal to noise ratio. Final image is shown at 2x magnification without interpolation. 
The influenza hemagglutinin was partially co-localized with the sphingolipid domains. Confocal 
microscopy was performed by Vladimir Luzinov at the National Institutes of Health. 
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Fig. 2.14 SEM and 15N-enrichment images of a cholesterol-depleted Clone 15 fibroblast cell. (a) 
Secondary electron microscopy image of a cholesterol-depleted Clone 15 fibroblast cell. (b) 
Montage of 15N-enrichment images of the same cholesterol-depleted Clone 15 cell. The color 
scale shows the 15N-sphingolipid enrichment compared to an unlabeled cell. The mean 15N-
enrichment for domain-free regions and the entire cell are 8.9 (open arrow, s.d. = 6.4), and 10.3 
(solid arrow, s.d. = 8.7), respectively. Lateral variations in the 15N-enrichment, and thus the 
sphingolipid distribution, were detected.  
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Fig. 2.15 Secondary electron microscopy (SEM) and NanoSIMS images of a second Clone 15 
fibroblast cell that was treated with methyl-beta-cyclodextrin (mβCD). (a) The SEM images of 
the Cell 2 mβCD was cropped and rotated for comparison to the NanoSIMS images. (b) Montage 
of 15N-enrichment images acquired on the same mβCD-treated Clone 15 cell. The color scale 
shows the measured 15N-sphingolipid enrichment at each pixel. The mean 15N-enrichment for 
domain-free regions and the entire cell are 14.2 (open arrow, s.d. = 6.9), 17.2 (solid arrow, s.d. = 
11.8), respectively. 
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Fig. 2.16 Images of a third mβCD-treated Clone 15 fibroblast cell that were acquired with SEM 
and NanoSIMS. (a) The SEM image acquired of Cell 3 mβCD was rotated and cropped to 
facilitate comparison to the NanoSIMS images. (b) Montage of 15N-enrichment images of the 
same mβCD-treated Clone 15 fibroblast cell. The color scale shows the measured 12C15N-
/12C14N- ratio divided by the natural abundance ratio, corresponding to the 15N-sphingolipid 
enrichment compared to the unlabeled cell. The mean 15N-enrichment factors for domain-free 
regions and entire cell are 8.3 (open arrow, s.d. = 3.6), and 10.0 (solid arrow, s.d. = 5.3), 
respectively. 
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Fig. 2.17 The diameter of the 133Cs+ primary ion beam used to acquire the NanoSIMS images of 
the cells was determined by taking a line scan on the NanoSIMS secondary electron image 
(yellow line) and calculating the distance over which the secondary electron counts decreased 
from 84% to 16% of the maximum. The 84% and 16% intensity is indicated by vertical dashed 
lines, and the coordinates are provided near their positions on line scan. The 133Cs+ primary ion 
beam has a diameter of 69 nm. 
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Fig. 2.18 a) The frequency distribution of 15N-enrichment factors measured at 59,301 ROIs on 
Cell 1 (Figs. 2.2, 2.3, and 2.5) was fit with a normal distribution (8.9 ± 3.5) or a mixture of two 
normal distributions (7.8 ± 2.1 and 12.0 ± 3.7). b) Plot of the empirical and model cumulative 
distributions shows the data is better fit by the mixture of two normal distributions, confirming 
the plasma membrane contains sphingolipid-enriched domains. 
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Fig. 2.19 a) Frequency distribution for 15N-enrichment factors measured at 65,633 ROIs on Cell 
2 (Fig. 2.6a, c, and e) was fit with a unimodal normal distribution (9.9 ± 3.7) and a mixture of 
two normal distributions (8.9 ± 2.7 and 14.6 ± 3. 6). b) Plot of the cumulative distributions for 
the experimental and modeled data confirms that the experimental data is better fit by the 
mixture of two normal distributions.  
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Fig. 2.20 a) The frequency distribution for 15N-enrichment factors measured at 66,655 ROIs on 
Cell 3 (Fig. 2.6b, d, and f) was fit with a unimodal normal distribution (8.5 ± 3.7) and a mixture 
of two normal distributions (8.4 ± 2.7 and 14.7 ± 6.1). b) Plot of the empirical and model 
cumulative distributions confirms that the data is better fit by the mixture of two normal 
distributions.  
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Scheme 2.1 Conditions: (a) CH3COCl, MeOH, reflux, quantitative; (b) (Boc)2O, Et3N, THF, 
95%; (c) DMP, cat. BF3·OEt2, Acetone, 78%; (d) LAH, THF, 92%; (e) IBX, DMSO, 69%; (f) 
LiC≡C(CH2)12CH3, THF, -23oC, 74%; (g) Li, EtNH2, -78oC to r.t., 60%. 
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Table 2.1 Characteristics of cell membrane area and sphingolipid domains in Clone 15 cells. 
 
Cell 1 
rt 
Cell 2 
rt 
Cell 3 
rt 
Cell 1  
37 °C 
Cell 2  
37 °C 
Cell 3  
37 °C 
Cell 1 
mβCD 
Cell 2 
mβCD 
Cell 3 
mβCD 
Cell surface 
area (μm2) 718 518 513 1430 668 357 348 214 237 
Number of 
domains 2190 2729 1236 2352 2508 1479 158 342 309 
Mean domain 
area (μm2) 
0.033 ± 
0.023 
0.029 ± 
0.026 
0.038 ± 
0.032 
0.033 ± 
0.027 
0.025 ± 
0.020 
0.031 ± 
0.023 
0.025 ± 
0.019 
0.027 ± 
0.019 
0.031 ± 
0.024 
Mean effective 
domain 
diameter (nm) 
194 ± 
63 
182 ± 
67 
205 ± 
80 
194 ± 
72 
170 ± 
58 
189 ± 
64 
170 ± 
57 
177 ± 
59 
188 ± 
66 
Cell surface 
coverage (%) 10 15 9 8 10 13 1 4 4 
Domains/μm2 
body 5.8 6.4 3.2 2.7 4.9 5.1 0.9 1.8 1.8 
Domains/μm2 
extensions 0.9 1.3 1.1 1.3 0.7 1.4 0.2 0.8 0.5 
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Table 2.2 Characteristics of sphingolipid domains on Clone 15 cells that were subjected to 
various treatments. 
 Cell1 Cell 2 Cell 3 Cell 1 
37°C 
Cell 2 
37°C 
Cell 3 
37°C 
Cell 1 
mβCD 
Cell 2 
mβCD 
Cell 3 
mβCD 
Mean 15N-
enrichment 
factor on entire 
cell (mean ± σ) 
9.5 ± 
3.6 
10.3 ± 
3.7 
9.1 ± 
3.7 
8.5 ± 
4.6 
9.2 ± 
4.8 
6.3 ± 
3.4 
10.3 ± 
8.7 
17.2 ± 
11.8 
10.0 ± 
5.3 
Number (total 
area, μm2) of 
ROIs on cell 
surface 
59,301 
(457.5) 
65,633 
(506.3) 
66,655 
(514.2) 
145,332 
(1100) 
94,000 
(711.5) 
130,537 
(332.6) 
46,232 
(349.9) 
23,710 
(179.1) 
28,677 
(217.1) 
Minimum 
statistically 
significant local 
elevation in 15N-
enrichment 
12.0 14.3 13.8 8.9 13.0 10.4 21.7 28.0 15.5 
Mean 15N-
enrichment 
factor for non-
domains 
7.8 ± 
2.1 
8.9 ± 
2.7 
8.4 ± 
2.7 
5.1 ± 
1.9 
7.4 ± 
2.8 
5.6 ± 
2.4 
8.9 ± 
6.4 
14.2 ± 
6.9 
8.3 ± 
3.6 
p-value for test 
of difference in 
13C-enrichment 
factors in 
domain and 
non-domain 
areas (p < 0.05 
is statistically 
significant) 
0.99 0.34 0.59 0.52 0.46 0.50 0.45 0.48 0.49 
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Table 2.3 Characteristics of domain and non-domain regions of 15N-sphingolipid enrichment in 
isotope-labeled Clone 15 cells. 
 
 
 
 
 
 Cell 1  Cell 2  Cell 3  
Mean 15N-enrichment factors measured on entire cell (mean ± σ) 9.5 ± 
3.6 
10.3 ± 
3.7 
9.1 ± 
3.7 
Approach 1: 15N-enrichment factor measured in non-domain regions of cell 
 Mean 15N-enrichment factor in non-domain ROIs  7.5± 2.2 7.7 ± 2.1 
7.2 ± 
2.2 
Number of non-domain ROIs analyzed 23,846 4,886 22,584 
Total area of non-domain ROIs used to calculate the mean non-domain 15N-
enrichment factor (μm2) 183.9 37.7 174.2 
Minimum 15N-enrichment factor denoting a statistically significant elevation 
(meannon-domain + 2σnon-domain) 
11.9  12.0  11.7  
Approach 2: fits of experimental frequency distribution of 15N-enrichment factor 
Number of ROIs of cell used to construct frequency distribution 59,301 65,633 66,655 
Total area of all ROIs in frequency distribution (μm2) 457.5 506.3 514.2 
2 Normal distribution model: Mixing coefficient 0.6027 0.81 0.8954 
2 Normal distribution model: Mean 1 ± σ 7.8 ± 
2.1 
8.9 ± 
2.7 
8.4 ± 
2.7 
2 Normal distribution model: Mean 2 ± σ 12.0 ± 
3.7 
14.6 ± 
3.6 
14.7 ± 
6.1 
1 Normal fit: Mean ± σ 8.9 ± 
3.5 
9.9 ± 
3.7 
8.5 ± 
3.7 
p-value for Kruskal-Wallis test of whether 13C-enrichment factors measured in 
domain and non-domain membrane regions are statistically significant (p < 0.05 is 
statistically significant) 
0.99 0.34 0.59 
Mean 13C-enrichment factors measured on entire cell (mean ± σ) 16.3 ± 
22.5 
22.9 ± 
23.9 
26.3 ± 
25.6 
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Table 2.4 Statistics of isotope enrichment measured on cells in control experiments. 
Sample Description 15N-enrichment 13C-enrichment Area 
(μm2) 
Number of 
ROIs 
1 Metabolically labeled cell (positive control) 8.0 ± 3.2 12.4 ± 22.4 81.7 23,777 
2 
Metabolically labeled live cell 
incubated in label-free media for 
30 min 
8.8 ± 2.2 20.2 ± 12.9 84.1 6,126 
3 Live unlabeled cell incubated in labeling media for 30 min 1.1 ± 0.5 1.2 ± 5.6 78.5 22,843 
4 Fixed unlabeled cell incubated in labeling media for 30 min 1.0 ± 0.5 0.8 ± 5.1 69.1 20,115 
5 Unlabeled cell (negative control) 1.0 ± 1.0 0.7 ± 5.3 78.6 22,898 
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CHAPTER 3.  
SPHINGOLIPID DOMAINS IN THE PLASMA MEMBRANES  
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Introduction 
The plasma membrane of the cell is composed fundamentally of a lipid bilayer. Initially 
thought to a passive structural feature that simply separates the interior of the cell from its 
environment and provides a scaffold for membrane-associated and transmembrane proteins, the 
plasma membrane is now understood to be a dynamic structure with lateral organization that 
facilitates myriad cell processes.1 The last decade has seen a flurry of research devoted to 
understanding this lateral organization, and perhaps the most studied aspect of membrane 
structure is lipid rafts.2 These features are thought to be small (tens to hundreds of nanometers) 
domains within the membrane, characterized by enrichment in sphingolipids and cholesterol, that 
provide locations for protein clustering and platforms for various events such as signaling,3 
trafficking,4 and virus entry5 and budding.6 However, the existence of these assemblages remains 
controversial due to a lack of chemically specific and spatially well-resolved compositional data, 
and inconsistencies in the reported properties of lipid domains.7 
As described in the previous chapter, we used a high-resolution secondary ion mass 
spectrometry technique to map the distribution of 15N-enriched ions generated by the 
metabolically incorporated 15N-sphingolipids in the plasma membranes of intact fibroblast cells.8 
We demonstrated that the plasma membrane contained micrometer-scale sphingolipid patches 
consisting of numerous 15N-sphingolipid microdomains with mean diameters of ~200 nm. These 
assemblages are best referred to as sphingolipid domains, and not lipid rafts, because lipid rafts 
are defined as small membrane domains that are enriched with cholesterol and sphingolipids, and 
the cholesterol distribution was not chemically imaged previously.9 In this report, high-resolution 
imaging mass spectrometry was utilized to map the distribution of metabolically incorporated 
18O-cholesterol and 15N-sphingolipids in the plasma membranes of intact cells to evaluate the 
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degree of colocalization between these two components. As described in the previous chapter, 
we studied a mouse fibroblast cell line that stably expresses influenza hemagglutinin (Clone 15 
cell line), and the parent mouse fibroblast cell line that does not express influenza hemagglutinin 
(NIH-3T3 cell line). We selected these cell lines because sphingolipid-enriched domains are 
present in their plasma membranes,8 and the influenza hemagglutinin is hypothesized to cluster 
in domains enriched with cholesterol and sphingolipids.10,11  
Surprisingly, the sphingolipid domains in the plasma membrane were not enriched with 
cholesterol. By investigating the cholesterol distribution before and after mβCD treatment, we 
have determined that mβCD did not selectively remove the cholesterol from the domain or non-
domain regions in the plasma membrane. This finding agrees with the results described in the 
previous chapter in which we found that depletion of cellular cholesterol with methyl-β-
cyclodextrin (mβCD) did not abrogate sphingolipid microdomains, though it did reduce their 
abundance and long-range clustering.8  
Results 
Sphingolipid domains in the plasma membranes of mouse fibroblast cells are not enriched 
with cholesterol 
High resolution imaging mass spectrometry was used to analyze the intact plasma 
membranes of fixed mouse fibroblast cells to determine the distributions of sphingolipids and 
cholesterol. We metabolically incorporated distinct stable isotope labels into the cellular 
sphingolipids and cholesterol such that in the Clone 15 and NIH-3T3 cells, 88% and 92%, of the 
sphingolipids contained one nitrogen-15, respectively, and 56% and 68% of the cellular 
cholesterol contained one oxygen-18, respectively. To prepare the cells for high vacuum, they 
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were chemically fixed and air dried; as described in the previous chapter, this method of 
preservation does not induce lipid reorganization, and the 15N-sphinoglipid distributions we 
observe are representative of the distributions in live cells.8 The distributions of 15N-
sphingolipids and 18O-cholesterol in the plasma membranes were simultaneously visualized by 
constructing quantitative 15N-enrichment (12C15N-/12C14N- ratio divided by the natural abundance 
ratio, 0.00367) and 18O-enrichment (18O-/16O- divided by the natural abundance ratio, 0.0020052) 
images, respectively, which provides a value that quantifies the amount of 15N-sphingolipids or 
18O-cholesterol in the plasma membrane compared to an unlabeled (natural abundance) cell and 
negates concentration-independent effects such as topography.8,12  
Consistent with our previous findings, the 15N-enrichment images reveal irregular regions 
enriched with 15N-sphinoglipids (15N-enrichment is ~15-20 times natural abundance, as denoted 
by red, orange, and yellow regions in Fig. 3.1b) within a background of lower 15N-enrichment 
(15N-enrichment is ~5 times natural abundance, as denoted by blue regions in Fig. 3.1b). We 
observed micrometer-scale 15N-enriched regions that consist of clusters of sphingolipid domains 
with an average diameter of ~200 nm, and are concentrated primarily toward the center of the 
cell. Analysis of the 15N-enrichment factors measured at 3 by 3-pixel subregions on the Clone 15 
cell indicates that the plasma membrane contains two distinct populations of sphingolipids: a 
lower, baseline concentration that is present among the lipids that form the bulk membrane, and 
a higher concentration localized to discrete domains. From this analysis, we found that a 15N-
enrichment factor ≥9.28 represents a statistically significant elevation in the plasma membrane’s 
local 15N-sphingolipid abundance (mean 15N-enrichment factor for non-domain regions = 4.86, 1 
s.d. = 2.25). 
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Surprisingly, no obvious regions of cholesterol enrichment are visible in the 18O-
enrichment images. Instead, the cholesterol distribution appears to be constant within the plasma 
membrane (Fig. 3.1c). The cholesterol distribution also appeared to be homogeneous on the other 
three Clone 15 cells we analyzed (for example, see Fig. 3.2). Unlike the sphingolipids, the 
cholesterol distribution at the center appears to be the same as at the cell’s periphery. By visual 
inspection, the 18O-enrichment at the membrane regions that correspond to 15N-sphingolipid 
domains does not appear to be higher. Analysis of the mean (μ) 18O-enrichment in the domain (μ 
= 3.88, 1 s.d. = 9.28) and non-domain regions of the membrane (μ = 3.91, 1 s.d. = 5.96) and 
statistical analysis indicated the probability that the 18O-enrichment was higher in the 15N-
sphingolipid domains was ≤1%. Similarly, statistical analysis indicated that the probability that 
the 18O-enrichment in the 15N-sphingolipid domains was higher than in the non-domain regions 
of the membranes of the other three Clone 15 cells we analyzed was ≤21% (Table 3.1).  
The influenza hemagglutinin in the plasma membranes of the Clone 15 cells forms 
clusters that are hypothesized to be associated with sphingolipid- and cholesterol-enriched 
domains. Therefore, we also assessed whether the cholesterol distribution in the plasma 
membranes of mouse fibroblast cells that did not express influenza hemagglutinin (NIH-3T3 cell 
line, the parent cell line from which Clone 15 cell line was derived) differed from that of Clone 
15 cells. Domains enriched with 15N-sphingolipids were present in the plasma membranes of the 
NIH-3T3 cells (Fig. 3.3b, Fig. 3.4b), consistent with the results outlined in the previous chapter.8 
Similar to the Clone 15 cells, the 18O-enrichment images indicate that the 18O-cholesterol was 
not enriched within the 15N-sphingolipid domains (Fig. 3.3c, Fig. 3.4c). Quantitative analysis 
confirmed that statistically significant elevations in the 18O-enrichment were not present in the 
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15N-sphingolipid domains within the membranes of any of the four NIH-3T3 cells we analyzed 
(Table 1). 
 Based on these results, we conclude that cholesterol is not enriched in the sphingolipid 
domains present in the plasma membranes of the Clone 15 fibroblast cells and the parent 
fibroblast cell line that does not express hemagglutinin. Instead, cholesterol is evenly distributed 
within the plasma membrane. Thus, we reject the hypothesis that cohesive cholesterol-
sphingolipid interactions are responsible for sphingolipid clustering within the plasma 
membrane. 
mβCD does not remove cholesterol in a location-specific manner from the cell membrane 
Although our results indicate that the sphingolipid domains are not enriched with 
cholesterol, cholesterol depletion induces marked changes in cell physiology, including 
alterations in membrane stiffness,13 membrane-associated protein distribution,14 and cytoskeleton 
organization.15 In addition, in the previous chapter we showed that reduction of ~30% of the 
cholesterol in Clone 15 cells by treatment with mβCD does not eliminate the sphingolipid 
microdomains or alter their sizes, but it did drastically reduce the abundance and clustering of the 
sphingolipid microdomains. Therefore we investigated whether cholesterol depletion with mβCD 
induced a heterogeneous cholesterol distribution within the plasma membrane. 
 We analyzed metabolically labeled Clone 15 fibroblast cells whose cholesterol levels had 
been reduced by 30% by treatment with mβCD. Again, the montage of 15N-enrichment images 
shows that cholesterol depletion did not eliminate the heterogeneous distribution of sphingolipids 
(Fig. 3.5b and Fig. 3.6b). Sphingolipid-enriched regions, including domains and patches of 
clustered domains, that appear to range from hundreds of nanometers to a few microns in length 
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were still present in the plasma membrane. However, the surface coverage of these domains was 
reduced by ~75%, indicating that cholesterol depletion decreased the fraction of sphingolipids 
that were clustered into domains. The 18O-enrichment images show that mβCD treatment did not 
induce a heterogeneous distribution of cholesterol in the membrane, as the cholesterol remained 
relatively homogenously distributed (Fig. 3.5c and Fig. 3.6c). Quantitative analysis confirmed 
that 18O-enrichment, and thus the 18O-cholesterol abundance, within the 15N-sphingolipid 
domains and the non-domain regions on this cell did not exhibit statistically significant 
differences (Kruskal-Wallis test, p = 0.88). Likewise, the 18O-enrichments in the domain regions 
were not statistically different from those in the non-domain regions in the four other mβCD -
treated Clone 15 cells that we analyzed (Table 3.2). These data indicate that mβCD did not 
selectively remove cholesterol from the sphingolipid domains or from other discrete locations 
within the plasma membrane. 
Cholesterol depletion affects the actin cytoskeleton as assessed using fluorescence confocal 
microscopy 
If the formation of sphingolipid domains is not driven by sphingolipid-cholesterol 
interactions, other factors must be influencing membrane organization. Disruption of the actin 
cytoskeleton is known to affect membrane organization,16 so it is possible that cholesterol 
depletion affects membrane organization through the actin cytoskeleton instead of through 
disruption of sphingolipid- and cholesterol-enriched membrane domains. To evaluate the effect 
of cholesterol depletion on the cytoskeleton, fluorescence confocal microscopy was used to 
observe cells with fluorescently-labeled actin during cholesterol depletion. Human epithelial 
(HeLa) cells were selected for this experiment because they were more compatible with the 
actin-staining cell construct than either the Clone 15 or NIH-3T3 cells but were morphologically 
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consistent with these cells. The actin was labeled with GFP using CellLight Fluorescent Protein 
Constructs from Life Technologies, and the cells were excited with 488 nm light and observed 
before and during cholesterol depletion with 10 mM mβCD over the course of 45 min using 
confocal microscopy. The effects on the cytoskeleton were significant (Fig 3.7), as the fibers 
became less distinct and the cells retracted somewhat from their original dimensions. These 
changes are too dramatic to be attributed to photobleaching of the GFP over the course of the 
experiment. These images are representative of several locations that were imaged. This 
demonstrates that cholesterol depletion impacts the cytoskeleton in a global manner that far 
exceeds the disruption of discrete domains within the membrane. 
Cells quickly deploy cholesterol to the membrane during mβCD treatment 
During our initial processing of the NanoSIMS data for the cholesterol-depleted samples, 
it appeared that the amount of 18O-cholesterol signal obtained from the mβCD-treated samples 
was reduced by only ~20% as compared to untreated samples. This was unexpected, as analysis 
of the lipid extract of the whole cells indicated that ~30% of the total cellular cholesterol had 
been removed, and the vast majority of cholesterol is thought reside within the plasma 
membrane. This observation raised questions about the magnitude of the intracellular stores of 
cholesterol and how effectively these stores could be deployed to the membrane to replace the 
cholesterol removed by mβCD.  
These questions are answerable through a pair of experiments. The first experiment 
determines the percentage of total cellular cholesterol that the cell can transport to the membrane 
during depletion. This can be determined by comparing the amounts of total cellular cholesterol 
remaining in cells unable to transport cholesterol and in cells with normal cholesterol transport 
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after mβCD treatment. Cells that cannot transport cholesterol cannot replace the cholesterol in 
the membrane removed by mβCD as the depletion proceeds, and should retain a greater amount 
of total cellular cholesterol.  
The second experiment determines the percentage of membrane cholesterol that the cell 
can transport to the membrane during mβCD treatment. This can be found by comparing the 
amount of membrane cholesterol only in cells unable to transport cholesterol and in cells with 
normal transport. This provides information on the relative amount of membrane cholesterol that 
can be replaced from internal stores. 
Fluorescence-based 96-well plate assays were used to conduct both of these experiments 
with Clone 15 cells. For both experiments, three sample types were prepared: control cells (no 
treatment), cholesterol depletion only (treated with 10 mM mβCD for 15 min), and cholesterol 
transport inhibited and cholesterol depleted cells (treated with cholesterol transport inhibitor 
U18666A and mβCD). Experiments were performed with six wells of each sample type. The 
third set of cells was treated with the cholesterol transport inhibitor U18666A to abolish the 
cells’ ability to replace cholesterol removed by mβCD. Cells were grown overnight, and then the 
second and third sets of cells (transport unimpaired and transport impaired, respectively) were 
treated with mβCD. All three sets were then fixed with glutaraldehyde according to the 
procedure used to prepare cells for NanoSIMS analysis.8 
To measure the total cellular cholesterol, a membrane-permeable fluorescent compound 
that binds to cholesterol, Filipin III, was employed. After fixation, the cells were incubated with 
Filipin III, and the amount of cholesterol was assessed through the fluorescence intensity of the 
samples as measured using a plate reader. The fluorescence intensity was normalized to cell 
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count as assessed using propidium iodide, which intercalates between the bases of DNA; the 
propidium iodide signal is proportional to DNA material, and therefore, to cell count. mβCD-
treated cells with normal cholesterol transport contained 33% ± 46% and 37% ± 50% of total 
cellular cholesterol as compared with control cells in two repetitions of the experiment. mβCD-
treated cells with impaired cholesterol transport in the same three experiments contained 57% ± 
43% and 69% ± 39% of total cellular cholesterol as compared with control cells, respectively. 
Although the standard deviations are large within these values, the averages over six wells 
indicate that the cholesterol transport-impaired cells retained more cholesterol after depletion, 
indicating that cells normally transport cholesterol to the membrane during mβCD treatment (~1/5 
of total cellular cholesterol), which is removed as the cholesterol depletion proceeds; the cellular 
cholesterol in transport-impaired cells is protected from removal because it remains in the 
interior of the cell. This indicates that that a significant portion of the total cholesterol was in 
internal stores that could be mobilized to the membrane upon mβCD treatment. 
In the second experiment, the amount of plasma membrane cholesterol in cells was 
assessed using a cholesterol oxidase-based assay. Cholesterol oxidase is not membrane-
permeable, and so the internal cholesterol is not accessible to the enzyme. Three sets of cell 
samples, seven wells each, were prepared as before: the third set was treated with U18666A 
overnight, and subsequently the second and third sets of cells were treated with mβCD, and all 
three sets were fixed with glutaraldehyde. The assay produces a fluorescent read-out molecule 
via two reactions; first, the cholesterol oxidase catalyzes the oxidation of cholesterol and 
produces H2O2, then a second enzyme, horse radish peroxidase uses the H2O2 to convert the 
signal molecule, Amplex Red, from a non-fluorescent to the fluorescent form, resorufin. The 
relationship between the amount of cholesterol oxidized and the amount of fluorescent signal 
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molecule produced is linear. However, the results of these experiments were inconclusive; in 
four experiments, the results of two indicated that similar amounts of membrane cholesterol in 
transport unimpaired (52% ± 29% and 52% ± 19% of the amount of membrane cholesterol in 
control cells in two experiments) and transport impaired cells (50% ± 19% and 52% ± 9.1% of 
the amount of membrane cholesterol in control cells, respectively). Two other experiments 
showed that transport inhibited cells had more membrane cholesterol; cells with unimpaired 
cholesterol transport had 57% ± 19% and 39% ± 41% as compared to control cells, while cells 
with impaired cholesterol transport had 81% ± 13% and 57% ± 37% the amount of membrane 
cholesterol as compared to control cells in the same two experiments, respectively. Each sample 
set contains 5-7 wells. This was counter to the expected result, which was that transport-inhibited 
cells would have lower amounts of cholesterol in the membrane because they were unable to 
replenish lost membrane cholesterol.  
To obtain a conclusive result, more work is needed to optimize the experiment to reduce 
the standard deviation among values for each set of cells. Despite these ambiguous results from 
measuring the membrane cholesterol only, the first experiment in which total cellular cholesterol 
was measured supports the hypothesis that the cell can mobilize ~1/5 of total cell cholesterol to 
the membrane to replace the cholesterol being removed by mβCD during depletion. This helps to 
explain the discrepancy between the determination that ~30% of total cellular cholesterol was 
removed from cells under these depletion conditions, but the difference in 18O-cholesterol signal 
detected in the membrane between untreated and mβCD-treated cells in differed by only ~20%. 
The cells appear to have been replacing some of the membrane cholesterol from internal stores, 
minimizing the net reduction of cholesterol in the membrane. 
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Discussion 
The results of direct chemical imaging of cholesterol in the intact membranes of 
mammalian cells using high resolution secondary ion mass spectrometry reveal a homogeneous 
distribution of cholesterol. The concentration of cholesterol inside and outside of sphingolipid 
domains is statistically indistinguishable, meaning that sphingolipid domains are not enriched in 
cholesterol. This distribution was not affected by the presence of hemagglutinin in the cell 
membrane, and depletion using mβCD did not remove cholesterol in a location-selective manner. 
These results are contrary to the lipid raft hypothesis, which establishes co-enrichment of these 
two lipid components as part of the fundamental definition of a lipid raft,9 and they provoke a 
number of questions: if higher cholesterol concentrations are not always present in sphingolipid-
enriched domains, why have others concluded the opposite? And if sphingolipid-cholesterol 
interactions are not driving raft formation, what other explanations can account for 
heterogeneous membrane organization and the observed effects of cholesterol depletion? 
The hypothesis that sphingolipids and cholesterol colocalize in the plasma membrane to 
form lipid rafts was driven primarily by results of four types of experiments: 1) analysis of viral 
envelopes,17,18 2) extraction of detergent resistant membrane (DRM) fractions from cells,19,20 3) 
analysis of two- and three-component model membranes and the binding affinity of cholesterol 
with various lipid species,21 and 4) the observations that some cell functions and the overall cell 
structure were altered by cholesterol depletion. 
Influenza is a envelope virus, so named because the virus escapes an infected host cell by 
budding through its membrane, taking an envelope of lipids derived from the cell’s plasma 
membrane with it. For fifty years, it has been observed that several types of influenza have 
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envelopes that contain a higher proportion of cholesterol than is present in the host cell plasma 
membrane.17,18 It was concluded that viruses were exploiting a naturally-occurring feature in the 
plasma membrane of host cells that was enriched in cholesterol. These features were later 
associated with lipid rafts, as both rafts and influenza viral envelopes are believed to be enriched 
in sphingolipids as well as in cholesterol.22 However, these measurements are complicated by the 
fact that it is far easier to isolate pure virus particles for lipid composition analysis than it is to 
isolate the plasma membrane from all other cellular membranes (endoplasmic reticulum, Golgi 
apparatus, mitochondrial envelope, etc.), and it is possible that contamination from internal, 
sphingolipid- and cholesterol-deficient membranes have caused an underestimation of the 
cholesterol content in the plasma membrane.22 Moreover, it has not been determined whether 
influenza virus is capable of recruiting a particular lipid mixture around its proteins that does not 
naturally occur in the membrane in the form of lipid rafts, and it is possible that the virus is 
generating a domain enriched in sphingolipids and cholesterol for the purpose of budding.23 
 Secondly, extraction of DRM fractions was thought to efficiently isolate lipid rafts from 
the bulk membrane, and analysis of the components revealed they were enriched with cholesterol 
as compared to the bulk plasma membrane.20 This theory gained further support when it was 
found that cholesterol depletion before detergent extraction reduced or eliminated the DRM 
fraction recoverable from the plasma membrane, suggesting the cholesterol was integral to the 
formation and persistence of lipid rafts.24 However, it has been shown that components that 
originate in various membranes and compartments within the cell end up in the DRM fraction, 
and that cholesterol may be preferentially associating with the DRM fraction during the 
extraction,25 meaning that DRMs do not accurately represent features present in the native 
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membrane structure and that these results cannot be taken as proof that cholesterol associates 
with sphingolipids in the plasma membrane in living cells. 
 Thirdly, work in model systems has shown the cholesterol associates preferentially with 
sphingolipids over other types of lipids found in the cell membrane,26,21 and that cholesterol 
imposes a greater order on the lipids with which they associate.27 Detergent extraction 
experiments performed with model systems reinforced the results observed in cells, that phases 
high in cholesterol content were less soluble to detergent, and that the absence of cholesterol 
abolished this resistance.28 However, not all studies in model systems have supported the 
conclusion that lipid rafts are enriched in cholesterol as well as sphingolipids. Studies performed 
using such varied approaches including NMR, differential scanning calorimetry (DSC), x-ray 
diffraction (XRD), fluorescence microscopy, and component analysis of vesicles examining the 
diffusion and phase separation of lipids in model systems determined that cholesterol shows no 
preference for the liquid ordered (lo) state over the liquid disordered (ld) state and has no specific 
interactions with saturated lipids that would create an enrichment of cholesterol within 
sphingolipid-enriched domains.29,30 Cholesterol has, in fact, been shown to form complexes with 
phospholipids in model systems to roughly the same extent to which it forms complexes with 
sphingolipids.31 Moreover, Ayuyan and Cohen32 have shown that exposing fluorescent lipid 
species in model systems to fluorescent light can cause peroxidation of lipids and induce the 
formation of large domains artificially, casting doubt on the validity of this approach.33 
Fourthly, using fluorescence microscopy, many types of proteins are observed to cluster 
in the membrane, and this clustering is dependent upon cholesterol.34 When cells are depleted of 
cholesterol, the clustering behavior of the proteins changes dramatically and they either form 
much smaller clusters or assume a random distribution. Because previous experiments, as 
 109 
 
discussed above, had connected so solidly the concepts of cholesterol dependence with lipid 
rafts, these proteins were assumed to be clustering within lipid rafts.35 However, these 
experiments visualize only the localization of proteins and not lipids within the membrane, and 
are not generating chemically-specific compositional data with regards to either type of 
biomolecule. The lipid composition in these areas is entirely inferred from the localization of the 
observed proteins. 
Taken together, these contradictory results undermine the hypothesis that lipid rafts are, 
by definition, enriched in cholesterol, a hypothesis originating from indirect analysis of cell 
membranes, and potentially over-simplified model systems. On the other hand, direct analyses of 
cholesterol-sphingolipid interactions going back three decades have produced evidence that 
cholesterol partitions with both phospholipids and sphingolipids and provide a basis for the 
relatively homogeneous distribution of cholesterol in the plasma membrane of mammalian cells 
as we have observed.  
How, then, is it possible that numerous researchers examining plasma membrane 
organization in cells conclude that rafts must be cholesterol-enriched in order to function? 
Perhaps evidence arising from viral envelopes and detergent extraction was suggestive enough of 
sphingolipid- and cholesterol-enriched lipid rafts to establish the theory within the field, and 
subsequent experimental evidence was interpreted in light of this theory. Cholesterol is clearly 
important to cell function and the plasma membrane, as evidenced by depletion experiments that 
show drastic changes in cell function36,37 and membrane organization,38 and lipid rafts were 
invoked as a mechanism to explain these observations, but no direct evidence of the existence of 
lipid rafts has been produced. It appears increasingly likely that cholesterol directly influences 
some other downstream event or pathway besides membrane organization. 
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Another theory has emerged that illuminates the relationship between cholesterol and 
membrane organization and reconciles the results we present here with the common wisdom of 
the lipid raft field. The plasma membrane is intricately interconnected with the underlying 
cytoskeleton, which forms a meshwork that compartmentalizes the membrane bilayer by 
corralling or pinning membrane components into certain locations.34,39,40 It has been established 
that the integrity of the actin cytoskeleton is dependent upon cholesterol (but independent of 
cholesterol-enriched membrane domains), so if the cytoskeleton influences membrane 
organization, it is logical that cholesterol depletion would affection membrane organization 
indirectly through alteration of the cytoskeleton.16 This result could be difficult to distinguish 
from a direct relationship between cholesterol and sphingolipid-enriched domains. In addition, 
preliminary experiments performed by our research group indicate significant cytoskeletal 
remodeling during cholesterol depletion, signifying the global effects of cholesterol depletion on 
cells well beyond the disruption of individual lipid rafts. 
Increasing numbers of studies are reporting on the role of the cytoskeleton in membrane 
organization. A study employing stimulated emission depletion (STED) nanoscopy in tandem 
with fluorescence correlation spectroscopy (FCS) probed the diffusion rates of lipids with 
varying head groups and tail lengths/degree of saturation in male rat kangaroo kidney epithelial 
(PtK2) cells found that sphingomyelin, GM1, and similar lipids displayed diffusion rates 
characteristic of molecules forming transient complexes and becoming briefly trapped in areas 
~20 nm in diameter for 10-20 ms.41 Upon cholesterol depletion using enzymatic degradation, the 
diffusion of some of the raft-associated lipids such as sphingomyelin appeared to approach that 
of a freely-diffusing lipids but others like GM1 still experienced significant trapping. Treatment 
using an actin-depolymerizing drug (Latrunculin B) produced a similar pattern of altered 
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diffusion rates and, as the authors concluded, there appeared to be a strong correlation between 
the effects of cholesterol depletion and those of cytoskeleton disruption. This suggests that 
depletion of cholesterol affects the actin cytoskeleton, and the change in membrane organization 
seen after cholesterol depletion results from changes to the cytoskeleton and not to membrane 
domains directly.41 In a separate study, the disruption of the cytoskeleton using Latrunculin B 
increased protein mobility in the plasma membrane in MDCK cells, indicating that lipid-lipid 
interactions were only partially contributing to the lateral organization of the membrane.42 
Observation of a voltage-gated potassium channel and the actin cytoskeleton simultaneously 
using fluorescence microscopy revealed that the channels were restricted solely by the 
cytoskeleton and not by the membrane bilayer composition in HEK cells.43 
These results support a more complex model of membrane organization that is consistent 
with the cholesterol distribution data we present here. Instead of cholesterol-sphingolipid 
determining membrane organization, interactions with the cytoskeleton could significantly 
contribute to the organization of sphingolipids and other membrane components, where 
cholesterol abundance influences cytoskeletal organization through a mechanism that does not 
involve cholesterol-rich domains but is presently underdetermined. The cell relies upon having 
the correct cholesterol content for normal function, and acute cholesterol depletion has global 
effects on cell morphology and metabolism that reach far beyond local organization within the 
plasma membrane. It is therefore logical that cholesterol depletion would affect the membrane 
through several pathways. This would account for the cholesterol distribution we observed using 
high resolution secondary ion mass spectrometry, what is known about cell membrane biology, 
and the results obtained by other researchers. More research is needed to confirm this hypothesis 
and develop a more sophisticated understanding of membrane biology. 
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The experiments assessing the degree to which cells replace membrane cholesterol 
removed by mβCD indicate that cholesterol depletion must be severe in order to create a large 
cholesterol deficit in the membrane. Because cholesterol is so critical to the maintenance of 
proper membrane fluidity and function, it is not surprising that the cell would tightly control its 
concentration and would react quickly and dramatically to replace lost cholesterol. Clearly, the 
cell was unable to restore normal organization within the membrane and the cytoskeleton within 
the short time period between the onset of depletion and cells fixation based on the results 
obtained with NanoSIMS, but the effect of greatly enhanced cholesterol transport to the 
membrane may deserve consideration in depletion studies. 
Materials and Methods 
Materials. 18O-i-cholesteryl methyl ether was purchased from Sigma, and H218O was purchased 
from Olinax Inc. 96-well plates were purchased from Becton Dickinson Labware. U1866A 
cholesterol transport inhibitor was purchased from Cayman Chemical. The Amplex Red 
Cholesterol Assay Kit was purchased from Invitrogen. All other materials were obtained as listed 
in the Materials section of Chapter 2. 
Synthesis of 15N-sphingolipid precursors and 18O-cholesterol. A 1:1 mixture of sphingosine 
and sphinganine each bearing a single nitrogen-15 atom were synthesized as previously 
described in refs. 44, 45, and 8. The synthesis of 18O-cholesterol was carried out according to the 
methods published in references and 46 and 44, 47. 
Metabolic labeling of Cells. Cells were cultured in high-glucose DMEM supplemented with 
10% calf serum, 104 U/mL penicillin G, 10 mg/mL streptomycin, 3.2 μM mixture of 15N-
sphingolipid precursors, and 20 μM ethanolamine at 37°C and 5% CO2 for two days. Additional 
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15N-sphingolipid precursor mixture and ethanolamine were added on the second day to final 
concentrations of 3.2 μM and 20 μM, respectively, to maintain the available pool of isotope-
labeled metabolites. On Day 3, the cells were passaged into DMEM supplemented with 1% calf 
serum, 10% lipid-reduced fetal bovine serum, 3.2 μM mixture of 15N-sphingolipid precursors, 50 
μM 18O-cholesterol (2:5 mass ratio of 18O-cholesterol:fatty acid-free BSA), and 20 μM 
ethanolamine. Additional 15N-sphingolipid precursors, 18O-cholesterol, and ethanolamine were 
added on the fourth day to the final concentrations noted above to maintain the available pool of 
isotope-labeled metabolites. On Day 5, the cells were passaged into media identical to that used 
for the previous passage, and 5 mm by 5 mm silicon substrates coated with poly-L-lysine were 
included at the time of passaging. On Day 6, the silicon substrates were removed and processed 
for high resolution SIMS analysis, and the remaining cells were harvested and used to assess 
label incorporation. 
Cell preservation. See Methods in Chapter 2. 
Method and assessment of cholesterol depletion of cells. Harvesting and isotope enrichment 
determination were performed as described in Chapter 2. The amount of cholesterol as compared 
to total phospholipid in MΒCD-treated cells and in untreated, isotope-labeled (control) cells was 
determined as reported.48 
Lipid extraction and isotope enrichment assessment. Isotope incorporation was assessed as 
reported in Chapter 2. Gas chromatography-mass spectrometry (GCMS) was used to evaluate the 
incorporation of 18O-cholesterol. An Agilent 1100 LC and an Agilent MSD Trap XCT Plus mass 
spectrometer were used to perform the separation and mass analysis, respectively. Conditions 
used for the GC were: isothermal run was performed at 295°C for 15 min; the inlet was used in 
splitless mode at 280°C; the column used was an HP-5MS, 30 m in length, internal diameter 250 
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μm, film thickness 0.25 μm, and a helium gas flow rate of 2 mL/min. Enrichment of the lipid 
extract with 18O-cholesterol was determined using the molecular radical (M·) peaks of 16O-
cholesterol at m/z 386 and 18O-cholesterol at m/z 388.  
SEM imaging. Samples were imaged using a Hitachi S4800 high resolution SEM at 1 keV and 8 
mm working distance. 
NanoSIMS Analysis. To prevent sample charging during high resolution SIMS analysis, 
samples were coated with ~3 nm of iridium using a Cressington 208HR high resolution sputter 
coater with a MTM-20 thickness controller prior to mass spectrometry analysis. High resolution 
SIMS was performed using a Cameca NanoSIMS 50 instrument (Cameca, France) housed at 
Lawrence Livermore National Laboratory (Livermore, CA). Analysis regions of 15 x 15 µm2 
were acquired using a ~0.12 pA, 15 keV 133Cs+ primary ion beam with a ~75 nm spot size. Eight 
replicate scans of 512 x 512 pixels with a dwell time of 1 ms/pixel were acquired for each 15 x 
15 µm2 analysis region, resulting in a pixel size (29 x 29 nm2) smaller than the beam diameter. 
The 12C14N-, 12C15N-, 13C14N-, 16O-, and 18O- secondary ions were collected using a technique 
termed peak-hopping, in which two distinct magnetic fields are established and are used in 
alternating raster scans. This was necessary because the physical size of the trolleys precluded 
positioning them close enough to collect the 12C14N- and 13C14N- isobars simultaneously. B field 
1 was used to collect 16O-, 18O-, 12C14N-, and 12C15N- in scans 1, 3, 5, and 7; B field 2 was used to 
collect 16O-, 18O-, 12C14N-, and 13C14N- in scans 2, 4, 6, and 8. A mass resolving power of ~6,700 
was achieved. 
Image analysis. L'image (L.R. Nittler, Carnegie Institution of Washington) run on the PV-Wave 
platform (Visual Numerics, Inc.) was used to process high resolution SIMS data, including: 
determination of the primary ion beam diameter; generating isotope enrichment images; defining 
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regions of interest (ROIs); and exporting quantitative data from the ROIs.8 Quantitative 15N- and 
18O-enrichment images that reveal the distributions of 15N-sphingolipids and 18O-cholesterol, 
respectively, were constructed by taking the ratio of the signals from the isotope-labeled 
secondary ion and the corresponding unlabeled secondary ion (12C15N-/12C14N- and 18O-/16O-, 
respectively), dividing by the natural abundance ratio (0.00367 and 0.0020052, respectively), and 
applying a 3 x 3-pixel boxcar smoothing algorithm. This process results in isotope enrichment 
images with 87-nm-lateral resolution that reveal the amounts of 15N-sphingolipids and 18O-
cholesterol in the plasma membrane as compared to an unlabeled cell. MatLab was used to fit the 
15N-sphingolipid data to one- and two-population models and to administer the Kruskal-Wallis 
and Kolmogorov–Smirnov tests to the 15N-sphingolipid and 18O-cholesterol distribution data to 
determine the statistical likelihood of co-localization as described in Chapter 2. Assessment of 
clustering, nearest neighbor distances, and domain-domain distances were assessed as 
described.10 
Confocal microscopy. An Andor Technology Revolution System Spinning Disk Confocal 
Microscope (06-0217-MAB) running the Andor IQ software platform and equipped with a 
Yokagawa CSU22 realtime spinning disk confocal unit was used to image HeLa cells at 488 nm. 
Fluorescence-based assays. Fluorescence measurements of cells grown in 96-well plates and 
stained with Filipin III or cholesterol oxidase were performed using a Synergy HT Multi-Mode 
Microplate Reader Model SIAFRT (Biotek® Instruments, Inc., Winooski, VT). Wavelengths 
used for Filipin III visualization were 360/460 nm, and 530/590 nm for cholesterol oxidase 
assay. 
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Figures and Tables 
 
 
 
 
 
Fig. 3.1 Images of an untreated Clone 15 murine fibroblast cell. (a) SEM image of the cell 
showing its general shape and morphology. The region blocked in white is approximately the 
region analyzed using NanoSIMS. (b) A mosaic of 15 × 15 μm 15N-enrichment images of the 
cell, showing the relative sphinoglipid enrichment across the membrane. The mean 15N-
enrichment factors for domain-free regions and the entire cell are 8.9 (open arrow, s.d. = 4.3) and 
10.4 (solid arrow, s.d. = 8.7), respectively. (c) A mosaic of 15 × 15 μm 18O-enrichment images of 
the cell, showing the relative cholesterol enrichment across the membrane. The mean 18O-
enrichment factor for the entire cell is 5.6 (s.d. = 18). 
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Fig. 3.2 Images of an untreated Clone 15 murine fibroblast cell. (a) SEM image of the cell 
showing its general shape and morphology. The region blocked in white is approximately the 
region analyzed using NanoSIMS. (b) A mosaic of 15 × 15 μm 15N-enrichment images of the 
cell, showing the relative sphinoglipid enrichment across the membrane. The mean 15N-
enrichment factors for domain-free regions and the entire cell are 15.8 (open arrow, s.d. = 7.3) 
and 18.1 (solid arrow, s.d. = 15.0), respectively. (c) A mosaic of 15 × 15 μm 18O-enrichment 
images of the cell, showing the relative cholesterol enrichment across the membrane. The mean 
18O-enrichment factor for the entire cell is 5.0 (s.d. = 22). 
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Fig. 3.3 Images of a NIH-
3T3 murine fibroblast cell. 
(a) SEM image of the cell 
showing its general shape 
and morphology. (b) A 
mosaic of 15 × 15 μm 15N-
enrichment images of the 
cell, showing the relative 
sphinoglipid enrichment 
across the membrane. The 
mean 15N-enrichment 
factors for domain-free 
regions and the entire cell 
are 6.9 (open arrow, s.d. = 
2.6) and 8.5 (solid arrow, 
s.d. = 6.8), respectively. (c) 
A mosaic of 15 × 15 μm 
18O-enrichment images of 
the cell, showing the 
relative cholesterol 
enrichment across the 
membrane. The mean 18O-
enrichment factor for the 
entire cell is 2.6 (s.d. = 16). 
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Fig. 3.4 Images of a second NIH-
3T3 murine fibroblast cell. (a) 
SEM image of the cell showing 
its general shape and morphology. 
(b) A mosaic of 15 × 15 μm 15N-
enrichment images of the cell, 
showing the relative sphinoglipid 
enrichment across the membrane. 
The mean 15N-enrichment factors 
for domain-free regions and the 
entire cell are 8.0 (open arrow, 
s.d. = 3.9) and 9.8 (solid arrow, 
s.d. = 6.7), respectively.  (c) A 
mosaic of 15 × 15 μm 18O-
enrichment images of the cell, 
showing the relative cholesterol 
enrichment across the membrane. 
The mean 18O-enrichment factor 
for the entire cell is 5.4 (s.d. = 
23). 
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Fig. 3.5 Images of a cholesterol-
depleted Clone 15 murine fibroblast 
cell. (a) SEM image of the cell 
showing its general shape and 
morphology. (b) A mosaic of 15 × 15 
μm 15N-enrichment images of the 
cell, showing the relative 
sphinoglipid enrichment across the 
membrane. The mean 15N-
enrichment factors for domain-free 
regions and the entire cell are 9.4 
(open arrow, s.d. = 2.9) and 10.1 
(solid arrow, s.d. = 5.1), respectively. 
(c) A mosaic of 15 × 15 μm 18O-
enrichment images of the cell, 
showing the relative cholesterol 
enrichment across the membrane. 
The mean 18O-enrichment factor for 
the entire cell is 3.2 (s.d. = 18). 
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Fig. 3.6 Images of a second 
cholesterol-depleted Clone 15 
murine fibroblast cell. (a) SEM 
image of the cell showing its 
general shape and morphology. 
(b) A mosaic of 15 × 15 μm 
15N-enrichment images of the 
cell, showing the relative 
sphinoglipid enrichment across 
the membrane. The mean 15N-
enrichment factors for domain-
free regions and the entire cell 
are 9.2 (open arrow, s.d. = 3.0) 
and 10.0 (solid arrow, s.d. = 
5.3), respectively. (c) A mosaic 
of 15 × 15 μm 18O-enrichment 
images of the cell, showing the 
relative cholesterol enrichment 
across the membrane. The 
mean 18O-enrichment factor for 
the entire cell is 3.3 (s.d. = 17). 
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Fig. 3.7 HeLa cells expressing a fluorescent protein construct bound to the actin cytoskeleton 
underwent cholesterol depletion using 10 mM mβCD for 45 min. The cells were imaged using 
fluorescence confocal microscopy at five min intervals. The panels show the cells at time point 
a) 20 min, b) 25 min, c) 30 min, d) 35 min, e) 40 min, and f) 45 min. 
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Table 3.1 Results of statistical analysis assessing whether cholesterol enrichment in domain 
regions is greater than in non-domain regions. 
Sample μ ± 1 s.d. 
domain 
μ ± 1 s.d. non-
domain 
Probability that enrichment in domain is 
higher than in non-domain regions 
(Kolmogorov-Smirnov right-tail test) 
Clone 15 Cell 1 3.88 ± 9.28 3.91 ± 5.96 <1% 
Clone 15 Cell 2 6.40 ± 9.02 5.09 ± 7.11 12% 
Clone 15 Cell 3 5.10 ± 9.33 5.20 ± 8.28 21% 
Clone 15 Cell 4 4.04 ± 7.59 3.60 ± 5.43 <1% 
NIH-3T3 Cell 1 3.56 ± 5.63 2.94 ± 3.83 <1% 
NIH-3T3 Cell 2 3.33 ± 7.08 2.55 ± 3.68 <1% 
NIH-3T3 Cell 3 7.04 ± 25.85 5.02 ± 10.97 <1% 
NIH-3T3 Cell 4 2.99 ± 7.02 2.58 ± 4.14 <1% 
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Table 3.2 Results of statistical analysis assessing whether cholesterol enrichment in domain 
regions is the same as in non-domain regions. 
Sample μ ± 1 s.d. 
domain 
μ ± 1 s.d. non-
domain 
Probability that enrichment in domains is 
same as enrichment in non-domain regions 
(Kruskal-Wallis test) 
mβCD Clone 15 cell 1 3.30 ± 6.81 3.24 ± 5.80 88% 
mβCD Clone 15 cell 2 3.34 ± 6.77 3.51 ± 5.86 17% 
mβCD Clone 15 cell 3 5.33 ± 11.01 5.11 ± 28.90 59% 
mβCD Clone 15 cell 4 1.95 ± 6.81 4.73 ± 8.76 45% 
mβCD Clone 15 cell 5 2.72 ± 5.90 3.63 ± 6.41 53% 
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CHAPTER 4. 
IDENTIFYING DIFFERENTIATION STAGE OF INDIVIDUAL  
PRIMARY HEMATOPOIETIC CELLS FROM MOUSE BONE MARROW BY 
MULTIVARIATE ANALYSIS OF TIME OF FLIGHT-SECONDARY ION MASS 
SPECTROMETRY DATA 
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Introduction 
 The body’s full spectrum of blood and immune cells is generated from a small number of 
hematopoietic stem cells (HSCs) that are located within the bone marrow.1-4 HSCs self-renew 
and differentiate into increasingly less-rare and more-mature HCs.2,5-9 This renders HSCs of 
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significant value for clinical treatment of hematopoietic pathologies and as models of stem cell 
differentiation.10  
Presently, much research focuses on developing culture systems that mimic the bone 
marrow’s chemotactic and micromechanical properties to enable control over HSC 
differentiation. Engineered biomaterials that exhibit spatial variations in mechanical properties 
and ligand presentation are especially attractive because they enable screening effects of multiple 
microenvironments on HSC fate using a minimal number of cells.11-13 To utilize such 
combinatorial systems, rigorous methodologies to aid identification of HC differentiation stage at 
the single cell level with location specificity are highly attractive. Currently, differentiation stage 
is most commonly assessed via fluorescence microscopy using cocktails of differentiation stage 
specific antibodies;14 however ambiguity from single-cell fluorescence analysis of small cell 
populations can be a significant drawback.15  
We hypothesized that information about the expression profiles of cell surface antigens as 
well as other differences in cell surface chemistry could be acquired with time-of-flight 
secondary ion mass spectrometry (TOF-SIMS), and exploited to identify the differentiation stage 
of individual HCs within a culture. Mass spectral maps of the molecules at the surface of an 
individual cell can be collected with TOF-SIMS.16-18 Because the spectra collected from 
biomaterials using TOF-SIMS instruments equipped with liquid metal primary ion sources are 
dominated by low mass (m/z<300) fragment ions that are common to multiple biomolecules, 
multivariate analysis is often employed to discriminate the spectra of biomolecules and cells.16,19-
30 Unknown samples have also been identified with supervised multivariate models that are 
constructed from the TOF-SIMS data of known samples.20,27 For example, two different cell 
lines in a heterogeneous culture have been identified with location specificity by partial least-
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squares discriminant analysis (PLS-DA) of TOF-SIMS data.31 Though this work achieved the 
location-specific identification required for studies of HSC fate decision, the accuracy of 
identifying primary cells that exhibit higher intra-population heterogeneity than laboratory cells 
lines32 with this approach has not been quantitatively assessed.  
Here, we report our efforts to classify individual primary murine HCs according to their 
stage in the B lymphocyte differentiation pathway by multivariate analysis of TOF-SIMS data. 
We focus on identifying three populations of primary HCs that were isolated from murine bone 
marrow via conventional flow cytometry (Fig. 4.1): 1) hematopoietic stem and progenitor cells 
(HSPCs) that do not express lineage antigens (Lin-) but that do express Sca1 and cKit (Lin-Sca-
1+c-Kit+, LSK); 2) common lymphoid progenitors (CLPs, Lin-IL-7Rα+Sca-1medc-Kitmed); and 3) 
mature B cells (B220+IgM+).6,33 These populations represent distinct cell phenotypes during 
lymphopoiesis: uncommitted stem and progenitor cells (HSPCs), lineage specified progenitor 
cells (CLPs), and fully-differentiated cells (B cells). We further investigated use of TOF-SIMS 
data to identify differences between HSPC populations isolated from young and old mice. 
Though isolated using identical sorting criteria, significant age-related differences in HSC 
functionality have been previously reported, making classification approaches that do not rely on 
surface antigen expression especially significant.34-36 The potential for existence of populational 
subfractions with improved HSPC stemness, therefore, motivated study of whether TOF-SIMS 
approaches could segregate HSPCs isolated via identical flow conditions from young and old 
mice.  
Identification of the differentiation stage of individual primary HCs by multivariate 
analysis of TOF-SIMS data is complicated by the high degree of heterogeneity that exists within 
primary cell populations.37,38 Such intra-population heterogeneity can hinder the detection of the 
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differentiation-related spectral features.19,22 We selectively captured the spectral variation 
between, but not within, each cell population, by employing PLS-DA models constructed using 
spectra from HCs of known differentiation status (calibration data set) to accurately identify the 
differentiation state of test HC cells. The lowest error of identification was achieved when the 
intra-population spectral variance that may be caused by auto-specific and age-related 
differences in cell surface chemistry were minimized. This approach may enable identifying cell 
differentiation status and its relationship to location within a colony or engineered 
microenvironment.  
Results 
The Differentiation Status of Primary HCs Isolated from Mouse Bone Marrow Can Be 
Identified by PLS-DA of TOF-SIMS Data 
A PLS-DA model was constructed from a calibration data set consisting of the spectra 
acquired from 15 B cells, 13 CLPs, and 15 HSPCs isolated from five old mice. This PLS-DA 
model was then used to identify the differentiation stage of 15 B cells, 12 CLPs, and 15 HSPCs 
(test data set) also harvested from the same mice. To increase the probability that the 
identification was based on cell surface biomolecules and not contaminants, only the peaks that 
were related to amino acids, phosphocholine, and fatty acids were analyzed (cell-related peak set, 
Table 4.1.22,39 Fig. 4.2A – 4.2C shows the identifications made with the PLS-DA model, where 
the cells that exceeded the classification threshold (red dashed lines in Fig. 4.2A – 4.2C) were 
identified as the indicated population. Table 4.2 lists the sensitivity (the fraction of cells in the 
specified population correctly identified as that population), specificity (the fraction of cells from 
other populations that were correctly identified as not in the specified population) and error 
(average of the false positive and false negative rates) for identifying each HC population. The 
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differentiation stages of the calibration cells were re-identified with high sensitivity and 
specificity, and the errors for identifying the B cells, CLPs, and HSPCs in the calibration set 
were only 0%, 2%, and 10%, respectively. Likewise, the differentiation stages of the cells in the 
test set were also identified with high sensitivity, high selectivity, and low error (3%, 8%, and 
11% identification error for the test B cells, CLPs, and HSPCs, respectively). Thus, the variance 
in the peaks related to amino acids, phosphocholine, and fatty acids in the spectra was 
characteristic of HC populations, and could be exploited to identify the differentiation stage of 
individual HCs. 
The contributions of each mass peak to the spectral variance that identifies the B cells, 
CLPs, and HSPCs are shown in the variable importance in projection (VIP) plots (Fig. 4.2D – 
4.2F). Peaks with VIP scores greater than unity are important towards identifying the indicated 
population.42 For at least two of the three cell types, peaks m/z 53, 55, 86, 130, 148, 166, 184, 
190, 205, 206, 210, and 279 have high VIP scores. Although some of these peaks are related to 
multiple biomolecules, phosphocholine, fatty acids, glutamine, glutamic acid, leucine, and 
tryptophan are likely candidates for the parent molecules because these biomolecules are related 
to two or more of the peaks with high VIP scores. 
Though analysis of only the peaks related to amino acids, phosphocholine, and fatty acids 
increases the probability that the identifications are based on biomolecules and not sample-
specific contaminants, it precludes detecting differentiation-related variations in other cell 
surface components, such as glycans.43,44 Higher sensitivity and specificity of identifying the 
calibration and test cells was achieved when PLS-DA was performed using all of the peaks 
between 50 and 300 m/z that were not related to known contaminants (Table 4.2 and Fig. 4.3). 
However, the resulting model may not be applicable towards identifying the differentiation stage 
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of other cell samples if the peaks with high VIP scores were related to sample-specific 
contaminants, and not cell biomolecules. 
Extent of Intra-Population Variation between HCs from Mice that Differ in Age 
This approach to identifying HC differentiation status would have greater applicability if 
the PLS-DA model could be constructed using the spectra of cells that were harvested from 
different mice as those in the test set. However, primary cells from different mice exhibit auto-
specific and age-related differences in cell surface chemistry.32,34 Though subtle, these 
differences may increase the intra-population spectral variance between the calibration and test 
cells to a level that is detrimental to identifying cell differentiation stage. To investigate whether 
such changes in cell surface chemistry induce detectable spectral variance within each HC 
population, PCA was performed on the spectra of cells that were harvested from two sets of 
C57BL/6 mice that differed in age: 10-month-old (old) and 2- to 4-month-old (young) mice. 
These two age groups were selected because HSCs from mice of these ages exhibit identical 
surface antigen expression but significant functional and epigenetic differences.34-36 Note that the 
intra-population spectral variation detected between these old and young cells is likely larger 
than that exhibited by the cells that are used to study HSC fate decisions (typically < 6 months of 
age).38,45-48  
The B cells from the old and young mice were not separated on the first principal 
component (PC) of the PCA model (Fig. 4.4). This indicates the linear combination of mass 
peaks whose intensities varied the most (26%) within this B cell population was not caused by 
auto-specific or age-related changes in cell chemistry. However, the B cell spectra from the 
young and old mice were separated on PC2 and PC3; the young B cells had positive scores on 
PC2 and PC3, whereas the old B cells had negative scores on PC2 and/or PC3 (Fig. 4.5A). The 
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majority of the peaks with high negative loadings on both PC2 and PC3, and therefore, higher 
normalized intensities in the spectra of the B cells from the old mice, were mainly related to 
lipids (m/z 86, 166, 168, 182, 184, and 224). In contrast, many of the peaks with high positive 
loadings on PC2 and PC3, and higher normalized intensities in the spectra of B cells from the 
young mice, were related to amino acids (m/z 51, 130, 155, 178, 179, 205, 263, and 279). This 
suggests that the B cells from the young mice had a higher ratio of proteins to lipids on their 
surfaces than the B cells from the old mice. 
For the PCA models constructed for the CLPs and HSPCs, the first PCs captured 
approximately half of the spectral variance in the data set and separated the spectra of cells from 
the old and young mice (Fig. 4.5B – 4.5C). Thus, the major source of spectral variation in the 
HSPC and CLP populations could be attributed to age-related and auto-specific differences in 
cell surface chemistry. In both models, the CLPs and HSPCs from the young mice had positive 
scores on PC1 and PC2, whereas the CLPs and HSPCs from the old mice had negative scores on 
PC1 and/or PC2. The peaks with high negative loadings on PC1 and PC2 were mainly related to 
lipids, whereas peaks that were mainly related to amino acids had high positive loadings on these 
two PCs (Fig. 4.5B – 4.5C). Thus, like the B cells, the surfaces of the CLPs and HSPCs from the 
old mice have lower protein to lipid ratios than the surfaces of the CLPs and HSPCs from the 
young mice. 
Effects of Intra-Population Variation between the Calibration and Test Spectra on the 
Identification of HC Differentiation Stage 
We next assessed whether the intra-population spectral variance detected with PCA was 
significant enough to compromise the identification of HC differentiation stage. The spectra of 
30 B cells, 25 CLPs, and 29 HSPCs that were harvested from the old mice were used to construct 
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a PLS-DA model that was used to identify the differentiation stage of the 20 B cells, 20 CLPs, 
and 14 HSPCs in the test data set from the young mice. Self-identification of the old B cells, 
CLPs, and HSPCs in the calibration set was achieved with ≤4% error (Fig. 4.6A – 4.6C), Table 
4.3), demonstrating the variance between the calibration cells was well-captured by the model. 
The peaks with high VIP scores (Fig. 4.6D – 4.6F) were similar to those in Fig. 4.2D – 4.2F. 
Identification of the differentiation stage of the test HCs from the young mice using this model 
was less accurate, as the errors for identifying the test B cells, CLPs, and HSPCs from the young 
mice were 19%, 26% and 11%, respectively (Table 4.3). Thus, auto-specific and age-related 
differences in the calibration and test spectra appeared to compromise the identification of HC 
differentiation stage. 
Finally, we investigated whether use of the complete peak set improved the precision of 
identifying HC differentiation stage. The errors in identifying the calibration cells were ≤6% 
(Table 4.3), respectively, which is similar to that achieved with the cell-related PLS-DA model. 
Inclusion of the mass peaks that were related to unknown biomolecules in the analysis was 
detrimental to identifying the differentiation status of the test cells from the young mice; the 
prediction error rose to 34%, 26%, and 49% for the test B cells, CLPs, and HSPCs, respectively 
(Fig. 4.9 and Table 4.3). Thus, the peaks not related to amino acids, phosphocholine, or fatty 
acids varied significantly between the spectra in the calibration and test sets. Additional work 
towards identifying the parent molecules that produced the unknown peaks with high VIP scores 
is required to determine whether the spectral variation between the calibration and test cells was 
due to contaminant molecules or changes in cell surface chemistry.  
 
 
 136 
 
Conclusion and Outlook 
We have shown that TOF-SIMS data encodes for the differences in the surface chemistry 
of HCs at distinct differentiation states, and this chemical data can be related to differentiation 
stage using PLS-DA. Additionally, differences in cell surface chemistry that may be distinctive 
of individual organisms or aging are also encrypted in the TOF-SIMS data. These auto-specific 
and age-related differences in the surface chemistry of the cells in the calibration and test sets 
induce spectral variance that compromises the identification of HC differentiation stage. 
Consequently, the cells employed to construct the PLS-DA model should be from the same age 
group as the unknown cells in the test set to optimize precision. We expect that the 
differentiation stage of individual HCs in experimental culture systems may be identified with 
less than 10% error if the PLS-DA model is constructed using the spectra of cells that were 
isolated from the same mice as the experimental cells.  
Having demonstrated the feasibility of identifying the differentiation stage of individual 
primary HCs by multivariate analysis of TOF-SIMS data, ongoing work is looking to improve 
our capacity to identify additional HC subpopulations with greater precision. Most significantly, 
the HSPC population used in these analyses contains a mix of stem and progenitor cells with 
differential long-term stem cell potential (Fig. 4.1). Future work will examine significantly more 
rare hematopoietic subpopulations (i.e. LSK CD150+CD244-CD48-)15 that are specifically 
enriched for the most primitive HSCs subpopulations and which show significant age-related 
changes in stemness.48 The identification of the mass peaks associated with glycans and other 
cell surface biomolecules whose abundances vary with differentiation stage or age will facilitate 
these efforts.  
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The multivariate analysis of TOF-SIMS data approach described herein complements 
traditional immunolabeling methods and functional assays used to identify HC differentiation 
stage. We anticipate that multivariate analysis of TOF-SIMS data may also facilitate elucidating 
the biomolecular changes that accompany age-related deficits in HC function.  
Materials and Methods 
Hematopoietic cell isolation and preparation. The hematopoietic subpopulations were isolated 
from the femoral and tibial bone marrow of female C57BL/6 mice (Jackson Labs). Distinct age 
ranges were used for ‘old’ (10 months old) and ‘young’ (2 – 4 months old) mice. Euthanization 
and tissue collection were performed using IACUC approved methods. After isolation, the bones 
were gently crushed with a mortar and pestle, washed with a solution of phosphate buffered 
saline (PBS) + 2% fetal bovine serum (FBS) (PBS/FBS), and filtered with a 40 µm sterile filter 
to isolate whole bone marrow. All subsequent steps were then performed in a PBS/FBS solution 
on ice. Red blood cells were then lysed with ACK lysis buffer (Invitrogen, Carlsbad, CA) and re-
suspended in PBS/FBS with Fc receptor-blocking antibody to reduce non-specific antibody 
binding. Aliquots of the mononuclear bone marrow cell population were then stained with 
distinct antibody cocktails to facilitate identification of the HSPC, CLP, and B cell populations 
using standardized sorting protocols.50,51 HSPCs (Lin- Sca-1+c-Kit+) were identified with a 
cocktail of antibodies: PE-conjugated Sca-1 (1:100), APC-conjugated c-Kit (1:200), a FITC-
conjugated Lineage (Lin) cocktail (CD5, B220, Mac-1, CD8a, Gr-1, Ter-119; 1:200), and a 
propidium iodide (PI) nuclear stain. CLPs (Lin-IL-7Rα+Sca-1medc-Kitmed) were identified with a 
cocktail of antibodies: PE-conjugated Sca-1 (1:200), APC-conjugated c-Kit (1:200), PE-Cy 7-
conjugated IL-7Rα (0.2 mg/mL), a fluorescein isothiocyanate-(FITC)-conjugated Lin cocktail 
(1:200), and a 4',6-diamidino-2-phenylindole (DAPI) nuclear stain. Mature B cells (B220+IgM+) 
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were isolated with a cocktail of antibodies: FITC-conjugated B220 (1:200), eFluor 450-
conjugated IgM (0.2 mg/mL), and a PI nuclear stain. All antibodies were supplied by 
eBioscience (San Diego, CA). Distinct HSPC, CLP, and B-cell populations were then isolated 
using a BD FACS Aria II flow cytometer operated by the BD FACS Diva software. FACS plots 
for HSPCs, CLPs, and B-cells showed populations consistent with previous results in the 
literature.6,7,50-53, Cells were collected on polylysine-coated substrates on ice and were then 
chemically fixed in 4% glutaraldehyde diluted with PBS within 4 hr after collection, followed by 
osmication in 0.4% osmium tetroxide diluted with triple-distilled water and filtered using a 0.22 
μm syringe filter directly prior to use. Cells were rinsed for 20 min in triple distilled water and 
allowed to air dry. To facilitate locating the cells in the TOF-SIMS, optical maps of each sample 
substrate were created with an optical microscope (Leica DM6000 B, Q-Imaging EXi Blue 
Fluorescence Microscope) that was operated in reflectance mode. 
TOF-SIMS. Spectra were acquired with a PHI Trift-III TOF-SIMS (Physical Electronics 
Incorporated, Chanhassen, MN) instrument with a 197Au+ liquid ion gun that was operated at 22 
kV with a total primary ion dose of 3 x 1013 ions/cm2. Positive-ion spectra with a mass range of 0 
to 800 amu were acquired using unbunched mode.  
Data analysis. Multivariate analysis was performed using the PLS Toolbox (v.6.2.1, Eigenvector 
Research, Manson, WA) run in MATLAB (v.7.12.0 R2011a, MathWorks Inc., Natick, MA). 
Unit mass binned spectra of individual cells were extracted from the TOF-SIMS images and 
imported into the PLS toolbox. Outlier spectra that exhibit unusual variation were identified as 
described in the Supplemental Information and Fig. 4.7, and excluded from further analysis. 
PLS-DA Model Construction. PLS-DA was performed on the peaks in the m/z 50 to 300 range. 
This range was selected because ions with m/z < 50 are not chemically specific16 and peaks with 
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m/z > 300 have poor detection reproducibility using our instrumentation.23 Two different peak 
sets were employed: 1) a cell-related peak set consisting of the mass peaks that are known to be 
produced by phosphocholine, fatty acids, and amino acids22 but not common surface 
contaminants (m/z 73, 133, 147, 207, 221, and 281)39 (Table 4.1); and 2) a complete peak set that 
consisted of all mass peaks from m/z 50 to 300 except those related to the aforementioned 
contaminants. Previous studies indicated that the cell-related peak set is applicable to chemically 
fixed biological samples.22,40 Each peak was normalized to the total intensity of the remaining 
peaks in the spectrum and autoscaled to the data set. The PLS-DA model was constructed using 
the minimum number of latent variables (LVs) required to capture at least 80% of the variance in 
the test spectra. Identification plots were generated to determine which cells exceed the 
classification threshold for the indicated class, where the classification threshold was estimated 
using Bayes’ Theorem.41 Variable importance in projection (VIP) score plots that show the 
magnitude that each mass peak contributes to identifying the indicated cell population were also 
generated. See the Supplemental Information and Fig 4.8 for details of the construction of 
specific PLS-DA models.  
Construction of Principal Component Analysis (PCA) Models of each HC Population. Each 
spectrum was filtered so that it consisted of only the cell-related peaks within the m/z 50 to 300 
range, and each peak was normalized to the total intensity of the remaining peaks in the 
spectrum. A data set consisting of the spectra of cells that were harvested from the old and young 
mice was created for each HC population. Each peak in the data set was autoscaled, and a 
separate PCA model was constructed for the B cells, CLPs, and HSPCs. The PCA model 
contained the minimum number of PCs that were required to separate the cells harvested from 
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the young and old mice. Scores plots that show the projection of each sample onto the PCs and 
loading plots that show the contribution of each peak to each PC were generated.  
Identification of outliers in the spectra acquired from the two groups of mice. Spectra that exhibit 
unusual variation that might be caused by sample contamination or high levels of inorganic ions 
that alter the relative intensity of the other mass peaks in the spectra can compromise the 
predicative ability of a multivariate model.19,25 To detect the spectra that exhibited unusual 
variance compared to the rest of the cells that were harvested from the same set of mice, PCA 
was performed on the mass peaks between 1 and 300 m/z in the spectra. The upper mass of 300 
m/z was selected because peaks with m/z > 300 have poor detection reproducibility using our 
instrumentation.23 Each mass peak was normalized to the total intensity of the peaks in the 
spectrum and autoscaled to the spectra in the data set. Two separate PCA models with two 
principal components (PCs) were constructed: one for the cell spectra from the old mice, and 
another for the cell spectra from the young mice. The plot of the Hotelling’s T2 statistic versus 
the Q residual contributions (Fig. 4.7) was used to identify the samples that had a Q statistic 
greater than the 95% confidence limit, which indicates the sample exhibited unusual variance 
that was not captured by the model. For the data set consisting of the cells harvested from the 
five old mice, the spectra from 6 HSPCs, 5 CLPs, and 1 B cell (arrows, Fig 4.7A) were identified 
as outliers. Spectra from 3 HSPCs, 2 CLPs, and 1 B cell (arrows, Fig 4.7B) that were harvested 
from the group of young mice were identified as outliers and excluded from further analysis. 
These outlier spectra were excluded from further analysis.  
PLS-DA Model for Identification of the Differentiation Stage of Hematopoietic Cells Isolated 
from the Same Mice. After removing the outlier spectra, the remaining normalized spectra in the 
old mice data set were divided into two sets that were nearly equal in size: an old mice 
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calibration set consisting of 15, 13, and 15 randomly selected B cells, CLPs, and HSPCs, and an 
old mice test set consisting of spectra from the remaining 15, 12, and 13 B cells, CLPs, and 
HSPCs. Using the cell-related peak set, a preliminary PLS-DA model was constructed and 
refined by excluding the mass peaks with Q contributions above 30% (m/z 90, 91, 110, 111, 122, 
136, 138, 188, 200, 212, 231, and 238) (Fig. 4.8A). The peaks with these high Q residual 
contributions had intensities that varied significantly between cells but were not indicative of 
differentiation status. Using the remaining spectra, a PLS-DA model was constructed that 
consisted of five LVs that captured 61.2% of the variance in the calibration data, and 81.4% of 
the variance in the test spectra. The PLS-DA model was then used to predict the differentiation 
status of the cells in the test set. When this process was repeated using the complete peak set 
described above, a PLS-DA model with 4 LVs that captured 43.1% and 83.4% of the variance in 
the calibration and test spectra, respectively, was constructed and used to predict the 
differentiation status of the cells in the test set.  
PLSDA Model of Spectra from Hematopoietic Cells Isolated from Different Mice. Data 
preprocessing was identical as that described for PLS-DA model construction using data from 
the same mice. The calibration set of data that was used to for this experiment consisted of all the 
(non-outlier) spectra that had been acquired from the five old mice. These data were 
preprocessed using the same procedure as that described for the construction of the other PLS-
DA model. This new calibration set consisted of the spectra from 30 B cells, 25 CLPs, and 29 
HSPCs that were isolated from the five old mice. The preliminary PLSDA model that was 
constructed using the cell-related peaks in the calibration set of spectra from the old mice was 
refined by excluding the mass peaks with Q contributions above 60% (m/z 71, 90, 138, 188, 190, 
194, 196, 200, 212, 231, 240, and 241) (Fig. 4.8B). The refined PLS-DA model consisted of 6 
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LVs that captured 65.9% and 82.3% of the variance in the calibration and test spectra, 
respectively. This model was then used to predict the differentiation status of 20 test B cells, 20 
test CLPs, and 14 test HSPCs that were harvested from the three young mice. This process of 
PLS-DA model construction and testing was repeated using the same spectra for the calibration 
and test set, but the complete peak set (described above) was employed. The PLS-DA model 
constructed using the complete peak set consisted of 4 LVs that captured 39.8% and 81.0% of 
the spectral variance in the calibration and test data sets, respectively. 
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Figures and Tables 
 
 
 
Fig. 4.1 Cellular constituents of HSC-mediated hematopoiesis. The blue, green, and red 
envelopes indicate the cell populations used in this study. The HSPC population (Lin-Scal+cKit+) 
used in our study (blue envelope) contains long-term HSCs (LT-HSCs) capable of sustained 
hematopoietic reconstitution, short-term HSCs (ST-HSCs) capable of limited hematopoietic 
constitution, and multipotent progenitors (MPPs) which retain lymphoid/myeloid lineage 
plasticity. B cell lymphopoiesis is marked by MPP progression to a common lymphoid 
progenitor (CLP, green envelope) cell capable of generating all T lymphocytes, B lymphocytes, 
dendritic cells (DC), and natural killer (NK) cells. B lymphopoiesis further progresses through a 
sequence of defined precursor populations: pre-pro-B cell, pro-B cell, pre-B cell, immature-B 
cell (Im-B), and finally mature B cell (red envelope).6 Additional cell constituents depicted: 
CMP, common myeloid progenitor; MEP, megakaryotic/erythroid progenitor; GMP, 
granulocyte/monocyte progenitor. Image modified from Passegue et al.49 
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Fig. 4.2 Identification plots and VIP score plots for the PLS-DA models constructed using the 
cell-related peaks in the calibration spectra of HCs that were harvested from the same mice as the 
cells in the test set. The cells that exceeded the classification threshold (red dashed line) in the 
prediction plots were identified as (A) B cells, (B) CLPs, and (C) HSPCs. The VIP score plots 
for this model show the importance of each mass peak towards the identification of the (D) B 
cells, (E) CLPs, and (F) HSPCs. Peaks with VIP scores greater than unity are important for 
identifying the indicated population.  
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Fig. 4.3 The (A) B cell, (B) CLP, and (C) HSPC identification plots for the PLS-DA model 
constructed using the complete peak set show the cells that exceed the threshold (red dashed 
line) for identification as the indicated cell type. The VIP plots for the (D) B cells, (E) CLPs, and 
(F) HSPCs show that many peaks from unknown sources were important towards identifying the 
indicated population (purple peaks). 
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Fig. 4.4 (A) PC score plot shows that PC1 captured the largest percentage of spectral variation in 
the B cell spectra, but did not separate the B cell spectra according to the age of the mice that the 
cells were harvested from. The elliptical region that is outlined with the dashed blue line 
represents the 95% confidence limit of the PC model. (B) The loadings plot shows the 
contribution of each peak to the variation captured by each PC. 
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Fig. 4.5 PC score and loadings plots were constructed using the spectra from the B cells (A), 
CLPs (B), and HSPCs (C) that were harvested from the old and young mice. The region within 
the dashed blue line on each score plot represents the border for the 95% confidence limit of the 
entire PC model. The loading plots for each cell type show the extent that each mass peak 
contributed to the variance captured by the indicated PC.  
 
 
 
 
 
 
 
 
 
 151 
 
 
Fig. 4.6 The differentiation stages of HCs harvested from young mice were identified using a 
PLS-DA model that was created using the cell-related peaks in a calibration set of spectra from 
HCs harvested from old mice. The cells that exceeded the threshold (red dashed line) were 
identified as (A) B cells, (B) CLPs, and (C) HSPCs. The VIP score plots show the importance of 
each mass peak towards the identification of the (D) B cells, (E) CLPs, and (F) HSPCs.  
 
 
 
 
 
 
 
 
 
 
 
 
 152 
 
 
 
Fig. 4.7 Identification of outlier spectra from cells harvested from the old (A) and young (B) 
mice. Using the spectra acquired for each group of cells, a PC model with two principal 
components was constructed using the mass peaks in the 1 – 300 m/z range. Outlier samples 
exhibited spectral variation that was not captured by the PCA model. The outlier spectra 
(indicated with black arrows) have Q residual values that are greater than the 95% confidence 
interval (horizontal dashed line). These samples were removed from the data set and excluded 
from further analysis. 
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Fig. 4.8 Plots show the contributions of the peaks in the cell-related peak set to the overall Q 
residual and Hotelling’s T2 statistic in the preliminary PLS-DA models. Peaks with high Q 
residual contributions and low Hotelling’s T2 contributions vary in a manner that is not related to 
HC differentiation status. (A) The preliminary PLS-DA model that was used to test the 
differentiation status of cells that were harvested from the same aged mice as the calibration set 
was refined by excluding the mass peaks with Q contributions above 30% (red). (B) The 
preliminary PLS-DA model that was used to test the differentiation status of cells that were 
harvested from young mice was refined by excluding the mass peaks with Q contributions above 
60% (red).  
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Fig. 4.9 The (G) B cell, (H) CLP, and (I) HSPC identification plots for the PLS-DA model that 
was constructed using the complete peak set show that the inclusion of the peaks from unknown 
sources was detrimental to identifying each cell population. The VIP plots for the (J) B cells, (K) 
CLPs, and (L) HSPCs shows that many of the peaks that were important towards identifying the 
cells in each population were not included in the cell-related peak set (purple peaks). The parent 
molecules that produced these fragments are not known. 
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Fig. 4.10 The (A) B cell, (B) CLP, and (C) HSPC identification plots for the PLS-DA model 
constructed using the complete peak set show the cells that exceed the threshold (red dashed 
line) for identification as the indicated cell type. The VIP plots for the (D) B cells, (E) CLPs, and 
(F) HSPCs show that many peaks from unknown sources were important towards identifying the 
indicated population (purple peaks). 
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Fig. 4.11 (A) PC score plot shows that PC1 captured the largest percentage of spectral variation 
in the B cell spectra, but did not separate the B cell spectra according to the age of the mice that 
the cells were harvested from. The elliptical region that is outlined with the dashed blue line 
represents the 95% confidence limit of the PC model. (B) The loadings plot shows the 
contribution of each peak to the variation captured by each PC. 
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Table 4.1 List of the mass peaks in the cell-specific peak set and the biomolecules that are 
related to these peaks.16,22 Peaks that are produced by common surface contaminants were 
omitted.39  
Mass 
(m/z) Related Biomolecule 
Mass 
(m/z) 
 
Related Biomolecule 
51 phenylalanine 103 phenylalanine 
53 lipid (C4H5+) 104 lipid fragment (C5H14NO+), lysine 
54 lipid fragment (13C12C3H5+) 106 serine 
55 lipid fragment (C4H7
+), arginine, lysine, 
cysteine, valine, leucine, histidine 107 tyrosine 
56 lipid fragment (C3H6N
+), lysine, methionine, 
glutamine, asparagine, threonine, isoleucine 110 histidine 
57 
lipid fragment (C4H9+), valine, serine, alanine, 
arginine, cysteine, aspartic acid, leucine, 
threonine, glycine 
111 lipid fragment (C8H15+) 
58 lipid fragment (C3H8N+), isoleucine 112 alanine 
59 lipid fragment (13C12C2H8N+), arginine, valine 116 serine, tyrosine, threonine, proline 
60 lipid fragment (C3H10N+), serine 117 tryptophan, proline 
61 methionine 122 cysteine 
67 lipid fragment (C5H7+) 123 tyrosine 
68 lipid fragment (C4H6N+), proline 128 serine 
69 lipid fragment (C5H9
+), isoleucine, histidine, 
lysine 130 glutamine, tryptophan, glutamic acid 
70 lipid fragment (C4H8N
+), proline, leucine, 
glutamic acid, asparagine, arginine 132 isoleucine, leucine 
71 lipid fragment (C5H11+) 133 asparagine 
72 lipid fragment (C4H10N+), valine 134 alanine, aspartic acid 
74 lipid fragment (C4H12N+) threonine 136 tyrosine 
76 cysteine, glycine 138 proline 
77 phenylalanine 143 tryptophan 
81 lipid fragment (C6H9+), alanine 146 lipid fragment (C5H9NPO2+) 
82 lipid fragment (C5H8N+), histidine 148 lipid fragment (C5H11NPO2+), glutamic acid 
83 lipid fragment (C6H11+) 150 lipid fragment (C5H13NPO2+), methionine 
84 lipid fragment (C5H10N
+), lysine, glutamine, 
glutamic acid 155 asparagine, aspartic acid 
85 lipid fragment (C6H13+) 156 histidine 
86 lipid fragment (C5H12N+), isoleucine, leucine 159 tryptophan 
87 asparagine 165 tyrosine 
88 lipid fragment (C5H14N+), aspartic acid 166 
lipid fragment (C5H13NPO3+), methionine, 
phenylalanine 
90 alanine 168 lipid fragment (C5H15NPO3+) 
91 lipid fragment (C7H7
+), serine, phenylalanine, 
methionine 175 arginine, glutamic acid 
93 lipid fragment (C7H9+) 177 asparagine 
95 lipid fragment (C7H11+), histidine 178 glycine 
97 lipid fragment (C7H13+) 179 alanine 
98 lipid fragment (C5H8NO+), glycine 182 lipid fragment (C5H13NPO4+), tyrosine 
100 lipid fragment (C5H10NO+) 184 lipid fragment (C5H15NPO4+) 
101 glutamine 188 tryptophan 
102 lipid fragment (C5H12NO+), glutamic acid 190 lipid fragment (C7H13NPO3+) 
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Table 4.1 (cont) List of the mass peaks in the cell-specific peak set and the biomolecules that are 
related to these peaks.16,22 Peaks that are produced by common surface contaminants were 
omitted.39 
Mass 
(m/z) Related Biomolecule 
Mass 
(m/z) 
 
Related Biomolecule 
194 lipid fragment (C7H17NPO3+) 235 valine 
200 Glycine 238 lipid fragment (C8H17NPO5+) 
196 lipid fragment (C6H15NPO4+) 239 threonine 
198 lipid fragment (C6H17NPO4+) 240 lipid fragment (C8H19NPO5+) 
205 tryptophan 241 cysteine 
206 lipid fragment (C5H14NPO4Na+) 246 
lipid fragment (C8H18NPO4Na+ or 
C8H18NPO5Li+) 
210 lipid fragment (C7H17NPO4+) 252 lipid fragment (C8H15NPO6+) 
212 lipid fragment (C7H19NPO4+) 254 lipid fragment (C8H17NPO6+) 
219 aspartic acid, cysteine 256 lipid fragment (C8H19NPO6+) 
224 lipid fragment (C7H15NPO5+) 263 isoleucine, leucine 
226 lipid fragment (C7H17NPO5+) 279 aspartic acid, glutamine 
231 proline 282 lipid fragment (C9H17NPO7+) 
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Table 4.2 The sensitivity, specificity, and class error of differentiation stage identification made 
with the PLS-DA model constructed using the cell-specific peak set and the complete peak set. 
 Cell-Specific Peak Set Complete Peak Set 
 B Cells CLPs HSPCs B Cells CLPs HSPCs 
Sensitivity of Identification of 
Calibration Samples 
1.0 1.0 0.87 1.0 0.92 1.0 
Specificity of Identification of 
Calibration Samples 
1.0 0.97 0.93 1.0 1.0 0.85 
Sensitivity of Identification of 
Test Samples  
0.93 0.83 1.0 1.0 0.92 1.0 
Specificity of Identification of 
Test Samples 
1.0 1.0 0.78 1.0 1.0 0.85 
Class Error of Identification of 
Calibration Samples 
0 0.02 0.10 0 0 0.02 
Class Error of Identification of 
Test Samples 
0.03 0.08 0.11 0 0.04 0.07 
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Table 4.3 The sensitivity, specificity, and class error of identification of the differentiation stage 
of HCs harvested from old (calibration set) and young (test set) mice determined for the PLS-DA 
models constructed using the cell-specific peak set and the complete peak set.  
 Cell-Specific Peak Set Complete Peak Set 
 B Cells CLPs HSPCs B Cells CLPs HSPCs 
Sensitivity of Identification of 
Calibration Samples 
1.0 1.0 0.97 0.93 1.0 0.93 
Specificity of Identification of 
Calibration Samples 
0.98 0.97 0.96 0.96 0.98 0.95 
Sensitivity of Identification of 
Test Samples  
0.65 0.95 0.86 0.35 1.0 0.14 
Specificity of Identification of 
Test Samples 
0.97 0.53 0.93 0.97 0.47 0.88 
Class Error of Identification of 
Calibration Samples 
0.01 0.02 0.04 0.05 0.01 0.06 
Class Error of Identification of 
Test Samples 
0.19 0.26 0.11 0.34 0.26 0.49 
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CHAPTER 5. 
DISTINGUISHING CELLS BASED ON THE AMOUNT OF MEMBRANE-EXPRESSED 
SIALIC ACID USING MULTIVARIATE ANALYSIS OF TIME OF FLIGHT-
SECONDARY ION MASS SPECTROMETRY DATA 
Introduction 
There exist few reliable methods for distinguishing cells that are similar in origin and 
differ only in subtle variations in the expression levels of biomolecules expressed in the 
membrane. Sorting distinct cell populations such as those from related tissues, from a single 
differentiation pathway, or transfected from untransfected cells is typically accomplished using 
fluorescent antibody labeling against only two or three proteins that vary the most between 
different cells.1 There is substantial subjectivity and a non-negligible error rate in identifying 
related cell types this way, particularly if the cells are adhered to substrates and not sorted using 
flow cytometry.  
Glycans have been largely underutilized as way to profile cells. Found predominantly 
expressed in the plasma membrane in eukaryotes, glycans are polysaccharides that can take 
linear or branched forms and can be homo- or hetero-polymers of sugar residues. They 
frequently form glycoconjugates with proteins and lipids and can substantially modulate the 
biological activity of these biomolecules as they relate to functions such as signaling, binding, 
and assembly.2 The polymeric nature of glycans allows for immense diversity of structures based 
on only a few monomers, and profiling glycans has been found to be useful for identifying 
disease states.3,4 However, developing a method for profiling glycans chemically poses a 
challenge because these biomolecules are composed of so few component monomers, which are 
in turn composed of a limited number of atoms.  
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As an alternative to antibody labeling, time-of-flight secondary ion mass spectrometry 
(TOF-SIMS) can be used to characterize cell type1,5,6,7 with a focus on glycans that richly encode 
information about cell type or disease state. TOF-SIMS analysis samples all biomolecules on the 
cell surface, including proteins and lipids as well as glycans, creating a far more complex set of 
data from each cell than what can be obtained from the expression level of two or three proteins 
as is the case in antibody labeling. Moreover, TOF-SIMS can be performed on adherent cells, 
dispensing with the necessity of detaching them from the context of their substrate. This is 
particularly advantageous on substrates with location-specific properties, enabling researchers to 
observe which substrate properties attract or encourage certain cell types over others.8,9 
However, this method requires that cells be preserved and dehydrated, so it is compatible only 
with cells that are not needed for further experiments. 
To most effectively extract the data contained in TOF-SIMS spectra to identify cell types, 
multivariate analysis (MVA) can be used to reduce the complexity of the data and identify the 
peaks most useful for determining cell type.5,10 As discussed in Chapter 1, one type of MVA 
called partial least squares discriminant analysis (PLS-DA) constructs a linear regression model 
of an original data set by identifying the observable and predictable variables common to 
members of that data set, and projecting the new, linear combinations onto a new space. In 
practice, PLS-DA can be used to construct a model guided by a training set of known samples. 
This model is then applied to unknown samples in order to classify them.11 When PLS-DA is 
applied to TOF-SIMS data, the new predictable variables are combinations of peaks and their 
relative intensities. The new predictable variables are characteristic of each cell type even if the 
individual secondary ions are not characteristic of a single sample because they are too small to 
be useful for molecule identification. Because PLS-DA requires use of a set of known samples, it 
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is a supervised technique. This is in contrast to the unsupervised MVA approach principal 
component analysis (PCA), which can be used to determine differences among samples (i.e., 
mass spectra) without requiring a training set or any information about the classes. PCA 
identifies the commonalities among the data points and creates a new set of variables, called 
principal components (PCs), which are linear combinations of the original variables. This 
method separates the samples based on the most salient differences that it identifies without any 
given information about the definitions of the populations. It can be employed to identify the 
most important peaks for identifying the different sample types. 
To test whether MVA techniques can be used to separate different glycosylation patterns 
in TOF-SIMS spectra, NIH-3T3 murine fibroblast cells with varying amounts of sialic acid (SA) 
and GM1, a SA-containing ganglioside present in the membrane of mammalian cells, were 
analyzed using TOF-SIMS and separated using PCA and PLS-DA. GM1 is a well-characterized 
membrane biomolecule that has a terminal sialic acid (SA) residue and has implications for 
neuronal plasticity and bacterial infection. The amount of SA in the membrane was altered by 
either culturing the cells in the presence of excess GM1 to increase its membrane abundance, or 
by incubating the cells with an enzyme, neuraminidase, which cleaves the terminal SA residue of 
all glycans, including that of GM1. Control, SA-enriched (SA+), and SA-depleted (SA-) cells 
were compared in this experiment. 
Results and Discussion 
NIH-3T3 cells can be Differentiated Based on the Amount of SA in the Membrane 
Twelve of each of the three sample types, control cells, SA+, and SA- were analyzed by 
TOF-SIMS, and resulting spectral data were used to build the statistical models. First, a PCA 
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model was constructed to allow the identification of samples exhibiting unusual variance as well 
as the peaks that most contribute to sample identification, and to assess whether the sample types 
would separate from one another. All thirty-six samples were used to construct the PCA model 
and a complete peak set from m/z 1 to 300 excluding known contaminant peaks 7, 23, 27, 28, 29, 
39, 41, 73, 147, 207, 221, and 281. Four PCs were selected, capturing 92.94% of the variance. 
Based on Q values (unusual degree of variance not captured by the model) and Hotelling’s T2 
values (unusual degree of variance within the model), four of the thirty-six samples were 
excluded: two control, one SA+, and one SA- cell. Two remaining samples exhibited Q values 
that exceeded the threshold, but the values were much smaller than for those samples already 
excluded, and neither separated drastically from the remaining samples so they were retained 
within the model.  
The scores plot of PC1 versus PC2 is shown in Fig. 5.1. All three sample types overlap 
significantly, indicating that the PCA model is unable to effectively separate them. However, the 
three sample types are not completely mixed, and there is some grouping of sample types 
together. The control samples lie generally in between the SA+ and the SA- samples, which 
would be expected if the model were separating based on the amount of SA on the sample 
surface. Fig. 5.2 shows the loadings plot for the PCA model, indicating which peaks were 
important for separation on PC1, which captured over 40% of the variance among the samples. 
Peaks at m/z 58, 59, 86, and 184 have the highest positive loadings, while peaks at m/z 55, 67, 69 
and 81 have the highest negative loadings.  
To confirm whether any of these peaks arise from SA, a pure sample of SA was analyzed 
with TOF-SIMS, and the resulting spectrum is shown in Fig. 5.3. The most prominent secondary 
are 29, 30, 41, 43, 55, 57, 60, 102, 130, 274, and 292. The only peak that appears in both the 
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loadings plot for the PCA model and in the list of significant secondary ion peaks for SA is that 
at m/z 55, which indicates that the PCA model is not relying on SA-specific peaks to separate the 
samples. 
Having determined the best samples to include, a PLS-DA model was then constructed 
using the sample set excluding the four samples with unusual variance and the complete peak set 
excluding contaminants (see above), selecting 5 LVs that captured 94.7% of the variance. Fig. 
5.2 shows the identification plots of (A) control, (B) SA+, and (C) SA- cells. The model 
accurately predicts the identity of the SA+ and SA- samples, with no false positives or false 
negatives. However, the model less accurately predicts the identity of the control samples, as two 
SA- cells were misclassified as control samples (false positives). Fig. 5.5 shows the associated 
variable importance in the projection (VIP) plots for (A) control, (B) SA+, and (C) SA- cells, 
indicating which peaks contributed most to the classifications. The peaks at m/z 42, 58, 69, and 
86 are significant for all three sample types, and the peak at m/z 184 is well above unity in the 
VIP plots for control and SA- samples. 
Notably, similar to the PCA model, none of the ions that the PLS-DA model relied upon 
most heavily to make predictions about the three sample types match prominent ions in the TOF-
SIMS spectrum of SA (Fig 5.3). This is surprising because the samples differed according to the 
amount of sialic acid present in the plasma membrane, and other biomolecules should have been 
comparable in abundance among all three sample types. The peaks at m/z 58 and 86, which 
loaded highly in the VIP plots, are relatively minor peaks in the SA spectrum. The most 
prominent secondary ion peak for SA is at m/z 43, which has high loadings for identifying the 
control samples but not the other two sample types. 
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To fully understand the basis on which the model is separating and predicting the 
samples, more cell samples need to be prepared and analyzed to determine which peaks 
consistently have high loadings in the VIP plots. It is unknown why the PLS-DA model is able to 
separate the three sample types with relatively good accuracy when the only difference among 
the three types should be the amount of SA, but the model appears to be minimally utilizing 
peaks specific to SA to make the distinctions. Potentially, a significant amount of the low 
molecular fragments, which stem from hydrocarbons or nitrogen-containing hydrocarbon 
secondary ions, could be originating from SA, and the model is relying upon these ions even 
though they are common to several types of biomolecules. Another possibility is that there was 
sample-specific surface contamination on one or all samples, or that differences other than in the 
abundance of surface SA arose from the different treatments the cells received, possibly related 
to different buffers, exposure to enzyme, or fixation procedures, and that the PLS-DA model 
separated the samples based on these SA-unrelated differences. 
A different choice of cell line may prove advantageous to the optimization of this 
experiment. For example, metastatic cell lines have been shown to express more SA,12 so 
repeating this experiment with a cell line derived from a metastatic tumor (of which there are 
many) may produce better results. The further development of this experiment will elucidate 
whether TOF-SIMS in conjunction with MVA can be used to profile membrane-expressed 
glycans on cells for the purpose of identifying cell type and/or disease state in single cells. 
Materials and Methods 
Materials. GM1 was purchased from Avanti Polar Lipids. Neuraminidase from the organism 
Clostridium perfringens (C. welchii) was purchased from Sigma-Aldrich. Standard growth 
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medium, high glucose Dulbecco’s modification of Eagle’s medium (DMEM), was purchased 
through the University of Illinois Cell Media Facility, supplemented with 10% calf serum 
purchased from Hyclone. Culture dishes and other cell culturing materials were obtained from 
Sarstedt. Silicon substrates were purchased from Ted Pella. Poly-L-lysine and glutaraldehyde 
were purchased from Electron Microscopy Sciences. 
Preparation of Cell Samples. SA-enriched cells: NIH-3T3 murine fibroblast cells were cultured 
in DMEM supplemented with 20 μM GM1 in 35 × 10 mm culture dishes. Three poly-L-lysine-
coated 5 mm × 5 mm silicon substrates were included in the dish. The cells were grown 
overnight, then fixed in 4% glutaraldehyde (GA) for 30 min, rinsed, and air dried. SA-depleted 
cells: NIH-3T3 cells were grown overnight on three poly-L-lysine-coated 5 mm × 5 mm silicon 
substrates. Samples were chemically fixed in 4% GA for 30 min at room temp, then incubated in 
700 μL of 250 mU of neuraminidase at 37°C overnight. Cells were rinsed and then air dried. 
Control cells: NIH-3T3 cells were grown overnight on three poly-L-lysine-coated 5 mm × 5 mm 
silicon substrates. Samples were chemically fixed in 4% GA for 30 min, rinsed, and air dried. 
TOF-SIMS analysis. Cell samples were analyzed the day after fixation to avoid any potential 
degradation. Spectra of individual cells were acquired using a PHI Trift-III TOF-SIMS (Physical 
Electronics Incorporated, Chanhassen, MN) equipped with a 197 Au+ liquid ion gun operated at 
22 kV with a total primary ion dose of 3 × 1013 ions/cm2 and a beam current of 5 nA. The raster 
scan size was 80 μm. Positive ion spectra in unbunched mode with a mass range of 0 to 800 amu 
were acquired. 
Data analysis. MVA was performed using the PLS Toolbox (v.6.2.1, Eigenvector Research, 
Manson, WA) run in MATLAB (v.7.12.0 R2011a, MathWorks Inc., Natick, MA). Unit mass 
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binned spectra of individual cells were extracted from TOF-SIMS images using WinCadence and 
imported into the PLS toolbox. The PLS-DA model was constructed using the peaks in the m/z 
1-300 range. Each peak was normalized to the total intensity of the other peaks in the spectrum 
and mean-centered to the data set. Samples were divided randomly and evenly into a training set 
used to build the model and a prediction set to test the accuracy of the model. Identification plots 
were generated to determine the cells that exceeded the classification threshold for each sample 
type, using Bayes’ Theorem to estimate the threshold.13  
Notes and Acknowledgements: JFF performed all of the work described in this chapter. 
Portions of this work were carried out in the Frederick Seitz Materials Research Laboratory 
Central Facilities, Univ. of Illinois, which is partially supported by the U.S. Department of 
Energy (DOE) under grants DEFG02- 07ER46453 and DE-FG02-07ER46471.  
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Figures 
 
 
Fig. 5.1 Scores plot from PCA analysis of control, SA+, and SA- cells. Ellipses in solid lines and 
in dashed lines indicate the border at the 95% confidence limit for each group and the whole 
model, respectively. The PCA model was constructed using a complete peak set including all 
m/z peaks 1-300 except 7, 23, 27, 28, 29, 39, 41, 73, 147, 207, 221, and 281, and selecting four 
PCs, which captured 92.94% of the variance. The data was normalized and mean centered. 
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Fig 5.2 Loadings plot for the PCA model, showing which peaks with high positive and negative 
loadings (above and below the axis, respectively) and were utilized most significantly by the 
PCA model to separate the samples on PC1, which captured over 40% of the variance.  
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Fig. 5.3 TOF-SIMS spectrum of pure SA. Peaks prominent in this spectrum represent major 
secondary ions produced by SA that are potentially important for classifying cell samples based 
on the amount of SA expressed on the plasma membrane. 
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Fig. 5.4 Identification plots for the PLS-DA model constructed using a complete peak set 
including all m/z peaks 1-300 except 7, 23, 27, 28, 29, 39, 41, 73, 147, 207, 221, and 281, and 
the calibrated spectra of NIH-3T3 cells. The cells above the red dashed lined marking the 
classification threshold were identified as (A) control cells, (B) SA+ cells, and (C) SA- cells. 
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Fig. 5.5 The VIP score plots for the PLS-
DA model constructed using a complete 
peak set including all m/z peaks 1-300 
except 7, 23, 27, 28, 29, 39, 41, 73, 147, 
207, 221, and 281, indicating the 
importance of each mass peak in the 
course of identifying the (A) control 
cells, (B) SA+ cells, and (C) SA- cells. 
Peaks with VIP scores greater than unity 
are important for identifying the 
indicated population. 
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CHAPTER 6. 
CONCLUSIONS AND FUTURE OBJECTIVES 
 The body of work described in Chapters 2 and 3 demonstrate that high resolution imaging 
secondary ion mass spectrometry (SIMS) is a suitable technique for probing the membrane 
organization of intact cells with a resolution better than 100 nm. This enables the 
characterization of features in mammalian cell membranes that have heretofore eluded direct 
chemical analysis though they have been studied for decades. The feature receiving particular 
attention is lipid rafts, which have been strictly defined as small membrane domains co-enriched 
with sphingolipids and cholesterol. The distributions of sphingolipids and cholesterol were 
determined using high resolution SIMS, and the results do not support the existence of lipid rafts, 
as defined as cholesterol- and sphingolipid-enriched membrane domains.1  
The distribution of sphingolipids in the membranes of murine fibroblast cells was found 
to be heterogeneous, forming domains with an average diameter of 200 nm that tended to cluster 
together into one-to-two micron-sized patches. This organization was sensitive to cholesterol 
depletion, which disrupted the long range organization of patches, but did not disturb the short 
range order. These results largely confirm the current understanding of membrane 
microdomains. 
However, the cholesterol distribution determined using high resolution SIMS is contrary 
to that described by the lipid raft hypothesis. Instead of observing cholesterol co-localized with 
sphingolipids within domains, cholesterol is distributed relatively homogeneously, and there is 
no statistically significant enrichment of cholesterol within the sphingolipid-enriched domains. 
Depletion of cholesterol using methyl-beta-cyclodextrin showed that cholesterol was not 
removed from selective locations in the membrane, as had been hypothesized. As this finding 
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about cholesterol distribution in the membrane is at odds with a significant portion of the 
literature published regarding membrane organization, it will likely be met with skepticism that 
will, ideally, inspire a thorough evaluation of this aspect of membrane organization. The 
conclusions presented here should help settle the “lipid raft” controversy.2 Further inquiry may 
reveal a more nuanced understanding of cell membrane biology. 
It will also be of great interest to apply this methodology of isotope labeling and high 
resolution SIMs analysis to other cell types and to cells grown under various conditions. The 
time-intensive nature of the analysis limits the ability of a single researcher to analyze many cells 
in their entirety, but if this work is extended over time and to several researchers, a considerable 
pool of data can be generated that will reveal trends and commonalities that may not be apparent 
in the small numbers of cells analyzed here. Rather than a snapshot of the membranes of a 
handful of murine fibroblast cells, this approach can more fully illuminate the nature of 
mammalian cell membranes in general as well as answer questions about cell functions such as 
transport, cell motility, and infection. 
Also presented in Chapters 4 and 5 are promising proof-of-concept experiments that 
demonstrate the capability of differentiating closely-related cells based on multivariate analysis 
(MVA) of time-of-flight (TOF) SIMS. The standard technique for separating a mixture of cells is 
antibody labeling of cell type-specific protein markers and sorting using fluorescence activated 
cell sorting (FACS). TOF-SIMS is an excellent complementary technique for situations where 
cells do not have to be recovered, it is detrimental to remove the cells from their substrate 
(location information is important), and/or where cells are difficult to distinguish based on the 
expression of two or three proteins. TOF-SIMS samples all of the biomolecules presented on the 
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surface of the cells, providing significantly more information about the membrane than can be 
gleaned from antibody labeling. 
Applying MVA to the data acquired through TOF-SIMS analysis makes use of all the 
data collected, even if the fragmented ions in the spectrum are too small to be useful for 
identifying the parent biomolecule or their origin is unknown. Both supervised and unsupervised 
techniques, such as partial least squares discriminant analysis (PLS-DA) and principle 
component analysis (PCA), respectively, can be used to classify unknown samples with a high 
degree of accuracy. These methods were effective at correctly identifying “unknown” samples in 
both sample sets assayed. One sample set was comprised of three types of primary stem cells 
within a single differentiation pathway. Primary cells are notorious for having significantly 
greater cell-to-cell variation than exists in cultured cells, and it was not certain that this approach 
would be able to identify the commonalities among cells in the same differentiation state. 
However, the results are quite promising even for this challenging sample set.  
In contrast, the second set of samples was comprised of cells from the same line that were 
treated to change the expression level of a single biomolecule, sialic acid, and it was uncertain 
that the technique would be capable of differentiation cells based on such a small difference. 
More work is needed to flesh out the boundaries and determine the reliability of this 
methodology, and more experiments should be done to confirm the results presented here as well 
as to investigate how accurately the identity of samples with other types of small changes can be 
determined (such as varying protein or lipid expression). However, the success of this 
preliminary study is encouraging, and taken together, the TOF-SIMS/MVA analysis presented 
here provides an impetus to develop the method further for applications such as tissue 
engineering and the generation of scaffolds that promote certain types of cells to grow.  
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